{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "7f6a1aaa",
   "metadata": {
    "pycharm": {
     "name": "#%% md\n"
    }
   },
   "source": [
    "# MIT (TA1): From Paper and Code to annotated extraction\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8f6cdd8b",
   "metadata": {
    "pycharm": {
     "name": "#%% md\n"
    }
   },
   "source": [
    "## 0. Preprocessing"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "d07d53d5",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2023-10-31T20:46:33.318025Z",
     "iopub.status.busy": "2023-10-31T20:46:33.317685Z",
     "iopub.status.idle": "2023-10-31T20:46:33.371256Z",
     "shell.execute_reply": "2023-10-31T20:46:33.370929Z"
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [],
   "source": [
    "import requests, os\n",
    "GPT_KEY = os.environ.get('OPENAI_API_KEY')\n",
    "API_ROOT = \"http://localhost:8000/\""
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d382c8c7",
   "metadata": {
    "pycharm": {
     "name": "#%% md\n"
    }
   },
   "source": [
    "## 1. MIT annotation end to end pipeline"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7fe51f05",
   "metadata": {
    "pycharm": {
     "name": "#%% md\n"
    }
   },
   "source": [
    "#### We bring every annotation step together: for the original paper text, let's integrate all the extraction modules and output the MIT extraction:\n",
    "[http://3.83.68.208/#/Paper-2-annotated-vars/upload_file_annotate_annotation_upload_file_extract__post](http://3.83.68.208/#/Paper-2-annotated-vars/upload_file_annotate_annotation_upload_file_extract__post)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "0ab278fe",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2023-10-31T20:46:33.372971Z",
     "iopub.status.busy": "2023-10-31T20:46:33.372877Z",
     "iopub.status.idle": "2023-10-31T20:46:33.807061Z",
     "shell.execute_reply": "2023-10-31T20:46:33.806749Z"
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\"attributes\":[{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit0\"},\"mentions\":[{\"id\":{\"id\":\"mit0\"},\"name\":\"ame\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit0\"},\"description\":\"description\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit0\"},\"description\":\"description\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"mit0-value\"},\"value\":{\"amount\":\"numerical value\",\"grounding\":null,\"extraction_source\":null},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"groundings\":[{\"grounding_text\":\"description\",\"grounding_id\":\"dc:description\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"\",\"grounding_id\":\"fbbt:00045003\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit1\"},\"mentions\":[{\"id\":{\"id\":\"mit1\"},\"name\":\"---\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit1\"},\"description\":\"---\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit1\"},\"description\":\"---\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"mit1-value\"},\"value\":{\"amount\":\"---\",\"grounding\":null,\"extraction_source\":null},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"groundings\":[{\"grounding_text\":\"purely intentional entity\",\"grounding_id\":\"apollosv:00000000\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Bat coronavirus (BtCoV/A910/2005)\",\"grounding_id\":\"ncbitaxon:389159\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit2\"},\"mentions\":[{\"id\":{\"id\":\"mit2\"},\"name\":\"SARS-CoV-2\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit2\"},\"description\":\"Severe Acute Respiratory Syndrome Coronavirus 2\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"N gene of severe acute respiratory syndrome coronavirus 2\",\"grounding_id\":\"ogg:3043740575\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"S gene of severe acute respiratory syndrome coronavirus 2\",\"grounding_id\":\"ogg:3043740568\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit3\"},\"mentions\":[{\"id\":{\"id\":\"mit3\"},\"name\":\"VOC\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit3\"},\"description\":\"Variants of Concern\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Dermatoglyphic variants\",\"grounding_id\":\"hp:0005882\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"EEG with constitutional variants\",\"grounding_id\":\"hp:0011176\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit4\"},\"mentions\":[{\"id\":{\"id\":\"mit4\"},\"name\":\"NPI\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit4\"},\"description\":\"Non-pharmaceutical interventions\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"non-pharmaceutical interventions\",\"grounding_id\":\"cemo:non-pharmaceutical_interventions\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Pharmaceutical Preparations\",\"grounding_id\":\"ndfrt:N0000000001\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit5\"},\"mentions\":[{\"id\":{\"id\":\"mit5\"},\"name\":\"Alpha/B1.1.17 variant\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit5\"},\"description\":\"Variant of SARS-CoV-2\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"SARS-CoV-2 Alpha variant\",\"grounding_id\":\"cido:0000371\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"SARS-CoV-2 Kappa variant\",\"grounding_id\":\"cido:0000383\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit6\"},\"mentions\":[{\"id\":{\"id\":\"mit6\"},\"name\":\"Delta/B.1.617 variant\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit6\"},\"description\":\"Variant of SARS-CoV-2\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"SII B.1.617.2\",\"grounding_id\":\"vo:0005335\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"SARS-CoV-2 Alpha variant\",\"grounding_id\":\"cido:0000371\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit7\"},\"mentions\":[{\"id\":{\"id\":\"mit7\"},\"name\":\"vaccine breakthrough\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit7\"},\"description\":\"Infection with SARS-CoV-2 despite vaccination\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"SARS-COV-2 Infection\",\"grounding_id\":\"idocovid19:0001287\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Post-vaccination rotavirus infection\",\"grounding_id\":\"hp:0020091\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit8\"},\"mentions\":[{\"id\":{\"id\":\"mit8\"},\"name\":\"vaccine types\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit8\"},\"description\":\"Different types of COVID-19 vaccines\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"COVID-19 subunit vaccine\",\"grounding_id\":\"vo:0005202\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"COVID-19 DNA vaccine\",\"grounding_id\":\"vo:0005203\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit9\"},\"mentions\":[{\"id\":{\"id\":\"mit9\"},\"name\":\"wild type\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit9\"},\"description\":\"Original strain of SARS-CoV-2\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"wild type haemoglobin\",\"grounding_id\":\"idomal:0001234\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"+/+\",\"grounding_id\":\"miro:00000032\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit10\"},\"mentions\":[{\"id\":{\"id\":\"mit10\"},\"name\":\"asymptomatic infections\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit10\"},\"description\":\"Infections without symptoms\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Recurrent infections\",\"grounding_id\":\"hp:0002719\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Recurrent skin infections\",\"grounding_id\":\"hp:0001581\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit11\"},\"mentions\":[{\"id\":{\"id\":\"mit11\"},\"name\":\"symptomatic infections\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit11\"},\"description\":\"Infections with symptoms\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Recurrent infections\",\"grounding_id\":\"hp:0002719\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Recurrent skin infections\",\"grounding_id\":\"hp:0001581\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit12\"},\"mentions\":[{\"id\":{\"id\":\"mit12\"},\"name\":\"vaccine rollout\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit12\"},\"description\":\"Distribution and administration of vaccines\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"distribution\",\"grounding_id\":\"cemo:distribution\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"influenza vaccines\",\"grounding_id\":\"vo:0003495\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit13\"},\"mentions\":[{\"id\":{\"id\":\"mit13\"},\"name\":\"booster vaccine\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit13\"},\"description\":\"Additional dose of vaccine to enhance immunity\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Booster\",\"grounding_id\":\"ncit:C28320\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"vaccine dose\",\"grounding_id\":\"vo:0000595\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit14\"},\"mentions\":[{\"id\":{\"id\":\"mit14\"},\"name\":\"N501Y mutation\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit14\"},\"description\":\"Mutation in SARS-CoV-2 spike protein\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"S-N501Y\",\"grounding_id\":\"cido:0000277\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"SARS Subunit Spike Protein Vaccine\",\"grounding_id\":\"vo:0011486\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit15\"},\"mentions\":[{\"id\":{\"id\":\"mit15\"},\"name\":\"E484K mutation\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit15\"},\"description\":\"Mutation in SARS-CoV-2 spike protein\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"SARS Subunit Spike Protein Vaccine\",\"grounding_id\":\"vo:0011486\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"E484K in SARS-CoV-2 S protein\",\"grounding_id\":\"cido:0000668\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit16\"},\"mentions\":[{\"id\":{\"id\":\"mit16\"},\"name\":\"transmissibility\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit16\"},\"description\":\"Ability of a virus to spread between individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"SARS-CoV-2 transmissibility\",\"grounding_id\":\"idocovid19:0001279\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"spread\",\"grounding_id\":\"probonto:k0000049\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit17\"},\"mentions\":[{\"id\":{\"id\":\"mit17\"},\"name\":\"COVID-19\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit17\"},\"description\":\"Coronavirus disease 2019\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Severe acute respiratory syndrome coronavirus 2\",\"grounding_id\":\"ncbitaxon:2697049\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"COVID-19\",\"grounding_id\":\"idocovid19:0001141\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit18\"},\"mentions\":[{\"id\":{\"id\":\"mit18\"},\"name\":\"infection rate (β)\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit18\"},\"description\":\"Rate at which the virus spreads\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"rate\",\"grounding_id\":\"probonto:k0000603\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Response Rate\",\"grounding_id\":\"ncit:C94502\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit19\"},\"mentions\":[{\"id\":{\"id\":\"mit19\"},\"name\":\"recovery rate (Ɣ)\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit19\"},\"description\":\"\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"AE recovery rate\",\"grounding_id\":\"oae:0001869\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"incomplete AE recovery\",\"grounding_id\":\"oae:0001873\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit20\"},\"mentions\":[{\"id\":{\"id\":\"mit20\"},\"name\":\"βW\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit20\"},\"description\":\"virus infectivity of the wild-type strain\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"SARS-CoV-2 infectivity\",\"grounding_id\":\"idocovid19:0001284\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"wild type haemoglobin\",\"grounding_id\":\"idomal:0001234\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit21\"},\"mentions\":[{\"id\":{\"id\":\"mit21\"},\"name\":\"βV\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit21\"},\"description\":\"vaccine escape rate\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Ventricular escape rhythm\",\"grounding_id\":\"hp:0005155\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"rate\",\"grounding_id\":\"probonto:k0000603\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit22\"},\"mentions\":[{\"id\":{\"id\":\"mit22\"},\"name\":\"ω1\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit22\"},\"description\":\"vaccination rate\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit22\"},\"description\":\"vaccination rate for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"vaccination rate\",\"grounding_id\":\"askemo:0000012\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"secondary vaccination\",\"grounding_id\":\"vo:0000903\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit23\"},\"mentions\":[{\"id\":{\"id\":\"mit23\"},\"name\":\"ω2\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit23\"},\"description\":\"dosing interval\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit23\"},\"description\":\"dosing interval for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"generation interval\",\"grounding_id\":\"cemo:generation_interval\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"confidence interval\",\"grounding_id\":\"stato:0000196\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit24\"},\"mentions\":[{\"id\":{\"id\":\"mit24\"},\"name\":\"ηR\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit24\"},\"description\":\"rate of loss of immunity due to infection\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit24\"},\"description\":\"rate of transition from recovered class to SVR\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"acquired immunity to malaria\",\"grounding_id\":\"idomal:0000543\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"rate\",\"grounding_id\":\"probonto:k0000603\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit25\"},\"mentions\":[{\"id\":{\"id\":\"mit25\"},\"name\":\"βX R\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit25\"},\"description\":\"rate of infection of individuals with partial immunity from having recovered from a different variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Recovered Rate\",\"grounding_id\":\"ncit:C173781\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit26\"},\"mentions\":[{\"id\":{\"id\":\"mit26\"},\"name\":\"σX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit26\"},\"description\":\"ratio of asymptomatic versus symptomatic infections\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit26\"},\"description\":\"ratio of asymptomatic versus symptomatic infections for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"asymptomatic host\",\"grounding_id\":\"apollosv:00000236\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"epstein-barr virus infection AE\",\"grounding_id\":\"oae:0007029\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit27\"},\"mentions\":[{\"id\":{\"id\":\"mit27\"},\"name\":\"αX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit27\"},\"description\":\"degree of increased infectivity β (due to mobility) of asymptomatic infected individuals compared to symptomatic ones\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"SARS-CoV-2 infectivity\",\"grounding_id\":\"idocovid19:0001284\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"asymptomatic human female infected by SARS-CoV-2\",\"grounding_id\":\"cido:0000297\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit28\"},\"mentions\":[{\"id\":{\"id\":\"mit28\"},\"name\":\"γX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit28\"},\"description\":\"disease recovery rate\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit28\"},\"description\":\"disease recovery rate for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"AE recovery rate\",\"grounding_id\":\"oae:0001869\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"incomplete AE recovery\",\"grounding_id\":\"oae:0001873\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit29\"},\"mentions\":[{\"id\":{\"id\":\"mit29\"},\"name\":\"λ\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit29\"},\"description\":\"NPI stringency\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit29\"},\"description\":\"NPI stringency for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"importin subunit alpha-5 (human)\",\"grounding_id\":\"pr:P52294\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"National Provider Identifier\",\"grounding_id\":\"opmi:0000503\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit30\"},\"mentions\":[{\"id\":{\"id\":\"mit30\"},\"name\":\"μI\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit30\"},\"description\":\"mortality rate of infected individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit30\"},\"description\":\"mortality rate of infected individuals for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"stato:0000414\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"neonatal mortality rate\",\"grounding_id\":\"sdgio:00020030\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit31\"},\"mentions\":[{\"id\":{\"id\":\"mit31\"},\"name\":\"βX V\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit31\"},\"description\":\"vaccine escape rate for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Ventricular escape rhythm\",\"grounding_id\":\"hp:0005155\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Disease-specific Survival Rate\",\"grounding_id\":\"ncit:C94504\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit32\"},\"mentions\":[{\"id\":{\"id\":\"mit32\"},\"name\":\"βX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit32\"},\"description\":\"virus infectivity of a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit32\"},\"description\":\"infection rate for unvaccinated individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"SARS-CoV-2 infectivity\",\"grounding_id\":\"idocovid19:0001284\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"specific host infectivity\",\"grounding_id\":\"vsmo:0000144\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit33\"},\"mentions\":[{\"id\":{\"id\":\"mit33\"},\"name\":\"μ\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit33\"},\"description\":\"natural death rate\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Death by Natural Cause\",\"grounding_id\":\"ncit:C82465\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"rate\",\"grounding_id\":\"probonto:k0000603\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit34\"},\"mentions\":[{\"id\":{\"id\":\"mit34\"},\"name\":\"VM\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit34\"},\"description\":\"rate of reduced infection for vaccinated individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"vaccinated with a licensed vaccine\",\"grounding_id\":\"vo:0001378\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"vaccinated\",\"grounding_id\":\"vo:0001376\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit35\"},\"mentions\":[{\"id\":{\"id\":\"mit35\"},\"name\":\"V\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit35\"},\"description\":\"vaccine type (either V1 or V2)\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"ViroKey SARS-CoV-2 RT-PCR Test v2.0\",\"grounding_id\":\"cido:0020325\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"KimForest SARS-CoV-2 Detection Kit v1\",\"grounding_id\":\"cido:0020179\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[{\"id\":{\"id\":\"8-1\"},\"name\":\"location_key\",\"dataset\":{\"id\":{\"id\":\"8\"},\"name\":\"usa-vaccinations.csv\",\"metadata\":\"https://github.com/DARPA-ASKEM/program-milestones/blob/main/6-month-milestone/evaluation/scenario_3/ta_1/google-health-data/usa-vaccinations.csv\"}}]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit36\"},\"mentions\":[{\"id\":{\"id\":\"mit36\"},\"name\":\"M\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit36\"},\"description\":\"vaccine type (either V1 or V2)\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"ViroKey SARS-CoV-2 RT-PCR Test v2.0\",\"grounding_id\":\"cido:0020325\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"KimForest SARS-CoV-2 Detection Kit v1\",\"grounding_id\":\"cido:0020179\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[{\"id\":{\"id\":\"8-1\"},\"name\":\"location_key\",\"dataset\":{\"id\":{\"id\":\"8\"},\"name\":\"usa-vaccinations.csv\",\"metadata\":\"https://github.com/DARPA-ASKEM/program-milestones/blob/main/6-month-milestone/evaluation/scenario_3/ta_1/google-health-data/usa-vaccinations.csv\"}}]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit37\"},\"mentions\":[{\"id\":{\"id\":\"mit37\"},\"name\":\"AX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit37\"},\"description\":\"class for asymptomatic infections of vaccinated and unvaccinated individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"unvaccinated with a licensed vaccine\",\"grounding_id\":\"vo:0001379\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"unvaccinated organism\",\"grounding_id\":\"vo:0001383\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit38\"},\"mentions\":[{\"id\":{\"id\":\"mit38\"},\"name\":\"IXV\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit38\"},\"description\":\"class for symptomatic infections of vaccinated individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"vaccinated with a licensed vaccine\",\"grounding_id\":\"vo:0001378\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"vaccinated\",\"grounding_id\":\"vo:0001376\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit39\"},\"mentions\":[{\"id\":{\"id\":\"mit39\"},\"name\":\"μXV\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit39\"},\"description\":\"mortality rate for symptomatic infections of vaccinated individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"stato:0000414\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"neonatal mortality rate\",\"grounding_id\":\"sdgio:00020030\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit40\"},\"mentions\":[{\"id\":{\"id\":\"mit40\"},\"name\":\"dIXV\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit40\"},\"description\":\"change in the number of symptomatic infections of vaccinated individuals over time\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"vaccinated in route\",\"grounding_id\":\"vo:0000547\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"vaccinated with a licensed vaccine\",\"grounding_id\":\"vo:0001378\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit41\"},\"mentions\":[{\"id\":{\"id\":\"mit41\"},\"name\":\"dt\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit41\"},\"description\":\"change in time\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"\",\"grounding_id\":\"fbbt:00000624\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"DT Polio Adsorbed\",\"grounding_id\":\"vo:0010709\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit42\"},\"mentions\":[{\"id\":{\"id\":\"mit42\"},\"name\":\"total\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit42\"},\"description\":\"total number of individuals in a specific class\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"protein total increased AE\",\"grounding_id\":\"oae:0001658\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"protein total decreased AE\",\"grounding_id\":\"oae:0001659\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit43\"},\"mentions\":[{\"id\":{\"id\":\"mit43\"},\"name\":\"W\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit43\"},\"description\":\"class for recovered individuals with immunity to the variant they were infected with\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Susceptible-Infected-Resistant model\",\"grounding_id\":\"apollosv:00000549\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit44\"},\"mentions\":[{\"id\":{\"id\":\"mit44\"},\"name\":\"A\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit44\"},\"description\":\"class for recovered individuals with partial immunity to a different variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit45\"},\"mentions\":[{\"id\":{\"id\":\"mit45\"},\"name\":\"D\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit45\"},\"description\":\"class for recovered individuals with partial immunity to a different variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit46\"},\"mentions\":[{\"id\":{\"id\":\"mit46\"},\"name\":\"PZ\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit46\"},\"description\":\"class for recovered individuals with immunity to all three viruses\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit47\"},\"mentions\":[{\"id\":{\"id\":\"mit47\"},\"name\":\"AZ\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit47\"},\"description\":\"class for recovered individuals with immunity to all three viruses\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit48\"},\"mentions\":[{\"id\":{\"id\":\"mit48\"},\"name\":\"γ\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit48\"},\"description\":\"rate of recovery for infected individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"recovery rate\",\"grounding_id\":\"askemo:0000013\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"AE recovery rate\",\"grounding_id\":\"oae:0001869\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit49\"},\"mentions\":[{\"id\":{\"id\":\"mit49\"},\"name\":\"dAX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit49\"},\"description\":\"change in the number of asymptomatic infections over time\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"relative change in new infections\",\"grounding_id\":\"cemo:relative_change_in_new_infections\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"epstein-barr virus infection AE\",\"grounding_id\":\"oae:0007029\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit50\"},\"mentions\":[{\"id\":{\"id\":\"mit50\"},\"name\":\"S\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit50\"},\"description\":\"susceptible population\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"susceptible population\",\"grounding_id\":\"apollosv:00000234\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"count of susceptible population\",\"grounding_id\":\"apollosv:00000087\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit51\"},\"mentions\":[{\"id\":{\"id\":\"mit51\"},\"name\":\"SVR\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit51\"},\"description\":\"class for recovered individuals with partial immunity\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit52\"},\"mentions\":[{\"id\":{\"id\":\"mit52\"},\"name\":\"RY\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit52\"},\"description\":\"class for recovered individuals with immunity to a different variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit53\"},\"mentions\":[{\"id\":{\"id\":\"mit53\"},\"name\":\"RF\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit53\"},\"description\":\"class for recovered individuals with immunity to all three viruses\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit54\"},\"mentions\":[{\"id\":{\"id\":\"mit54\"},\"name\":\"dRF\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit54\"},\"description\":\"change in the number of individuals in RF class over time\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Class\",\"grounding_id\":\"rdfs:Class\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Class\",\"grounding_id\":\"owl:Class\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit55\"},\"mentions\":[{\"id\":{\"id\":\"mit55\"},\"name\":\"dRX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit55\"},\"description\":\"change in the number of individuals in RX class over time\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"Class\",\"grounding_id\":\"owl:Class\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Class\",\"grounding_id\":\"rdfs:Class\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"mit56\"},\"mentions\":[{\"id\":{\"id\":\"mit56\"},\"name\":\"IY\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit56\"},\"description\":\"infected individuals of a different variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":null,\"groundings\":[{\"grounding_text\":\"human infected by SARS-CoV-2\",\"grounding_id\":\"cido:0000292\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"transmission coefficient\",\"grounding_id\":\"apollosv:00000191\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[]}},{\"type\":\"document_collection\",\"amr_element_id\":null,\"payload\":{\"documents\":[{\"id\":{\"id\":\"1\"},\"source_file\":\"44b9158cad9a3098e5272cf906ef88a2__filename\",\"doi\":\"\"}]}}]}\n"
     ]
    }
   ],
   "source": [
    "scenario_2_paper = \"text_s41598-022-06159-x.txt\"\n",
    "with open(scenario_2_paper, 'rb') as f:\n",
    "    files = {'file': ('filename', f)}\n",
    "    params = {\"gpt_key\": GPT_KEY}\n",
    "    response = requests.post(API_ROOT + \"annotation/upload_file_extract\",  params=params,  files=files)\n",
    "    assert response.status_code == 200, response.text\n",
    "    json_str = response.text\n",
    "print(json_str)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "7a295411",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2023-10-31T20:46:33.808815Z",
     "iopub.status.busy": "2023-10-31T20:46:33.808706Z",
     "iopub.status.idle": "2023-10-31T20:46:33.875576Z",
     "shell.execute_reply": "2023-10-31T20:46:33.875289Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "                <iframe\n",
       "                    id=\"jsonviewer_RtyeqVFL\">\n",
       "                </iframe>\n",
       "                <script>\n",
       "                    function init (){\n",
       "                        console.log('within iframe script')\n",
       "\n",
       "                        document.getElementById(\"jsonviewer_RtyeqVFL\").onload = () => {\n",
       "                            console.log('loaded iframe')\n",
       "                            let iframe = document.getElementById(\"jsonviewer_RtyeqVFL\")\n",
       "                            var iframeWindow = document.getElementById(\"jsonviewer_RtyeqVFL\").contentWindow;\n",
       "                            iframe.style.width = \"100%\";\n",
       "                            iframe.style.height = \"630px\";\n",
       "                            let data = {\"json_str\": \"{\\n  \\\"attributes\\\": [\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit0\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit0\\\"\\n            },\\n            \\\"name\\\": \\\"ame\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit0\\\"\\n            },\\n            \\\"description\\\": \\\"description\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit0\\\"\\n            },\\n            \\\"description\\\": \\\"description\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit0-value\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"numerical value\\\",\\n              \\\"grounding\\\": null,\\n              \\\"extraction_source\\\": null\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"description\\\",\\n            \\\"grounding_id\\\": \\\"dc:description\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"\\\",\\n            \\\"grounding_id\\\": \\\"fbbt:00045003\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit1\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit1\\\"\\n            },\\n            \\\"name\\\": \\\"---\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit1\\\"\\n            },\\n            \\\"description\\\": \\\"---\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit1\\\"\\n            },\\n            \\\"description\\\": \\\"---\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit1-value\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"---\\\",\\n              \\\"grounding\\\": null,\\n              \\\"extraction_source\\\": null\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"purely intentional entity\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000000\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Bat coronavirus (BtCoV/A910/2005)\\\",\\n            \\\"grounding_id\\\": \\\"ncbitaxon:389159\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit2\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit2\\\"\\n            },\\n            \\\"name\\\": \\\"SARS-CoV-2\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit2\\\"\\n            },\\n            \\\"description\\\": \\\"Severe Acute Respiratory Syndrome Coronavirus 2\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"N gene of severe acute respiratory syndrome coronavirus 2\\\",\\n            \\\"grounding_id\\\": \\\"ogg:3043740575\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"S gene of severe acute respiratory syndrome coronavirus 2\\\",\\n            \\\"grounding_id\\\": \\\"ogg:3043740568\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit3\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit3\\\"\\n            },\\n            \\\"name\\\": \\\"VOC\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit3\\\"\\n            },\\n            \\\"description\\\": \\\"Variants of Concern\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Dermatoglyphic variants\\\",\\n            \\\"grounding_id\\\": \\\"hp:0005882\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"EEG with constitutional variants\\\",\\n            \\\"grounding_id\\\": \\\"hp:0011176\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit4\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit4\\\"\\n            },\\n            \\\"name\\\": \\\"NPI\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit4\\\"\\n            },\\n            \\\"description\\\": \\\"Non-pharmaceutical interventions\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"non-pharmaceutical interventions\\\",\\n            \\\"grounding_id\\\": \\\"cemo:non-pharmaceutical_interventions\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Pharmaceutical Preparations\\\",\\n            \\\"grounding_id\\\": \\\"ndfrt:N0000000001\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit5\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit5\\\"\\n            },\\n            \\\"name\\\": \\\"Alpha/B1.1.17 variant\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit5\\\"\\n            },\\n            \\\"description\\\": \\\"Variant of SARS-CoV-2\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 Alpha variant\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000371\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 Kappa variant\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000383\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit6\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit6\\\"\\n            },\\n            \\\"name\\\": \\\"Delta/B.1.617 variant\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit6\\\"\\n            },\\n            \\\"description\\\": \\\"Variant of SARS-CoV-2\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SII B.1.617.2\\\",\\n            \\\"grounding_id\\\": \\\"vo:0005335\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 Alpha variant\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000371\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit7\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit7\\\"\\n            },\\n            \\\"name\\\": \\\"vaccine breakthrough\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit7\\\"\\n            },\\n            \\\"description\\\": \\\"Infection with SARS-CoV-2 despite vaccination\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-COV-2 Infection\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001287\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Post-vaccination rotavirus infection\\\",\\n            \\\"grounding_id\\\": \\\"hp:0020091\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit8\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit8\\\"\\n            },\\n            \\\"name\\\": \\\"vaccine types\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit8\\\"\\n            },\\n            \\\"description\\\": \\\"Different types of COVID-19 vaccines\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"COVID-19 subunit vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0005202\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"COVID-19 DNA vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0005203\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit9\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit9\\\"\\n            },\\n            \\\"name\\\": \\\"wild type\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit9\\\"\\n            },\\n            \\\"description\\\": \\\"Original strain of SARS-CoV-2\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"wild type haemoglobin\\\",\\n            \\\"grounding_id\\\": \\\"idomal:0001234\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"+/+\\\",\\n            \\\"grounding_id\\\": \\\"miro:00000032\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit10\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit10\\\"\\n            },\\n            \\\"name\\\": \\\"asymptomatic infections\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit10\\\"\\n            },\\n            \\\"description\\\": \\\"Infections without symptoms\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recurrent infections\\\",\\n            \\\"grounding_id\\\": \\\"hp:0002719\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Recurrent skin infections\\\",\\n            \\\"grounding_id\\\": \\\"hp:0001581\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit11\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit11\\\"\\n            },\\n            \\\"name\\\": \\\"symptomatic infections\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit11\\\"\\n            },\\n            \\\"description\\\": \\\"Infections with symptoms\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recurrent infections\\\",\\n            \\\"grounding_id\\\": \\\"hp:0002719\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Recurrent skin infections\\\",\\n            \\\"grounding_id\\\": \\\"hp:0001581\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit12\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit12\\\"\\n            },\\n            \\\"name\\\": \\\"vaccine rollout\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit12\\\"\\n            },\\n            \\\"description\\\": \\\"Distribution and administration of vaccines\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"distribution\\\",\\n            \\\"grounding_id\\\": \\\"cemo:distribution\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"influenza vaccines\\\",\\n            \\\"grounding_id\\\": \\\"vo:0003495\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit13\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit13\\\"\\n            },\\n            \\\"name\\\": \\\"booster vaccine\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit13\\\"\\n            },\\n            \\\"description\\\": \\\"Additional dose of vaccine to enhance immunity\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Booster\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C28320\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"vaccine dose\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000595\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit14\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit14\\\"\\n            },\\n            \\\"name\\\": \\\"N501Y mutation\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit14\\\"\\n            },\\n            \\\"description\\\": \\\"Mutation in SARS-CoV-2 spike protein\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"S-N501Y\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000277\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"SARS Subunit Spike Protein Vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0011486\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit15\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit15\\\"\\n            },\\n            \\\"name\\\": \\\"E484K mutation\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit15\\\"\\n            },\\n            \\\"description\\\": \\\"Mutation in SARS-CoV-2 spike protein\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS Subunit Spike Protein Vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0011486\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"E484K in SARS-CoV-2 S protein\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000668\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit16\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit16\\\"\\n            },\\n            \\\"name\\\": \\\"transmissibility\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit16\\\"\\n            },\\n            \\\"description\\\": \\\"Ability of a virus to spread between individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 transmissibility\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001279\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"spread\\\",\\n            \\\"grounding_id\\\": \\\"probonto:k0000049\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit17\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit17\\\"\\n            },\\n            \\\"name\\\": \\\"COVID-19\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit17\\\"\\n            },\\n            \\\"description\\\": \\\"Coronavirus disease 2019\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Severe acute respiratory syndrome coronavirus 2\\\",\\n            \\\"grounding_id\\\": \\\"ncbitaxon:2697049\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"COVID-19\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001141\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit18\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit18\\\"\\n            },\\n            \\\"name\\\": \\\"infection rate (\\\\u03b2)\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit18\\\"\\n            },\\n            \\\"description\\\": \\\"Rate at which the virus spreads\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"rate\\\",\\n            \\\"grounding_id\\\": \\\"probonto:k0000603\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Response Rate\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C94502\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit19\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit19\\\"\\n            },\\n            \\\"name\\\": \\\"recovery rate (\\\\u0194)\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit19\\\"\\n            },\\n            \\\"description\\\": \\\"\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"AE recovery rate\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001869\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"incomplete AE recovery\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001873\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit20\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit20\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b2W\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit20\\\"\\n            },\\n            \\\"description\\\": \\\"virus infectivity of the wild-type strain\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 infectivity\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001284\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"wild type haemoglobin\\\",\\n            \\\"grounding_id\\\": \\\"idomal:0001234\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit21\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit21\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b2V\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit21\\\"\\n            },\\n            \\\"description\\\": \\\"vaccine escape rate\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Ventricular escape rhythm\\\",\\n            \\\"grounding_id\\\": \\\"hp:0005155\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"rate\\\",\\n            \\\"grounding_id\\\": \\\"probonto:k0000603\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit22\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit22\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03c91\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit22\\\"\\n            },\\n            \\\"description\\\": \\\"vaccination rate\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit22\\\"\\n            },\\n            \\\"description\\\": \\\"vaccination rate for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"vaccination rate\\\",\\n            \\\"grounding_id\\\": \\\"askemo:0000012\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"secondary vaccination\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000903\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit23\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit23\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03c92\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit23\\\"\\n            },\\n            \\\"description\\\": \\\"dosing interval\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit23\\\"\\n            },\\n            \\\"description\\\": \\\"dosing interval for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"generation interval\\\",\\n            \\\"grounding_id\\\": \\\"cemo:generation_interval\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"confidence interval\\\",\\n            \\\"grounding_id\\\": \\\"stato:0000196\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit24\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit24\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b7R\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit24\\\"\\n            },\\n            \\\"description\\\": \\\"rate of loss of immunity due to infection\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit24\\\"\\n            },\\n            \\\"description\\\": \\\"rate of transition from recovered class to SVR\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"acquired immunity to malaria\\\",\\n            \\\"grounding_id\\\": \\\"idomal:0000543\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"rate\\\",\\n            \\\"grounding_id\\\": \\\"probonto:k0000603\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit25\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit25\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b2X R\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit25\\\"\\n            },\\n            \\\"description\\\": \\\"rate of infection of individuals with partial immunity from having recovered from a different variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered Rate\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C173781\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit26\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit26\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03c3X\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit26\\\"\\n            },\\n            \\\"description\\\": \\\"ratio of asymptomatic versus symptomatic infections\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit26\\\"\\n            },\\n            \\\"description\\\": \\\"ratio of asymptomatic versus symptomatic infections for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"asymptomatic host\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000236\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"epstein-barr virus infection AE\\\",\\n            \\\"grounding_id\\\": \\\"oae:0007029\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit27\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit27\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b1X\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit27\\\"\\n            },\\n            \\\"description\\\": \\\"degree of increased infectivity \\\\u03b2 (due to mobility) of asymptomatic infected individuals compared to symptomatic ones\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 infectivity\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001284\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"asymptomatic human female infected by SARS-CoV-2\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000297\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit28\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit28\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b3X\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit28\\\"\\n            },\\n            \\\"description\\\": \\\"disease recovery rate\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit28\\\"\\n            },\\n            \\\"description\\\": \\\"disease recovery rate for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"AE recovery rate\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001869\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"incomplete AE recovery\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001873\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit29\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit29\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03bb\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit29\\\"\\n            },\\n            \\\"description\\\": \\\"NPI stringency\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit29\\\"\\n            },\\n            \\\"description\\\": \\\"NPI stringency for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"importin subunit alpha-5 (human)\\\",\\n            \\\"grounding_id\\\": \\\"pr:P52294\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"National Provider Identifier\\\",\\n            \\\"grounding_id\\\": \\\"opmi:0000503\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit30\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit30\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03bcI\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit30\\\"\\n            },\\n            \\\"description\\\": \\\"mortality rate of infected individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit30\\\"\\n            },\\n            \\\"description\\\": \\\"mortality rate of infected individuals for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"mortality rate\\\",\\n            \\\"grounding_id\\\": \\\"stato:0000414\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"neonatal mortality rate\\\",\\n            \\\"grounding_id\\\": \\\"sdgio:00020030\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit31\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit31\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b2X V\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit31\\\"\\n            },\\n            \\\"description\\\": \\\"vaccine escape rate for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Ventricular escape rhythm\\\",\\n            \\\"grounding_id\\\": \\\"hp:0005155\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Disease-specific Survival Rate\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C94504\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit32\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit32\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b2X\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit32\\\"\\n            },\\n            \\\"description\\\": \\\"virus infectivity of a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit32\\\"\\n            },\\n            \\\"description\\\": \\\"infection rate for unvaccinated individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 infectivity\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001284\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"specific host infectivity\\\",\\n            \\\"grounding_id\\\": \\\"vsmo:0000144\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit33\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit33\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03bc\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit33\\\"\\n            },\\n            \\\"description\\\": \\\"natural death rate\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Death by Natural Cause\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C82465\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"rate\\\",\\n            \\\"grounding_id\\\": \\\"probonto:k0000603\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit34\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit34\\\"\\n            },\\n            \\\"name\\\": \\\"VM\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit34\\\"\\n            },\\n            \\\"description\\\": \\\"rate of reduced infection for vaccinated individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated with a licensed vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001378\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001376\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit35\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit35\\\"\\n            },\\n            \\\"name\\\": \\\"V\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit35\\\"\\n            },\\n            \\\"description\\\": \\\"vaccine type (either V1 or V2)\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"ViroKey SARS-CoV-2 RT-PCR Test v2.0\\\",\\n            \\\"grounding_id\\\": \\\"cido:0020325\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"KimForest SARS-CoV-2 Detection Kit v1\\\",\\n            \\\"grounding_id\\\": \\\"cido:0020179\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"8-1\\\"\\n            },\\n            \\\"name\\\": \\\"location_key\\\",\\n            \\\"dataset\\\": {\\n              \\\"id\\\": {\\n                \\\"id\\\": \\\"8\\\"\\n              },\\n              \\\"name\\\": \\\"usa-vaccinations.csv\\\",\\n              \\\"metadata\\\": \\\"https://github.com/DARPA-ASKEM/program-milestones/blob/main/6-month-milestone/evaluation/scenario_3/ta_1/google-health-data/usa-vaccinations.csv\\\"\\n            }\\n          }\\n        ]\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit36\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit36\\\"\\n            },\\n            \\\"name\\\": \\\"M\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit36\\\"\\n            },\\n            \\\"description\\\": \\\"vaccine type (either V1 or V2)\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"ViroKey SARS-CoV-2 RT-PCR Test v2.0\\\",\\n            \\\"grounding_id\\\": \\\"cido:0020325\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"KimForest SARS-CoV-2 Detection Kit v1\\\",\\n            \\\"grounding_id\\\": \\\"cido:0020179\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"8-1\\\"\\n            },\\n            \\\"name\\\": \\\"location_key\\\",\\n            \\\"dataset\\\": {\\n              \\\"id\\\": {\\n                \\\"id\\\": \\\"8\\\"\\n              },\\n              \\\"name\\\": \\\"usa-vaccinations.csv\\\",\\n              \\\"metadata\\\": \\\"https://github.com/DARPA-ASKEM/program-milestones/blob/main/6-month-milestone/evaluation/scenario_3/ta_1/google-health-data/usa-vaccinations.csv\\\"\\n            }\\n          }\\n        ]\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit37\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit37\\\"\\n            },\\n            \\\"name\\\": \\\"AX\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit37\\\"\\n            },\\n            \\\"description\\\": \\\"class for asymptomatic infections of vaccinated and unvaccinated individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"unvaccinated with a licensed vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001379\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"unvaccinated organism\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001383\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit38\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit38\\\"\\n            },\\n            \\\"name\\\": \\\"IXV\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit38\\\"\\n            },\\n            \\\"description\\\": \\\"class for symptomatic infections of vaccinated individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated with a licensed vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001378\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001376\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit39\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit39\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03bcXV\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit39\\\"\\n            },\\n            \\\"description\\\": \\\"mortality rate for symptomatic infections of vaccinated individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"mortality rate\\\",\\n            \\\"grounding_id\\\": \\\"stato:0000414\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"neonatal mortality rate\\\",\\n            \\\"grounding_id\\\": \\\"sdgio:00020030\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit40\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit40\\\"\\n            },\\n            \\\"name\\\": \\\"dIXV\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit40\\\"\\n            },\\n            \\\"description\\\": \\\"change in the number of symptomatic infections of vaccinated individuals over time\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated in route\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000547\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated with a licensed vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001378\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit41\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit41\\\"\\n            },\\n            \\\"name\\\": \\\"dt\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit41\\\"\\n            },\\n            \\\"description\\\": \\\"change in time\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"\\\",\\n            \\\"grounding_id\\\": \\\"fbbt:00000624\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"DT Polio Adsorbed\\\",\\n            \\\"grounding_id\\\": \\\"vo:0010709\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit42\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit42\\\"\\n            },\\n            \\\"name\\\": \\\"total\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit42\\\"\\n            },\\n            \\\"description\\\": \\\"total number of individuals in a specific class\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"protein total increased AE\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001658\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"protein total decreased AE\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001659\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit43\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit43\\\"\\n            },\\n            \\\"name\\\": \\\"W\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit43\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with immunity to the variant they were infected with\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Susceptible-Infected-Resistant model\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000549\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit44\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit44\\\"\\n            },\\n            \\\"name\\\": \\\"A\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit44\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with partial immunity to a different variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit45\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit45\\\"\\n            },\\n            \\\"name\\\": \\\"D\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit45\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with partial immunity to a different variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit46\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit46\\\"\\n            },\\n            \\\"name\\\": \\\"PZ\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit46\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with immunity to all three viruses\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit47\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit47\\\"\\n            },\\n            \\\"name\\\": \\\"AZ\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit47\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with immunity to all three viruses\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit48\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit48\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b3\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit48\\\"\\n            },\\n            \\\"description\\\": \\\"rate of recovery for infected individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"recovery rate\\\",\\n            \\\"grounding_id\\\": \\\"askemo:0000013\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"AE recovery rate\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001869\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit49\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit49\\\"\\n            },\\n            \\\"name\\\": \\\"dAX\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit49\\\"\\n            },\\n            \\\"description\\\": \\\"change in the number of asymptomatic infections over time\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"relative change in new infections\\\",\\n            \\\"grounding_id\\\": \\\"cemo:relative_change_in_new_infections\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"epstein-barr virus infection AE\\\",\\n            \\\"grounding_id\\\": \\\"oae:0007029\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit50\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit50\\\"\\n            },\\n            \\\"name\\\": \\\"S\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit50\\\"\\n            },\\n            \\\"description\\\": \\\"susceptible population\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"susceptible population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000234\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"count of susceptible population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000087\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit51\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit51\\\"\\n            },\\n            \\\"name\\\": \\\"SVR\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit51\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with partial immunity\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit52\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit52\\\"\\n            },\\n            \\\"name\\\": \\\"RY\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit52\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with immunity to a different variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit53\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit53\\\"\\n            },\\n            \\\"name\\\": \\\"RF\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit53\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with immunity to all three viruses\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit54\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit54\\\"\\n            },\\n            \\\"name\\\": \\\"dRF\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit54\\\"\\n            },\\n            \\\"description\\\": \\\"change in the number of individuals in RF class over time\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Class\\\",\\n            \\\"grounding_id\\\": \\\"rdfs:Class\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Class\\\",\\n            \\\"grounding_id\\\": \\\"owl:Class\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit55\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit55\\\"\\n            },\\n            \\\"name\\\": \\\"dRX\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit55\\\"\\n            },\\n            \\\"description\\\": \\\"change in the number of individuals in RX class over time\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Class\\\",\\n            \\\"grounding_id\\\": \\\"owl:Class\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Class\\\",\\n            \\\"grounding_id\\\": \\\"rdfs:Class\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"mit56\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit56\\\"\\n            },\\n            \\\"name\\\": \\\"IY\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit56\\\"\\n            },\\n            \\\"description\\\": \\\"infected individuals of a different variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": null,\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"human infected by SARS-CoV-2\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000292\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"transmission coefficient\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000191\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": []\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"document_collection\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"documents\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"1\\\"\\n            },\\n            \\\"source_file\\\": \\\"44b9158cad9a3098e5272cf906ef88a2__filename\\\",\\n            \\\"doi\\\": \\\"\\\"\\n          }\\n        ]\\n      }\\n    }\\n  ]\\n}\", \"width\": \"100%\", \"height\": \"600px\"}\n",
       "                    \n",
       "                            // postMessage to send the data to the iframe\n",
       "                            console.log('sender', window.location.origin)\n",
       "                            \n",
       "                            iframeWindow.postMessage(data,'*');\n",
       "                        };\n",
       "\n",
       "                            console.log('setting iframe content.')\n",
       "                            let viewer_html = atob(\"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\");\n",
       "                            let iframe = document.getElementById(\"jsonviewer_RtyeqVFL\");\n",
       "                            let iframeDocument = iframe.contentDocument || iframe.contentWindow.document;\n",
       "\n",
       "                            iframeDocument.open();\n",
       "                            iframeDocument.write(viewer_html);\n",
       "                            iframeDocument.close();\n",
       "                        }\n",
       "                    init();\n",
       "                </script>\n",
       "            </div>\n",
       "            "
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import ta1viewer # SAME REPO AS EXTRACTION VIEWER\n",
    "from ta1viewer import display_json\n",
    "#pip install git+https://github.com/orm011/ta1viewer.git@main\n",
    "display_json(json_str)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "aaba066a",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2023-10-31T20:46:33.877423Z",
     "iopub.status.busy": "2023-10-31T20:46:33.877303Z",
     "iopub.status.idle": "2023-10-31T20:46:33.882044Z",
     "shell.execute_reply": "2023-10-31T20:46:33.881791Z"
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "json_object = json.dumps(json.loads(json_str), indent=4)\n",
    "with open(\"m_temp_scenario_2.json\", \"w\") as f:\n",
    "    f.write(json_object)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7543b56f",
   "metadata": {
    "pycharm": {
     "name": "#%% md\n"
    }
   },
   "source": [
    "## 2. Interacting with the University of Arizona extraction"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8ac39918",
   "metadata": {
    "pycharm": {
     "name": "#%% md\n"
    }
   },
   "source": [
    "#### With both the University of Arizona and MIT extractions, we first build the entity matching mapping for all the extracted variable entities, and then integrate the two integration together with the unified TA1 data model.\n",
    "[http://3.83.68.208/#/TA1-Integration/upload_files_integration_integration_get_mapping_post](http://3.83.68.208/#/TA1-Integration/upload_files_integration_integration_get_mapping_post)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "88718f30",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2023-10-31T20:46:33.883340Z",
     "iopub.status.busy": "2023-10-31T20:46:33.883265Z",
     "iopub.status.idle": "2023-10-31T20:46:33.928246Z",
     "shell.execute_reply": "2023-10-31T20:46:33.927940Z"
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\"attributes\":[{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1687473227\"},\"mentions\":[{\"id\":{\"id\":\"T:1909222834\"},\"name\":\"NPI\",\"extraction_source\":{\"page\":1,\"block\":7,\"surrounding_passage\":\"In Ontario , Canada , the wild type was overtaken first by the Alpha / B1.1.17 variant , and then by the Delta / B.1.617 variant .\\nThe principal objective of the present study is to develop and apply a much expanded Susceptible-Infection-Recovered-type model to better understand the spread of multiple VOC , and assess the effectiveness of vaccination and non pharmaceutical interventions ( NPI ) .\\nThe model represents competition among VOC , and reveals their mutual inhibitory effects .\",\"char_start\":579,\"char_end\":582,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585267\"}},{\"id\":{\"id\":\"mit0\"},\"name\":\"ame\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1739817510\"},\"description\":\"effectiveness of vaccination and non-pharmaceutical interventions\",\"grounding\":[],\"extraction_source\":{\"page\":1,\"block\":7,\"surrounding_passage\":null,\"char_start\":512,\"char_end\":577,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585267\"}},{\"id\":{\"id\":\"mit0\"},\"description\":\"description\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit0\"},\"description\":\"description\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"mit0-value\"},\"value\":{\"amount\":\"numerical value\",\"grounding\":null,\"extraction_source\":null},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"groundings\":[{\"grounding_text\":\"description\",\"grounding_id\":\"dc:description\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"\",\"grounding_id\":\"fbbt:00045003\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1099021099\"},\"mentions\":[{\"id\":{\"id\":\"T:-1246793088\"},\"name\":\"VOC\",\"extraction_source\":{\"page\":1,\"block\":7,\"surrounding_passage\":\"A year after the initial wild-type Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS-CoV-2 ) strains began their devastation of the world , they were supplanted by new variants of concern ( VOC ) .\\nIn Ontario , Canada , the wild type was overtaken first by the Alpha / B1.1.17 variant , and then by the Delta / B.1.617 variant .\",\"char_start\":191,\"char_end\":194,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585467\"}},{\"id\":{\"id\":\"mit1\"},\"name\":\"---\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1660685213\"},\"description\":\"new variants of concern\",\"grounding\":[],\"extraction_source\":{\"page\":1,\"block\":7,\"surrounding_passage\":null,\"char_start\":166,\"char_end\":189,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585467\"}},{\"id\":{\"id\":\"mit1\"},\"description\":\"---\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit1\"},\"description\":\"---\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"mit1-value\"},\"value\":{\"amount\":\"---\",\"grounding\":null,\"extraction_source\":null},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"groundings\":[{\"grounding_text\":\"purely intentional entity\",\"grounding_id\":\"apollosv:00000000\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Bat coronavirus (BtCoV/A910/2005)\",\"grounding_id\":\"ncbitaxon:389159\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1012021369\"},\"mentions\":[{\"id\":{\"id\":\"T:1703120071\"},\"name\":\"VOC\",\"extraction_source\":{\"page\":1,\"block\":7,\"surrounding_passage\":\"Furthermore , the severity of a Delta outbreak depends not only on the NPI and vaccination rate but also on the vaccine types .\\nAlarmingly , despite Ontario 's existing NPI and relatively successful vaccine rollout , a future , more dangerous VOC could potentially infect a significant fraction of the province 's population and overwhelm the health care system .\\nTo stop that VOC , the province may need the simultaneous and rapid deployment of a third booster vaccine and stringent NPI .\",\"char_start\":1069,\"char_end\":1072,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585553\"}},{\"id\":{\"id\":\"mit2\"},\"name\":\"SARS-CoV-2\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-493884876\"},\"description\":\"future\",\"grounding\":[],\"extraction_source\":{\"page\":1,\"block\":7,\"surrounding_passage\":null,\"char_start\":1046,\"char_end\":1052,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585553\"}},{\"id\":{\"id\":\"mit2\"},\"description\":\"Severe Acute Respiratory Syndrome Coronavirus 2\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"N gene of severe acute respiratory syndrome coronavirus 2\",\"grounding_id\":\"ogg:3043740575\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"S gene of severe acute respiratory syndrome coronavirus 2\",\"grounding_id\":\"ogg:3043740568\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-779055136\"},\"mentions\":[{\"id\":{\"id\":\"T:2007310784\"},\"name\":\"VOC\",\"extraction_source\":{\"page\":1,\"block\":7,\"surrounding_passage\":\"Alarmingly , despite Ontario 's existing NPI and relatively successful vaccine rollout , a future , more dangerous VOC could potentially infect a significant fraction of the province 's population and overwhelm the health care system .\\nTo stop that VOC , the province may need the simultaneous and rapid deployment of a third booster vaccine and stringent NPI .\",\"char_start\":1201,\"char_end\":1204,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585638\"}},{\"id\":{\"id\":\"mit3\"},\"name\":\"VOC\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1802530407\"},\"description\":\"province\",\"grounding\":[],\"extraction_source\":{\"page\":1,\"block\":7,\"surrounding_passage\":null,\"char_start\":1210,\"char_end\":1218,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585638\"}},{\"id\":{\"id\":\"mit3\"},\"description\":\"Variants of Concern\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Dermatoglyphic variants\",\"grounding_id\":\"hp:0005882\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"EEG with constitutional variants\",\"grounding_id\":\"hp:0011176\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-657071160\"},\"mentions\":[{\"id\":{\"id\":\"T:-2109284684\"},\"name\":\"Beta from\",\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":\"Around that time , the Delta variant was first reported in the province .\\nBy 3 June 2021 , the Alpha variant has been reported from at least 160 countries , Beta from 113 countries , Gamma from 64 countries , and Delta from 62 countries .\\nSince then , the Delta variant has rapidly become the dominant circulating lineage .\",\"char_start\":894,\"char_end\":903,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585826\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-552097546\"},\"description\":\"least 160 countries\",\"grounding\":[],\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":null,\"char_start\":873,\"char_end\":892,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585826\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1574680068\"},\"mentions\":[{\"id\":{\"id\":\"T:115397170\"},\"name\":\"NPI\",\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":\"Initially , no pharmaceutical agents are known to be safe and effective at preventing or treating coronavirus disease 2019 ( COVID-19 ) 4 .\\nThis leaves public health authorities with nonpharmaceutical interventions ( NPI ) as the only recourse to reduce disease transmission ; these measures include bans on public gatherings , compulsory stay-at-home policies , mandating closures of schools and nonessential businesses , face mask ordinances , and quarantine .\\nEven though the WHO initially expected vaccine development to take 18 months5 , dedicated global efforts resulted in the approval of vaccines first in China6 and Russia7 in the summer of 2020 .\",\"char_start\":1398,\"char_end\":1401,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585938\"}},{\"id\":{\"id\":\"mit4\"},\"name\":\"NPI\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:600529022\"},\"description\":\"nonpharmaceutical interventions\",\"grounding\":[],\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":null,\"char_start\":1365,\"char_end\":1396,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.585938\"}},{\"id\":{\"id\":\"mit4\"},\"description\":\"Non-pharmaceutical interventions\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"non-pharmaceutical interventions\",\"grounding_id\":\"cemo:non-pharmaceutical_interventions\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Pharmaceutical Preparations\",\"grounding_id\":\"ndfrt:N0000000001\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-627600896\"},\"mentions\":[{\"id\":{\"id\":\"T:-1702094218\"},\"name\":\"VOC\",\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":\"In recent months , severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) variants associated with increased transmissibility have emerged and spread , one after another .\\nThe World Health Organization has designated a list of variants of concern ( VOC ) , including Alpha ( B.1.1.7 ) , Beta ( B.1.351 ) , Gamma ( P.1 ) , Delta ( B.1.617.2 ) , and Omicron ( B.1.1.529 ) , as well as multiple variants of interest1 .\\nViral lineages carrying the N501Y and / or E484K mutations , i.e ., the Alpha , Beta , and Gamma variants , were first identified in Ontario , Canada in December 20202 .\",\"char_start\":251,\"char_end\":254,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586031\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1796743511\"},\"description\":\"list of variants of concern\",\"grounding\":[{\"grounding_text\":\"identifier for species of case\",\"grounding_id\":\"apollosv:00000485\",\"source\":[],\"score\":0.7854529023170471,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.586057\"}}],\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":null,\"char_start\":222,\"char_end\":249,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586031\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1894470453\"},\"mentions\":[{\"id\":{\"id\":\"T:430060180\"},\"name\":\"SIR\",\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":\"A schematic diagram of the model is shown in Fig.1 .\\nA large number of epidemiological modeling studies have been published11 , many of which are based on the Susceptible-Infected-Recovered ( SIR ) formulation ( e.g ., 12-15 ) .\\nA key feature that distinguishes the present study from existing SIR-type models in that it is the first model to represent multiple SARS-CoV-2 VOC and their competition .\",\"char_start\":4022,\"char_end\":4025,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586136\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1729392404\"},\"description\":\"Susceptible-Infected-Recovered\",\"grounding\":[],\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":null,\"char_start\":3990,\"char_end\":4020,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586136\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:183719204\"},\"mentions\":[{\"id\":{\"id\":\"T:722931979\"},\"name\":\"Delta\",\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":\"Since then , the Delta variant has rapidly become the dominant circulating lineage .\\nAs of July 2021 , Delta represented the majority of infections in Ontario3 .\\nAt the time of this study , Omicron has begun spreading .\",\"char_start\":1073,\"char_end\":1078,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586244\"}},{\"id\":{\"id\":\"mit6\"},\"name\":\"Delta/B.1.617 variant\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-476419679\"},\"description\":\"majority of infections in Ontario3\",\"grounding\":[{\"grounding_text\":\"number of cases currently in icu\",\"grounding_id\":\"cemo:number_of_cases_currently_in_icu\",\"source\":[],\"score\":0.8028971552848816,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.586272\"}}],\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":null,\"char_start\":1095,\"char_end\":1129,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586244\"}},{\"id\":{\"id\":\"mit6\"},\"description\":\"Variant of SARS-CoV-2\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"SII B.1.617.2\",\"grounding_id\":\"vo:0005335\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"SARS-CoV-2 Alpha variant\",\"grounding_id\":\"cido:0000371\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-320992724\"},\"mentions\":[{\"id\":{\"id\":\"T:-1613533450\"},\"name\":\"Alpha\",\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":\"Viral lineages carrying the N501Y and / or E484K mutations , i.e ., the Alpha , Beta , and Gamma variants , were first identified in Ontario , Canada in December 20202 .\\nThese VOC quickly outcompeted earlier SARS-CoV-2 lineages and , as of late April 2021 , accounted for all new infections in Ontario , with Alpha being the most prevalent lineage1 .\\nAround that time , the Delta variant was first reported in the province .\",\"char_start\":700,\"char_end\":705,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586319\"}},{\"id\":{\"id\":\"mit5\"},\"name\":\"Alpha/B1.1.17 variant\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-934352954\"},\"description\":\"most prevalent lineage1\",\"grounding\":[],\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":null,\"char_start\":716,\"char_end\":739,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586319\"}},{\"id\":{\"id\":\"mit5\"},\"description\":\"Variant of SARS-CoV-2\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"SARS-CoV-2 Alpha variant\",\"grounding_id\":\"cido:0000371\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"SARS-CoV-2 Kappa variant\",\"grounding_id\":\"cido:0000383\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-380273488\"},\"mentions\":[{\"id\":{\"id\":\"T:71761250\"},\"name\":\"Omicron\",\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":\"As of July 2021 , Delta represented the majority of infections in Ontario3 .\\nAt the time of this study , Omicron has begun spreading .\\nInitially , no pharmaceutical agents are known to be safe and effective at preventing or treating coronavirus disease 2019 ( COVID-19 ) 4 .\",\"char_start\":1158,\"char_end\":1165,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586422\"}},{\"id\":{\"id\":\"mit7\"},\"name\":\"vaccine breakthrough\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-408090461\"},\"description\":\"time of this study, Omicron has begun spreading\",\"grounding\":[{\"grounding_text\":\"data set about Earth's atmosphere or some part of it\",\"grounding_id\":\"apollosv:00000594\",\"source\":[],\"score\":0.7653031349182129,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.586446\"}}],\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":null,\"char_start\":1138,\"char_end\":1185,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586422\"}},{\"id\":{\"id\":\"mit7\"},\"description\":\"Infection with SARS-CoV-2 despite vaccination\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"SARS-COV-2 Infection\",\"grounding_id\":\"idocovid19:0001287\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Post-vaccination rotavirus infection\",\"grounding_id\":\"hp:0020091\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-172046428\"},\"mentions\":[{\"id\":{\"id\":\"T:-1110622832\"},\"name\":\"A\",\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":\"A key feature that distinguishes the present study from existing SIR-type models in that it is the first model to represent multiple SARS-CoV-2 VOC and their competition .\\nWe refer to this model as a SV2 ( AIR ) 3 model , for its representation of two vaccine types ( V2 ) , asymptomatic infections ( A ) , and three VOC ( the power ' 3 ' refers to the three instantiations of each infected and recovered class ) .\\nThe SV2 ( AIR ) 3 model can answer the question : To what extent do the interactions and competition among VOC impact the spread of COVID-19 ?\",\"char_start\":4345,\"char_end\":4346,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586501\"}},{\"id\":{\"id\":\"mit10\"},\"name\":\"asymptomatic infections\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:2140386664\"},\"description\":\"asymptomatic infections\",\"grounding\":[{\"grounding_text\":\"Asymptomatic COVID-19 Infection Laboratory-Confirmed\",\"grounding_id\":\"ncit:C171547\",\"source\":[],\"score\":0.8376278281211853,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.586527\"}}],\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":null,\"char_start\":4320,\"char_end\":4343,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586501\"}},{\"id\":{\"id\":\"mit10\"},\"description\":\"Infections without symptoms\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Recurrent infections\",\"grounding_id\":\"hp:0002719\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Recurrent skin infections\",\"grounding_id\":\"hp:0001581\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-805696495\"},\"mentions\":[{\"id\":{\"id\":\"T:-1209834396\"},\"name\":\"V2\",\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":\"A key feature that distinguishes the present study from existing SIR-type models in that it is the first model to represent multiple SARS-CoV-2 VOC and their competition .\\nWe refer to this model as a SV2 ( AIR ) 3 model , for its representation of two vaccine types ( V2 ) , asymptomatic infections ( A ) , and three VOC ( the power ' 3 ' refers to the three instantiations of each infected and recovered class ) .\\nThe SV2 ( AIR ) 3 model can answer the question : To what extent do the interactions and competition among VOC impact the spread of COVID-19 ?\",\"char_start\":4315,\"char_end\":4317,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586552\"}},{\"id\":{\"id\":\"mit8\"},\"name\":\"vaccine types\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1450408391\"},\"description\":\"refer to this model as a SV2(AIR)3 model, for its representation of two vaccine types\",\"grounding\":[{\"grounding_text\":\"Semantic_Type\",\"grounding_id\":\"ncit:P106\",\"source\":[],\"score\":0.8575206995010376,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.586576\"}}],\"extraction_source\":{\"page\":1,\"block\":8,\"surrounding_passage\":null,\"char_start\":4228,\"char_end\":4313,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.586552\"}},{\"id\":{\"id\":\"mit8\"},\"description\":\"Different types of COVID-19 vaccines\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"COVID-19 subunit vaccine\",\"grounding_id\":\"vo:0005202\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"COVID-19 DNA vaccine\",\"grounding_id\":\"vo:0005203\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-308499566\"},\"mentions\":[{\"id\":{\"id\":\"T:87077992\"},\"name\":\"Fig.2a\",\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":\"Key measures of the pandemic are illustrated in Fig.2 .\\nThe total number of new infections exhibits two peaks ( Fig.2a ) , with the first wave in December 2020 driven by the wild type , and the second around March 2021 driven by Alpha .\\nBy mid June 2021 , the new infections are dominated by the Delta variant .\",\"char_start\":1291,\"char_end\":1297,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587143\"}},{\"id\":{\"id\":\"mit11\"},\"name\":\"symptomatic infections\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1325764302\"},\"description\":\"peaks\",\"grounding\":[],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":1284,\"char_end\":1289,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587143\"}},{\"id\":{\"id\":\"mit11\"},\"description\":\"Infections with symptoms\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Recurrent infections\",\"grounding_id\":\"hp:0002719\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Recurrent skin infections\",\"grounding_id\":\"hp:0001581\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1672592981\"},\"mentions\":[{\"id\":{\"id\":\"T:1997301942\"},\"name\":\"Fig.2c\",\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":\"The cumulative infection curves exhibit the steepest rise in December 2020 and March 2021 , corresponding to the two peaks in the new case counts .\\nBy the end of 2021 , 71 % of the Ontario population would have been vaccinated with at least one dose , with 57 % fully vaccinated ( Fig.2c ) .\\nAt that time , 11K would have died from COVID , with 36 , 47 , and 17 % from wild type , Alpha , and Delta , respectively ( Fig.2d ) .\",\"char_start\":2337,\"char_end\":2343,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587257\"}},{\"id\":{\"id\":\"mit9\"},\"name\":\"wild type\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1742903609\"},\"description\":\"57% fully vaccinated\",\"grounding\":[],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":2315,\"char_end\":2335,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587257\"}},{\"id\":{\"id\":\"mit9\"},\"description\":\"Original strain of SARS-CoV-2\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"wild type haemoglobin\",\"grounding_id\":\"idomal:0001234\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"+/+\",\"grounding_id\":\"miro:00000032\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1676757554\"},\"mentions\":[{\"id\":{\"id\":\"T:433557046\"},\"name\":\"least one dose of vaccine\",\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":\"The drop in the susceptible population becomes significant after December 2020 ( Fig.3a ) and is driven primarily by the vaccine deployment .\\nBy the end of June 2021 , only 37 % of the Ontario population are susceptible , with the majority having received at least one dose of vaccine ( Fig.3b , c ) .\\nThe number of active infections peaks at the end of 2020 , followed by an even higher peak at the end of spring ( Fig.3d ) .\",\"char_start\":2898,\"char_end\":2923,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587342\"}},{\"id\":{\"id\":\"mit12\"},\"name\":\"vaccine rollout\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit12\"},\"description\":\"Distribution and administration of vaccines\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:-1862708991\"},\"value\":{\"amount\":\"one\",\"grounding\":[],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":2904,\"char_end\":2907,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587342\"}}],\"groundings\":[{\"grounding_text\":\"human age within one month at vaccination\",\"grounding_id\":\"vo:0004944\",\"source\":[],\"score\":0.8113138675689697,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.587353\"}},{\"grounding_text\":\"distribution\",\"grounding_id\":\"cemo:distribution\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"influenza vaccines\",\"grounding_id\":\"vo:0003495\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1511085452\"},\"mentions\":[{\"id\":{\"id\":\"T:-1682762855\"},\"name\":\"11K\",\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":\"By the end of 2021 , 71 % of the Ontario population would have been vaccinated with at least one dose , with 57 % fully vaccinated ( Fig.2c ) .\\nAt that time , 11K would have died from COVID , with 36 , 47 , and 17 % from wild type , Alpha , and Delta , respectively ( Fig.2d ) .\\nThe year-end infection and death statistics are within 10 % of reported data in Ontario ( 750K infections and 10.2K deaths ) 16 .\",\"char_start\":2360,\"char_end\":2363,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587439\"}},{\"id\":{\"id\":\"mit13\"},\"name\":\"booster vaccine\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1149102777\"},\"description\":\"time, 11K would have died from COVID, with 36, 47, and 17% from wild type, Alpha, and Delta\",\"grounding\":[],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":2354,\"char_end\":2445,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587439\"}},{\"id\":{\"id\":\"mit13\"},\"description\":\"Additional dose of vaccine to enhance immunity\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Booster\",\"grounding_id\":\"ncit:C28320\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"vaccine dose\",\"grounding_id\":\"vo:0000595\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-303059524\"},\"mentions\":[{\"id\":{\"id\":\"T:1034756161\"},\"name\":\"Fig.3d\",\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":\"By the end of June 2021 , only 37 % of the Ontario population are susceptible , with the majority having received at least one dose of vaccine ( Fig.3b , c ) .\\nThe number of active infections peaks at the end of 2020 , followed by an even higher peak at the end of spring ( Fig.3d ) .\\nThese are the wild-type and Alpha-driven waves identified in Fig.2a and described above .\",\"char_start\":3048,\"char_end\":3054,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587566\"}},{\"id\":{\"id\":\"mit14\"},\"name\":\"N501Y mutation\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:176545860\"},\"description\":\"even higher peak at the end of spring\",\"grounding\":[{\"grounding_text\":\"rate of cases with at least one comorbidity\",\"grounding_id\":\"cemo:rate_of_cases_with_at_least_one_comorbidity\",\"source\":[],\"score\":0.810994029045105,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.587591\"}}],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":3009,\"char_end\":3046,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587566\"}},{\"id\":{\"id\":\"mit14\"},\"description\":\"Mutation in SARS-CoV-2 spike protein\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"S-N501Y\",\"grounding_id\":\"cido:0000277\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"SARS Subunit Spike Protein Vaccine\",\"grounding_id\":\"vo:0011486\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:527532433\"},\"mentions\":[{\"id\":{\"id\":\"T:79768610\"},\"name\":\"year-end infection\",\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":\"At that time , 11K would have died from COVID , with 36 , 47 , and 17 % from wild type , Alpha , and Delta , respectively ( Fig.2d ) .\\nThe year-end infection and death statistics are within 10 % of reported data in Ontario ( 750K infections and 10.2K deaths ) 16 .\\nPredicted population dynamics are shown in Fig.3 .\",\"char_start\":2474,\"char_end\":2492,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587650\"}},{\"id\":{\"id\":\"mit15\"},\"name\":\"E484K mutation\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit15\"},\"description\":\"Mutation in SARS-CoV-2 spike protein\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:-925241618\"},\"value\":{\"amount\":\"10\",\"grounding\":[],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":2525,\"char_end\":2527,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587650\"}}],\"groundings\":[{\"grounding_text\":\"SARS Subunit Spike Protein Vaccine\",\"grounding_id\":\"vo:0011486\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"E484K in SARS-CoV-2 S protein\",\"grounding_id\":\"cido:0000668\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1952535670\"},\"mentions\":[{\"id\":{\"id\":\"T:79768610\"},\"name\":\"year-end infection\",\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":\"At that time , 11K would have died from COVID , with 36 , 47 , and 17 % from wild type , Alpha , and Delta , respectively ( Fig.2d ) .\\nThe year-end infection and death statistics are within 10 % of reported data in Ontario ( 750K infections and 10.2K deaths ) 16 .\\nPredicted population dynamics are shown in Fig.3 .\",\"char_start\":2474,\"char_end\":2492,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587746\"}},{\"id\":{\"id\":\"mit16\"},\"name\":\"transmissibility\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit16\"},\"description\":\"Ability of a virus to spread between individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:-2077956845\"},\"value\":{\"amount\":\"%\",\"grounding\":[],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":2527,\"char_end\":2528,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587746\"}}],\"groundings\":[{\"grounding_text\":\"SARS-CoV-2 transmissibility\",\"grounding_id\":\"idocovid19:0001279\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"spread\",\"grounding_id\":\"probonto:k0000049\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1550505153\"},\"mentions\":[{\"id\":{\"id\":\"T:79768610\"},\"name\":\"year-end infection\",\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":\"At that time , 11K would have died from COVID , with 36 , 47 , and 17 % from wild type , Alpha , and Delta , respectively ( Fig.2d ) .\\nThe year-end infection and death statistics are within 10 % of reported data in Ontario ( 750K infections and 10.2K deaths ) 16 .\\nPredicted population dynamics are shown in Fig.3 .\",\"char_start\":2474,\"char_end\":2492,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587844\"}},{\"id\":{\"id\":\"mit17\"},\"name\":\"COVID-19\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit17\"},\"description\":\"Coronavirus disease 2019\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:-925241618\"},\"value\":{\"amount\":\"10\",\"grounding\":[],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":2525,\"char_end\":2527,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587844\"}},{\"id\":{\"id\":\"T:-2077956845\"},\"value\":{\"amount\":\"%\",\"grounding\":[],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":2527,\"char_end\":2528,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587844\"}}],\"groundings\":[{\"grounding_text\":\"Severe acute respiratory syndrome coronavirus 2\",\"grounding_id\":\"ncbitaxon:2697049\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"COVID-19\",\"grounding_id\":\"idocovid19:0001141\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:44342288\"},\"mentions\":[{\"id\":{\"id\":\"T:476191044\"},\"name\":\"entrance\",\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":\"On January 1 2020 , we assume that the entire Ontario population was susceptible , except for 15 infected symptomatic individuals ( wild-type ) .\\nThe Alpha strain was introduced into Ontario via the entrance of 50 asymptomatic infected individuals per day for 1.5months at the end of 2020 ; Delta was introduced similarly in February and March 2021 ( 25 asymptomatic infected individuals per day ) .\\nThese parameters were chosen to product simulation results that match the initial rise of each of the VOC , Vaccination became available on December 14 2020 ; details for vaccination rates can be found in the supplement .\",\"char_start\":565,\"char_end\":573,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587953\"}},{\"id\":{\"id\":\"mit18\"},\"name\":\"infection rate (β)\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit18\"},\"description\":\"Rate at which the virus spreads\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:1017812709\"},\"value\":{\"amount\":\"individuals per day\",\"grounding\":[{\"grounding_text\":\"average daily number of new infections generated per case (rt)\",\"grounding_id\":\"cemo:average_daily_number_of_new_infections_generated_per_case_rt\",\"source\":[],\"score\":0.7630041241645813,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.587977\"}}],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":602,\"char_end\":621,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.587953\"}}],\"groundings\":[{\"grounding_text\":\"rate\",\"grounding_id\":\"probonto:k0000603\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Response Rate\",\"grounding_id\":\"ncit:C94502\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1960087092\"},\"mentions\":[{\"id\":{\"id\":\"T:-560132878\"},\"name\":\"March 2021\",\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":\"On January 1 2020 , we assume that the entire Ontario population was susceptible , except for 15 infected symptomatic individuals ( wild-type ) .\\nThe Alpha strain was introduced into Ontario via the entrance of 50 asymptomatic infected individuals per day for 1.5months at the end of 2020 ; Delta was introduced similarly in February and March 2021 ( 25 asymptomatic infected individuals per day ) .\\nThese parameters were chosen to product simulation results that match the initial rise of each of the VOC , Vaccination became available on December 14 2020 ; details for vaccination rates can be found in the supplement .\",\"char_start\":703,\"char_end\":713,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588028\"}},{\"id\":{\"id\":\"mit19\"},\"name\":\"recovery rate (Ɣ)\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit19\"},\"description\":\"\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:-163972007\"},\"value\":{\"amount\":\"individuals per day\",\"grounding\":[{\"grounding_text\":\"average daily number of new infections generated per case (rt)\",\"grounding_id\":\"cemo:average_daily_number_of_new_infections_generated_per_case_rt\",\"source\":[],\"score\":0.7630041241645813,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.588052\"}}],\"extraction_source\":{\"page\":2,\"block\":2,\"surrounding_passage\":null,\"char_start\":740,\"char_end\":759,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588028\"}}],\"groundings\":[{\"grounding_text\":\"AE recovery rate\",\"grounding_id\":\"oae:0001869\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"incomplete AE recovery\",\"grounding_id\":\"oae:0001873\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1580628517\"},\"mentions\":[{\"id\":{\"id\":\"T:818956569\"},\"name\":\"alphaW\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Parameters that are varied include those that describe the clinical features of the viruses as well as provincial policy and pharmaceutical intervention .\\nClinical features of the viruses that were considered include its infectivity ( betaW ) , the fraction of infections that are asymptomatic ( sigmaW ) , the infectivity ratio between asymptomatic and symptomatic individuals ( alphaW ) , mortality rate ( muW ) , and recovery rates ( gammaWA and gammaWI , varied simultaneously ) .\\nRecall the baseline assumption that asymptomatic individuals are assumed to be more active and 3 times more likely to spread the disease than symptomatic ones ( alphaW = 3 ) .\",\"char_start\":824,\"char_end\":830,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588552\"}},{\"id\":{\"id\":\"mit20\"},\"name\":\"βW\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1795560910\"},\"description\":\"asymptomatic and symptomatic individuals\",\"grounding\":[{\"grounding_text\":\"becoming symptomatic\",\"grounding_id\":\"apollosv:00000224\",\"source\":[],\"score\":0.7515280842781067,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.588568\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":782,\"char_end\":822,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588552\"}},{\"id\":{\"id\":\"mit20\"},\"description\":\"virus infectivity of the wild-type strain\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"SARS-CoV-2 infectivity\",\"grounding_id\":\"idocovid19:0001284\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"wild type haemoglobin\",\"grounding_id\":\"idomal:0001234\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1846480138\"},\"mentions\":[{\"id\":{\"id\":\"T:-2140979605\"},\"name\":\"muW\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Parameters that are varied include those that describe the clinical features of the viruses as well as provincial policy and pharmaceutical intervention .\\nClinical features of the viruses that were considered include its infectivity ( betaW ) , the fraction of infections that are asymptomatic ( sigmaW ) , the infectivity ratio between asymptomatic and symptomatic individuals ( alphaW ) , mortality rate ( muW ) , and recovery rates ( gammaWA and gammaWI , varied simultaneously ) .\\nRecall the baseline assumption that asymptomatic individuals are assumed to be more active and 3 times more likely to spread the disease than symptomatic ones ( alphaW = 3 ) .\",\"char_start\":849,\"char_end\":852,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588628\"}},{\"id\":{\"id\":\"mit21\"},\"name\":\"βV\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:304322664\"},\"description\":\"mortality rate\",\"grounding\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"apollosv:00000445\",\"source\":[],\"score\":0.9990238547325134,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.588650\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":833,\"char_end\":847,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588628\"}},{\"id\":{\"id\":\"mit21\"},\"description\":\"vaccine escape rate\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Ventricular escape rhythm\",\"grounding_id\":\"hp:0005155\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"rate\",\"grounding_id\":\"probonto:k0000603\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1532099766\"},\"mentions\":[{\"id\":{\"id\":\"T:-1593074097\"},\"name\":\"betaW\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Parameters that are varied include those that describe the clinical features of the viruses as well as provincial policy and pharmaceutical intervention .\\nClinical features of the viruses that were considered include its infectivity ( betaW ) , the fraction of infections that are asymptomatic ( sigmaW ) , the infectivity ratio between asymptomatic and symptomatic individuals ( alphaW ) , mortality rate ( muW ) , and recovery rates ( gammaWA and gammaWI , varied simultaneously ) .\\nRecall the baseline assumption that asymptomatic individuals are assumed to be more active and 3 times more likely to spread the disease than symptomatic ones ( alphaW = 3 ) .\",\"char_start\":685,\"char_end\":690,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588744\"}},{\"id\":{\"id\":\"mit22\"},\"name\":\"ω1\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1685937370\"},\"description\":\"infectivity\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":672,\"char_end\":683,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588744\"}},{\"id\":{\"id\":\"mit22\"},\"description\":\"vaccination rate\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit22\"},\"description\":\"vaccination rate for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"vaccination rate\",\"grounding_id\":\"askemo:0000012\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"secondary vaccination\",\"grounding_id\":\"vo:0000903\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1960993140\"},\"mentions\":[{\"id\":{\"id\":\"T:1121912434\"},\"name\":\"alphaW\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Clinical features of the viruses that were considered include its infectivity ( betaW ) , the fraction of infections that are asymptomatic ( sigmaW ) , the infectivity ratio between asymptomatic and symptomatic individuals ( alphaW ) , mortality rate ( muW ) , and recovery rates ( gammaWA and gammaWI , varied simultaneously ) .\\nRecall the baseline assumption that asymptomatic individuals are assumed to be more active and 3 times more likely to spread the disease than symptomatic ones ( alphaW = 3 ) .\\nThus , the number of infections directly depends on , and is in fact highly sensitive to , betaW , sigmaW , alphaW , and also to the recovery rate gammaW , which impacts how many new infections an infected individual can cause .\",\"char_start\":1080,\"char_end\":1086,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588834\"}},{\"id\":{\"id\":\"mit23\"},\"name\":\"ω2\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit23\"},\"description\":\"dosing interval\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit23\"},\"description\":\"dosing interval for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:-1656338763\"},\"value\":{\"amount\":\"3\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":1089,\"char_end\":1090,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588834\"}}],\"groundings\":[{\"grounding_text\":\"generation interval\",\"grounding_id\":\"cemo:generation_interval\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"confidence interval\",\"grounding_id\":\"stato:0000196\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:2023095270\"},\"mentions\":[{\"id\":{\"id\":\"T:183896673\"},\"name\":\"I\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Small variations in these four parameters ( 5 % ) result in changes in the number of infections and deaths that are an order of magnitude larger ; see Fig.4 .\\nCOVID-19 mortality rate muW I affects the number of infected individuals who are alive and can participate in the spread of the disease .\\nBecause COVID-19 mortality rate can vary substantially depending on health care infrastructure , we varied muW I by 50 % .\",\"char_start\":1496,\"char_end\":1497,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588896\"}},{\"id\":{\"id\":\"mit24\"},\"name\":\"ηR\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:289633229\"},\"description\":\"COVID-19 mortality rate muW\",\"grounding\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"apollosv:00000445\",\"source\":[],\"score\":0.8306654095649719,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.588919\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":1468,\"char_end\":1495,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588896\"}},{\"id\":{\"id\":\"mit24\"},\"description\":\"rate of loss of immunity due to infection\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit24\"},\"description\":\"rate of transition from recovered class to SVR\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Meruvax I\",\"grounding_id\":\"vo:0003109\",\"source\":[],\"score\":0.994598925113678,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.588904\"}},{\"grounding_text\":\"acquired immunity to malaria\",\"grounding_id\":\"idomal:0000543\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"rate\",\"grounding_id\":\"probonto:k0000603\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:332339292\"},\"mentions\":[{\"id\":{\"id\":\"T:1787362729\"},\"name\":\"PZ\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"However , compared to other clinical features of SARSCoV-2 , the mortality rate has a relatively small effect on the infected population , since < 5 % of them die ( Fig.4 ) .\\nProvincial policy and pharmaceutical interventions that were considered include NPI that reduce the effective disease infectivity ( via scaling by lambda ) , vaccination rate ( omega1 ) , delay between the first and second vaccine doses ( omega2 , PZ and omega2 , AZ , varied simultaneously ) , and vaccine escape rate ( betaW V ) .\\nlambda and omega1 are varied by 5 % .\",\"char_start\":2213,\"char_end\":2215,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588944\"}},{\"id\":{\"id\":\"mit25\"},\"name\":\"βX R\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:2014054376\"},\"description\":\"omega2,PZ and omega2,AZ, varied\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":2206,\"char_end\":2237,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.588944\"}},{\"id\":{\"id\":\"mit25\"},\"description\":\"rate of infection of individuals with partial immunity from having recovered from a different variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Recovered Rate\",\"grounding_id\":\"ncit:C173781\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-302164219\"},\"mentions\":[{\"id\":{\"id\":\"T:-536825094\"},\"name\":\"AZ\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"However , compared to other clinical features of SARSCoV-2 , the mortality rate has a relatively small effect on the infected population , since < 5 % of them die ( Fig.4 ) .\\nProvincial policy and pharmaceutical interventions that were considered include NPI that reduce the effective disease infectivity ( via scaling by lambda ) , vaccination rate ( omega1 ) , delay between the first and second vaccine doses ( omega2 , PZ and omega2 , AZ , varied simultaneously ) , and vaccine escape rate ( betaW V ) .\\nlambda and omega1 are varied by 5 % .\",\"char_start\":2227,\"char_end\":2229,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589000\"}},{\"id\":{\"id\":\"mit26\"},\"name\":\"σX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1323344085\"},\"description\":\"omega2\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":2220,\"char_end\":2226,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589000\"}},{\"id\":{\"id\":\"mit26\"},\"description\":\"ratio of asymptomatic versus symptomatic infections\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit26\"},\"description\":\"ratio of asymptomatic versus symptomatic infections for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"asymptomatic host\",\"grounding_id\":\"apollosv:00000236\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"epstein-barr virus infection AE\",\"grounding_id\":\"oae:0007029\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1790727618\"},\"mentions\":[{\"id\":{\"id\":\"T:1466935117\"},\"name\":\"lambda\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"The Alpha and Delta strains are not included .\\nWe assume that NPI begin on March 1 2020 , with the restrictiveness index lambda taken to be uniformly 0.5 ( i.e ., infectivity beta 's halved ) for simplicity .\\nVaccination begins on April 1 2020 ( not the end of 2020 , for this simplified one-year simulation ) , with baseline dosing interval taken to be 4weeks for Pfizer and 8weeks for AstraZeneca ( dosing interval is one of the parameters varied ) 17 .\",\"char_start\":130,\"char_end\":136,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589054\"}},{\"id\":{\"id\":\"mit27\"},\"name\":\"αX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1018584051\"},\"description\":\"restrictiveness index\",\"grounding\":[{\"grounding_text\":\"Breteau Index\",\"grounding_id\":\"apollosv:00000311\",\"source\":[],\"score\":0.7518984079360962,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.589075\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":108,\"char_end\":129,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589054\"}},{\"id\":{\"id\":\"mit27\"},\"description\":\"degree of increased infectivity β (due to mobility) of asymptomatic infected individuals compared to symptomatic ones\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"SARS-CoV-2 infectivity\",\"grounding_id\":\"idocovid19:0001284\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"asymptomatic human female infected by SARS-CoV-2\",\"grounding_id\":\"cido:0000297\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:615518326\"},\"mentions\":[{\"id\":{\"id\":\"T:693162218\"},\"name\":\"beta's\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"The Alpha and Delta strains are not included .\\nWe assume that NPI begin on March 1 2020 , with the restrictiveness index lambda taken to be uniformly 0.5 ( i.e ., infectivity beta 's halved ) for simplicity .\\nVaccination begins on April 1 2020 ( not the end of 2020 , for this simplified one-year simulation ) , with baseline dosing interval taken to be 4weeks for Pfizer and 8weeks for AstraZeneca ( dosing interval is one of the parameters varied ) 17 .\",\"char_start\":182,\"char_end\":188,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589134\"}},{\"id\":{\"id\":\"mit28\"},\"name\":\"γX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:348377089\"},\"description\":\"i.e., infectivity\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":164,\"char_end\":181,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589134\"}},{\"id\":{\"id\":\"mit28\"},\"description\":\"disease recovery rate\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit28\"},\"description\":\"disease recovery rate for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"AE recovery rate\",\"grounding_id\":\"oae:0001869\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"incomplete AE recovery\",\"grounding_id\":\"oae:0001873\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-891560124\"},\"mentions\":[{\"id\":{\"id\":\"T:1230812496\"},\"name\":\"alphaX\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Thus , we will discuss cross-variant results .\\nAs can be seen in Fig.5 , most wild-type specific parameters have opposite effects on wild-type and on the other variants ( betaX , sigmaX , alphaX , gammaX , betaX V ) .\\nThis suggests that promoting the spread of the wild-type variant protects the population from Alpha and Delta , due to the partial natural immunity individuals acquire after recovering from wild-type infections .\",\"char_start\":4788,\"char_end\":4794,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589214\"}},{\"id\":{\"id\":\"mit29\"},\"name\":\"λ\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2121287105\"},\"description\":\"betaX, sigmaX\",\"grounding\":[{\"grounding_text\":\"Snoqualmie\",\"grounding_id\":\"ncit:C44815\",\"source\":[],\"score\":0.7998793125152588,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.589230\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":4773,\"char_end\":4786,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589214\"}},{\"id\":{\"id\":\"mit29\"},\"description\":\"NPI stringency\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit29\"},\"description\":\"NPI stringency for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"importin subunit alpha-5 (human)\",\"grounding_id\":\"pr:P52294\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"National Provider Identifier\",\"grounding_id\":\"opmi:0000503\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:919462373\"},\"mentions\":[{\"id\":{\"id\":\"T:1800332912\"},\"name\":\"betaX\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Thus , we will discuss cross-variant results .\\nAs can be seen in Fig.5 , most wild-type specific parameters have opposite effects on wild-type and on the other variants ( betaX , sigmaX , alphaX , gammaX , betaX V ) .\\nThis suggests that promoting the spread of the wild-type variant protects the population from Alpha and Delta , due to the partial natural immunity individuals acquire after recovering from wild-type infections .\",\"char_start\":4773,\"char_end\":4778,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589253\"}},{\"id\":{\"id\":\"mit30\"},\"name\":\"μI\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1335422591\"},\"description\":\"betaX V\",\"grounding\":[{\"grounding_text\":\"V antigen\",\"grounding_id\":\"vo:0010876\",\"source\":[],\"score\":0.7732263207435608,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.589268\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":4804,\"char_end\":4811,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589253\"}},{\"id\":{\"id\":\"mit30\"},\"description\":\"mortality rate of infected individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit30\"},\"description\":\"mortality rate of infected individuals for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"stato:0000414\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"neonatal mortality rate\",\"grounding_id\":\"sdgio:00020030\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-935644632\"},\"mentions\":[{\"id\":{\"id\":\"T:1286808048\"},\"name\":\"V\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Thus , we will discuss cross-variant results .\\nAs can be seen in Fig.5 , most wild-type specific parameters have opposite effects on wild-type and on the other variants ( betaX , sigmaX , alphaX , gammaX , betaX V ) .\\nThis suggests that promoting the spread of the wild-type variant protects the population from Alpha and Delta , due to the partial natural immunity individuals acquire after recovering from wild-type infections .\",\"char_start\":4810,\"char_end\":4811,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589294\"}},{\"id\":{\"id\":\"mit31\"},\"name\":\"βX V\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-631812455\"},\"description\":\"gammaX, betaX\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":4796,\"char_end\":4809,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589294\"}},{\"id\":{\"id\":\"mit31\"},\"description\":\"vaccine escape rate for a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"V antigen\",\"grounding_id\":\"vo:0010876\",\"source\":[],\"score\":0.7732263207435608,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.589302\"}},{\"grounding_text\":\"Ventricular escape rhythm\",\"grounding_id\":\"hp:0005155\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Disease-specific Survival Rate\",\"grounding_id\":\"ncit:C94504\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:553752076\"},\"mentions\":[{\"id\":{\"id\":\"T:1059618170\"},\"name\":\"fers\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Specifically , betaX ( X = W , A , or D ) , sigmaX , R was increased 4 folds to assess the alphaX , gammaX , and omega1 were increased by 5 % , lambda by 10 % , and muI , betaX V , and omega2 by 50 % .\\nbetaX scenario in which recovery from one variant of fers only limited protected from other VOCs .\\netaX R was doubled to test the effect of a shorter immunity period .\",\"char_start\":4286,\"char_end\":4290,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589335\"}},{\"id\":{\"id\":\"mit32\"},\"name\":\"βX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit32\"},\"description\":\"virus infectivity of a specific variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"id\":{\"id\":\"mit32\"},\"description\":\"infection rate for unvaccinated individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:364778551\"},\"value\":{\"amount\":\"one\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":4271,\"char_end\":4274,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589335\"}}],\"groundings\":[{\"grounding_text\":\"SARS-CoV-2 infectivity\",\"grounding_id\":\"idocovid19:0001284\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"specific host infectivity\",\"grounding_id\":\"vsmo:0000144\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1662231047\"},\"mentions\":[{\"id\":{\"id\":\"T:1904001986\"},\"name\":\"5%\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"As expected , changes in muW I are immediately reflected in the number of deaths .\\nHowever , compared to other clinical features of SARSCoV-2 , the mortality rate has a relatively small effect on the infected population , since < 5 % of them die ( Fig.4 ) .\\nProvincial policy and pharmaceutical interventions that were considered include NPI that reduce the effective disease infectivity ( via scaling by lambda ) , vaccination rate ( omega1 ) , delay between the first and second vaccine doses ( omega2 , PZ and omega2 , AZ , varied simultaneously ) , and vaccine escape rate ( betaW V ) .\",\"char_start\":1950,\"char_end\":1952,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589382\"}},{\"id\":{\"id\":\"mit33\"},\"name\":\"μ\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit33\"},\"description\":\"natural death rate\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"SG33-VP2/5\",\"grounding_id\":\"vo:0004706\",\"source\":[],\"score\":1.0000001192092896,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.589390\"}},{\"grounding_text\":\"Death by Natural Cause\",\"grounding_id\":\"ncit:C82465\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"rate\",\"grounding_id\":\"probonto:k0000603\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-465381980\"},\"mentions\":[{\"id\":{\"id\":\"T:-548675649\"},\"name\":\"gammaW\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Recall the baseline assumption that asymptomatic individuals are assumed to be more active and 3 times more likely to spread the disease than symptomatic ones ( alphaW = 3 ) .\\nThus , the number of infections directly depends on , and is in fact highly sensitive to , betaW , sigmaW , alphaW , and also to the recovery rate gammaW , which impacts how many new infections an infected individual can cause .\\nSmall variations in these four parameters ( 5 % ) result in changes in the number of infections and deaths that are an order of magnitude larger ; see Fig.4 .\",\"char_start\":1234,\"char_end\":1240,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589431\"}},{\"id\":{\"id\":\"mit34\"},\"name\":\"VM\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1627664391\"},\"description\":\"recovery rate\",\"grounding\":[{\"grounding_text\":\"Recovered Rate\",\"grounding_id\":\"ncit:C173781\",\"source\":[],\"score\":0.8412715196609497,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.589448\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":1220,\"char_end\":1233,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.589431\"}},{\"id\":{\"id\":\"mit34\"},\"description\":\"rate of reduced infection for vaccinated individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"vaccinated with a licensed vaccine\",\"grounding_id\":\"vo:0001378\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"vaccinated\",\"grounding_id\":\"vo:0001376\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1430855057\"},\"mentions\":[{\"id\":{\"id\":\"T:2122514767\"},\"name\":\"R\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Key model parameters were increased to determine the effects on the number of infections and deaths associated with each variant .\\nIn addition to parameters considered in the above analysis , we also considered two parameters that mediate VOC interactions : betaX R , rate of infection of individuals with partial immunity from having recovered from a different variant , and etaR , rate of loss of immunity due to infection .\\nSome of these parameters have distinct values for each of the variants .\",\"char_start\":3714,\"char_end\":3715,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590080\"}},{\"id\":{\"id\":\"mit35\"},\"name\":\"V\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1223032199\"},\"description\":\"rate of loss of immunity due to infection\",\"grounding\":[{\"grounding_text\":\"probability of infection over time\",\"grounding_id\":\"apollosv:00000530\",\"source\":[],\"score\":0.831021785736084,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.590105\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":3830,\"char_end\":3871,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590080\"}},{\"id\":{\"id\":\"mit35\"},\"description\":\"vaccine type (either V1 or V2)\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"ViroKey SARS-CoV-2 RT-PCR Test v2.0\",\"grounding_id\":\"cido:0020325\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"KimForest SARS-CoV-2 Detection Kit v1\",\"grounding_id\":\"cido:0020179\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[{\"id\":{\"id\":\"8-1\"},\"name\":\"location_key\",\"dataset\":{\"id\":{\"id\":\"8\"},\"name\":\"usa-vaccinations.csv\",\"metadata\":\"https://github.com/DARPA-ASKEM/program-milestones/blob/main/6-month-milestone/evaluation/scenario_3/ta_1/google-health-data/usa-vaccinations.csv\"}}]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:2134716306\"},\"mentions\":[{\"id\":{\"id\":\"T:2122514767\"},\"name\":\"R\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Key model parameters were increased to determine the effects on the number of infections and deaths associated with each variant .\\nIn addition to parameters considered in the above analysis , we also considered two parameters that mediate VOC interactions : betaX R , rate of infection of individuals with partial immunity from having recovered from a different variant , and etaR , rate of loss of immunity due to infection .\\nSome of these parameters have distinct values for each of the variants .\",\"char_start\":3714,\"char_end\":3715,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590151\"}},{\"id\":{\"id\":\"mit36\"},\"name\":\"M\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-240847643\"},\"description\":\"rate of infection of individuals with partial immunity\",\"grounding\":[{\"grounding_text\":\"rate of cases with at least one comorbidity\",\"grounding_id\":\"cemo:rate_of_cases_with_at_least_one_comorbidity\",\"source\":[],\"score\":0.8423323035240173,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.590168\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":3717,\"char_end\":3771,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590151\"}},{\"id\":{\"id\":\"mit36\"},\"description\":\"vaccine type (either V1 or V2)\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"ViroKey SARS-CoV-2 RT-PCR Test v2.0\",\"grounding_id\":\"cido:0020325\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"KimForest SARS-CoV-2 Detection Kit v1\",\"grounding_id\":\"cido:0020179\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":[{\"id\":{\"id\":\"8-1\"},\"name\":\"location_key\",\"dataset\":{\"id\":{\"id\":\"8\"},\"name\":\"usa-vaccinations.csv\",\"metadata\":\"https://github.com/DARPA-ASKEM/program-milestones/blob/main/6-month-milestone/evaluation/scenario_3/ta_1/google-health-data/usa-vaccinations.csv\"}}]}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1308192125\"},\"mentions\":[{\"id\":{\"id\":\"T:2122514767\"},\"name\":\"R\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Key model parameters were increased to determine the effects on the number of infections and deaths associated with each variant .\\nIn addition to parameters considered in the above analysis , we also considered two parameters that mediate VOC interactions : betaX R , rate of infection of individuals with partial immunity from having recovered from a different variant , and etaR , rate of loss of immunity due to infection .\\nSome of these parameters have distinct values for each of the variants .\",\"char_start\":3714,\"char_end\":3715,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590204\"}},{\"id\":{\"id\":\"mit37\"},\"name\":\"AX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-240847643\"},\"description\":\"rate of infection of individuals with partial immunity\",\"grounding\":[{\"grounding_text\":\"rate of cases with at least one comorbidity\",\"grounding_id\":\"cemo:rate_of_cases_with_at_least_one_comorbidity\",\"source\":[],\"score\":0.8423323035240173,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.590222\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":3717,\"char_end\":3771,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590204\"}},{\"id\":{\"id\":\"mit37\"},\"description\":\"class for asymptomatic infections of vaccinated and unvaccinated individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"unvaccinated with a licensed vaccine\",\"grounding_id\":\"vo:0001379\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"unvaccinated organism\",\"grounding_id\":\"vo:0001383\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1519012352\"},\"mentions\":[{\"id\":{\"id\":\"T:-485876254\"},\"name\":\"four parameters\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Thus , the number of infections directly depends on , and is in fact highly sensitive to , betaW , sigmaW , alphaW , and also to the recovery rate gammaW , which impacts how many new infections an infected individual can cause .\\nSmall variations in these four parameters ( 5 % ) result in changes in the number of infections and deaths that are an order of magnitude larger ; see Fig.4 .\\nCOVID-19 mortality rate muW I affects the number of infected individuals who are alive and can participate in the spread of the disease .\",\"char_start\":1340,\"char_end\":1355,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590258\"}},{\"id\":{\"id\":\"mit38\"},\"name\":\"IXV\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"mit38\"},\"description\":\"class for symptomatic infections of vaccinated individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:1959361323\"},\"value\":{\"amount\":\"%\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":1358,\"char_end\":1359,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590258\"}}],\"groundings\":[{\"grounding_text\":\"vaccinated with a licensed vaccine\",\"grounding_id\":\"vo:0001378\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"vaccinated\",\"grounding_id\":\"vo:0001376\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:795884335\"},\"mentions\":[{\"id\":{\"id\":\"T:-1390511752\"},\"name\":\"Fig.4\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"Because dosing interval can vary greatly within the population , and because vaccine escape rate is not sufficiently well characterized , these two parameters were varied by 50 % .\\nThe vaccine-related results suggest that among these three factors , an effective vaccine deployment ( captured in omega1 ) is the key in combating a pandemic , and success may be achieved even by means of a less-than-ideal vaccine with higher escape rate ( Fig.4 ) .\\nSince the predicted numbers of infections and deaths are substantially more sensitive to variations in omega1 than omega2 , if vaccine supply is limited , prioritizing the first dose by lengthening the dosing interval would be advisable , as was done in Canada .\",\"char_start\":3040,\"char_end\":3045,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590304\"}},{\"id\":{\"id\":\"mit39\"},\"name\":\"μXV\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:246592660\"},\"description\":\"higher escape rate\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":3020,\"char_end\":3038,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590304\"}},{\"id\":{\"id\":\"mit39\"},\"description\":\"mortality rate for symptomatic infections of vaccinated individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"stato:0000414\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"neonatal mortality rate\",\"grounding_id\":\"sdgio:00020030\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1041191212\"},\"mentions\":[{\"id\":{\"id\":\"T:-1931272243\"},\"name\":\"Fig.4\",\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":\"lambda and omega1 are varied by 5 % .\\nSince NPI are modelled by scaling betaW directly , they have large effects on model predictions ( Fig.4 ) .\\nVaccination rate has lesser but still significant effects on the spread of the disease .\",\"char_start\":2422,\"char_end\":2427,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590363\"}},{\"id\":{\"id\":\"mit40\"},\"name\":\"dIXV\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:817805856\"},\"description\":\"model predictions\",\"grounding\":[{\"grounding_text\":\"Susceptible-Infected-Resistant model\",\"grounding_id\":\"apollosv:00000549\",\"source\":[],\"score\":0.8817113041877747,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.590386\"}}],\"extraction_source\":{\"page\":3,\"block\":2,\"surrounding_passage\":null,\"char_start\":2403,\"char_end\":2420,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.590363\"}},{\"id\":{\"id\":\"mit40\"},\"description\":\"change in the number of symptomatic infections of vaccinated individuals over time\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"vaccinated in route\",\"grounding_id\":\"vo:0000547\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"vaccinated with a licensed vaccine\",\"grounding_id\":\"vo:0001378\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-535082164\"},\"mentions\":[{\"id\":{\"id\":\"T:762532133\"},\"name\":\"Fig.8b\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"Taken together , the asymptomatic patients , including those who are vaccinated , play a more significant role in spreading the Delta variant , compared to the wild type .\\nAnd that difference is even larger in the alternative scenario where most of the vaccines are AstraZeneca ( Fig.8b ) .\",\"char_start\":3302,\"char_end\":3308,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591207\"}},{\"id\":{\"id\":\"mit41\"},\"name\":\"dt\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1650338856\"},\"description\":\"alternative scenario where most of the vaccines are AstraZeneca\",\"grounding\":[{\"grounding_text\":\"COVAXIN\",\"grounding_id\":\"vo:0004991\",\"source\":[],\"score\":0.8232312798500061,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.591230\"}}],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":3237,\"char_end\":3300,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591207\"}},{\"id\":{\"id\":\"mit41\"},\"description\":\"change in time\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"\",\"grounding_id\":\"fbbt:00000624\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"DT Polio Adsorbed\",\"grounding_id\":\"vo:0010709\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1637552708\"},\"mentions\":[{\"id\":{\"id\":\"T:-486621082\"},\"name\":\"Fig.7a\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"With a larger portion of the vaccinated population now under reduced vaccine protection , the spread of the VOC is substantially accelerated .\\nBy the end of 2021 , the model predicts 794 new Delta infections a day , more than three times higher than the baseline prediction of 234 new Delta infections a day ( Fig.7a ) .\\nThe total number of Delta infections and related deaths are also significantly higher , predicted to be 62K and 882 at the end of 2021 , respectively , compared to baseline values of 39K and 689 ( Fig.7b , d ) .\",\"char_start\":990,\"char_end\":996,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591268\"}},{\"id\":{\"id\":\"mit42\"},\"name\":\"total\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-64792771\"},\"description\":\"day\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":985,\"char_end\":988,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591268\"}},{\"id\":{\"id\":\"mit42\"},\"description\":\"total number of individuals in a specific class\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"protein total increased AE\",\"grounding_id\":\"oae:0001658\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"protein total decreased AE\",\"grounding_id\":\"oae:0001659\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1830320991\"},\"mentions\":[{\"id\":{\"id\":\"T:-939186372\"},\"name\":\"NPI\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"Thus , we consider a scenario with less stringent NPI starting from the fall of 2021 ( September 1 2021 ) , with lambda increased from its baseline value of 0.4 to 0.5 onwards .\\nThe model predicts the reduced NPI would accelerate the spread of Delta , such that by March 2022 , the total number of Delta infections would be 50 % higher than baseline ( Fig.7b ) .\\nWho are getting infected by the Delta variant , and who are the carriers ?\",\"char_start\":2112,\"char_end\":2115,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591373\"}},{\"id\":{\"id\":\"mit43\"},\"name\":\"W\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2100959297\"},\"description\":\"reduced\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":2104,\"char_end\":2111,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591373\"}},{\"id\":{\"id\":\"mit43\"},\"description\":\"class for recovered individuals with immunity to the variant they were infected with\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Susceptible-Infected-Resistant model\",\"grounding_id\":\"apollosv:00000549\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1864118410\"},\"mentions\":[{\"id\":{\"id\":\"T:-121832131\"},\"name\":\"Delta\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"What if a larger fraction of the vaccines were AstraZeneca , as is the case in the UK18 .\\nA notable difference between the two vaccine types is that the Pfizer vaccine of fers stronger protection than AstraZeneca against all COVID variants , especially Delta , after either one or two doses .\\nFor instance , an individual having received both doses of the Pfizer vaccine is 88 % protected against the Delta variant , where as with the AstraZeneca vaccine the protection is only at 60 % 19 .\",\"char_start\":385,\"char_end\":390,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591445\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-385630701\"},\"description\":\"COVID variants\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":358,\"char_end\":372,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591445\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1461588612\"},\"mentions\":[{\"id\":{\"id\":\"T:-1763488841\"},\"name\":\"Fig.8a\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"This difference may be attributable to the vaccination status of the infected population .\\nDue to the larger vaccine breakthrough rate of the Delta variant , almost a quarter of the infected individuals have been vaccinated ( Fig.8a ) ; in contrast , for the wild type , vaccinated individuals make up a negligible fraction of the infected population ( Fig.3 ) .\\nBecause vaccination protects one from most major COVID-19 symptoms , most of the vaccinated infections are assumed to be asymptomatic ( 85 % compared to 50 % for the unvaccinated ) .\",\"char_start\":2721,\"char_end\":2727,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591545\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1754146058\"},\"description\":\"have been vaccinated\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":2699,\"char_end\":2719,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591545\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1956562617\"},\"mentions\":[{\"id\":{\"id\":\"T:350961012\"},\"name\":\"Fig.3\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"This difference may be attributable to the vaccination status of the infected population .\\nDue to the larger vaccine breakthrough rate of the Delta variant , almost a quarter of the infected individuals have been vaccinated ( Fig.8a ) ; in contrast , for the wild type , vaccinated individuals make up a negligible fraction of the infected population ( Fig.3 ) .\\nBecause vaccination protects one from most major COVID-19 symptoms , most of the vaccinated infections are assumed to be asymptomatic ( 85 % compared to 50 % for the unvaccinated ) .\",\"char_start\":2843,\"char_end\":2848,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591603\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1322440919\"},\"description\":\"negligible fraction of the infected population\",\"grounding\":[{\"grounding_text\":\"fraction of vector adults affected\",\"grounding_id\":\"apollosv:00000437\",\"source\":[],\"score\":0.8530557751655579,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.591664\"}}],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":2795,\"char_end\":2841,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591603\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1164908205\"},\"mentions\":[{\"id\":{\"id\":\"T:-726685136\"},\"name\":\"be 62K and 882 at the end of 2021, respectively, compared to baseline values of 39K and 689\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"By the end of 2021 , the model predicts 794 new Delta infections a day , more than three times higher than the baseline prediction of 234 new Delta infections a day ( Fig.7a ) .\\nThe total number of Delta infections and related deaths are also significantly higher , predicted to be 62K and 882 at the end of 2021 , respectively , compared to baseline values of 39K and 689 ( Fig.7b , d ) .\\nIf the provincial vaccination rate were lower , such that by September 1 2021 only 67 % of the population are vaccinated with at least one dose , compared to the baseline vaccinated percentage of 74 % ( Fig.7c ) , the total number of Delta infections and deaths would increase by 75 % by the end of March 2022 ; see Fig.7b , d. Beginning mid June 2021 , Ontario began to gradually reopen , with in-person classes set to resume in September .\",\"char_start\":1099,\"char_end\":1190,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591703\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:-461395540\"},\"value\":{\"amount\":\"882\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":1110,\"char_end\":1113,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591703\"}}],\"groundings\":[{\"grounding_text\":\"Sponsor-Investigator\",\"grounding_id\":\"ncit:C142695\",\"source\":[],\"score\":0.8208585381507874,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.591714\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1822299949\"},\"mentions\":[{\"id\":{\"id\":\"T:-1785832053\"},\"name\":\"protection\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"A notable difference between the two vaccine types is that the Pfizer vaccine of fers stronger protection than AstraZeneca against all COVID variants , especially Delta , after either one or two doses .\\nFor instance , an individual having received both doses of the Pfizer vaccine is 88 % protected against the Delta variant , where as with the AstraZeneca vaccine the protection is only at 60 % 19 .\\nWe conduct a simulation in which only 40 % of the vaccines are Pfizer .\",\"char_start\":586,\"char_end\":596,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591810\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:1522082591\"},\"value\":{\"amount\":\"19\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":611,\"char_end\":613,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591810\"}}],\"groundings\":[{\"grounding_text\":\"protection efficacy\",\"grounding_id\":\"vo:0000456\",\"source\":[],\"score\":0.8532915711402893,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.591819\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1839289179\"},\"mentions\":[{\"id\":{\"id\":\"T:-1785832053\"},\"name\":\"protection\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"A notable difference between the two vaccine types is that the Pfizer vaccine of fers stronger protection than AstraZeneca against all COVID variants , especially Delta , after either one or two doses .\\nFor instance , an individual having received both doses of the Pfizer vaccine is 88 % protected against the Delta variant , where as with the AstraZeneca vaccine the protection is only at 60 % 19 .\\nWe conduct a simulation in which only 40 % of the vaccines are Pfizer .\",\"char_start\":586,\"char_end\":596,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591897\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:1120267797\"},\"value\":{\"amount\":\"%\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":610,\"char_end\":611,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591897\"}}],\"groundings\":[{\"grounding_text\":\"protection efficacy\",\"grounding_id\":\"vo:0000456\",\"source\":[],\"score\":0.8532915711402893,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.591909\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:390122022\"},\"mentions\":[{\"id\":{\"id\":\"T:-1785832053\"},\"name\":\"protection\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"A notable difference between the two vaccine types is that the Pfizer vaccine of fers stronger protection than AstraZeneca against all COVID variants , especially Delta , after either one or two doses .\\nFor instance , an individual having received both doses of the Pfizer vaccine is 88 % protected against the Delta variant , where as with the AstraZeneca vaccine the protection is only at 60 % 19 .\\nWe conduct a simulation in which only 40 % of the vaccines are Pfizer .\",\"char_start\":586,\"char_end\":596,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591985\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:1522082591\"},\"value\":{\"amount\":\"19\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":611,\"char_end\":613,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591985\"}},{\"id\":{\"id\":\"T:1120267797\"},\"value\":{\"amount\":\"%\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":610,\"char_end\":611,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.591985\"}}],\"groundings\":[{\"grounding_text\":\"protection efficacy\",\"grounding_id\":\"vo:0000456\",\"source\":[],\"score\":0.8532915711402893,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.591994\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1137065363\"},\"mentions\":[{\"id\":{\"id\":\"T:939793819\"},\"name\":\"Fig.7b\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"The total number of Delta infections and related deaths are also significantly higher , predicted to be 62K and 882 at the end of 2021 , respectively , compared to baseline values of 39K and 689 ( Fig.7b , d ) .\\nIf the provincial vaccination rate were lower , such that by September 1 2021 only 67 % of the population are vaccinated with at least one dose , compared to the baseline vaccinated percentage of 74 % ( Fig.7c ) , the total number of Delta infections and deaths would increase by 75 % by the end of March 2022 ; see Fig.7b , d. Beginning mid June 2021 , Ontario began to gradually reopen , with in-person classes set to resume in September .\\nThe baseline model assumes that the NPI that remain will still reduce COVID-19 infectivity by 60 % .\",\"char_start\":1510,\"char_end\":1516,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592083\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:2092884841\"},\"description\":\"d. Beginning mid-June 2021\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":1517,\"char_end\":1543,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592083\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1311518691\"},\"mentions\":[{\"id\":{\"id\":\"T:-309991041\"},\"name\":\"end of March 2022\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"The total number of Delta infections and related deaths are also significantly higher , predicted to be 62K and 882 at the end of 2021 , respectively , compared to baseline values of 39K and 689 ( Fig.7b , d ) .\\nIf the provincial vaccination rate were lower , such that by September 1 2021 only 67 % of the population are vaccinated with at least one dose , compared to the baseline vaccinated percentage of 74 % ( Fig.7c ) , the total number of Delta infections and deaths would increase by 75 % by the end of March 2022 ; see Fig.7b , d. Beginning mid June 2021 , Ontario began to gradually reopen , with in-person classes set to resume in September .\\nThe baseline model assumes that the NPI that remain will still reduce COVID-19 infectivity by 60 % .\",\"char_start\":1487,\"char_end\":1504,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592175\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:-471645634\"},\"value\":{\"amount\":\"75\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":1476,\"char_end\":1478,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592175\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1669100175\"},\"mentions\":[{\"id\":{\"id\":\"T:1320840557\"},\"name\":\"vaccinated percentage\",\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":\"The total number of Delta infections and related deaths are also significantly higher , predicted to be 62K and 882 at the end of 2021 , respectively , compared to baseline values of 39K and 689 ( Fig.7b , d ) .\\nIf the provincial vaccination rate were lower , such that by September 1 2021 only 67 % of the population are vaccinated with at least one dose , compared to the baseline vaccinated percentage of 74 % ( Fig.7c ) , the total number of Delta infections and deaths would increase by 75 % by the end of March 2022 ; see Fig.7b , d. Beginning mid June 2021 , Ontario began to gradually reopen , with in-person classes set to resume in September .\\nThe baseline model assumes that the NPI that remain will still reduce COVID-19 infectivity by 60 % .\",\"char_start\":1371,\"char_end\":1392,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592266\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:-1807101167\"},\"value\":{\"amount\":\"%\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":8,\"surrounding_passage\":null,\"char_start\":1398,\"char_end\":1399,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592266\"}}],\"groundings\":[{\"grounding_text\":\"vaccinated\",\"grounding_id\":\"vo:0001376\",\"source\":[],\"score\":0.8089877963066101,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.592275\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1998430605\"},\"mentions\":[{\"id\":{\"id\":\"T:-261742887\"},\"name\":\"Neos\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"The spread of a hypothetical , deadlier VOC , Neos .\\nAlpha is more infectious than the wild type ; Delta is worse than Alpha ; Lambda may be even worse .\",\"char_start\":44,\"char_end\":48,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592687\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:785848723\"},\"description\":\"spread of a hypothetical, deadlier VOC\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":4,\"char_end\":42,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592687\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:786071264\"},\"mentions\":[{\"id\":{\"id\":\"T:1004466560\"},\"name\":\"its\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"To gain insights , we simulate a dangerous hypothetical variant , which we refer to as `` Neos .\\n'' Neos is designed to be deadlier by increasing its ( i ) infectivity ( 14 % higher than the Delta variant ) , ( ii ) vaccine escape rate ( 70 % for one dose of Pfizer or AstraZeneca , similar to Delta which is 67 % ; 25 % and 50 % for two doses of Pfizer and AstraZeneca , respectively ; compared to 12 % and 40 % for Delta ) , and ( iii ) fraction of asymptomatic infections ( 55 % instead of 50 % ) .\\nRecovery rate , mortality rate , and other clinical features are assumed to be the same as the wild type .\",\"char_start\":426,\"char_end\":429,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592737\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:103720924\"},\"value\":{\"amount\":\"%\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":750,\"char_end\":751,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592737\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1015129557\"},\"mentions\":[{\"id\":{\"id\":\"T:2003387435\"},\"name\":\"50%\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"To gain insights , we simulate a dangerous hypothetical variant , which we refer to as `` Neos .\\n'' Neos is designed to be deadlier by increasing its ( i ) infectivity ( 14 % higher than the Delta variant ) , ( ii ) vaccine escape rate ( 70 % for one dose of Pfizer or AstraZeneca , similar to Delta which is 67 % ; 25 % and 50 % for two doses of Pfizer and AstraZeneca , respectively ; compared to 12 % and 40 % for Delta ) , and ( iii ) fraction of asymptomatic infections ( 55 % instead of 50 % ) .\\nRecovery rate , mortality rate , and other clinical features are assumed to be the same as the wild type .\",\"char_start\":748,\"char_end\":751,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592796\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:436213608\"},\"value\":{\"amount\":\"55\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":733,\"char_end\":735,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592796\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:847069629\"},\"mentions\":[{\"id\":{\"id\":\"T:-1389549157\"},\"name\":\"70% for one dose of Pfizer or AstraZeneca, similar to Delta\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"To gain insights , we simulate a dangerous hypothetical variant , which we refer to as `` Neos .\\n'' Neos is designed to be deadlier by increasing its ( i ) infectivity ( 14 % higher than the Delta variant ) , ( ii ) vaccine escape rate ( 70 % for one dose of Pfizer or AstraZeneca , similar to Delta which is 67 % ; 25 % and 50 % for two doses of Pfizer and AstraZeneca , respectively ; compared to 12 % and 40 % for Delta ) , and ( iii ) fraction of asymptomatic infections ( 55 % instead of 50 % ) .\\nRecovery rate , mortality rate , and other clinical features are assumed to be the same as the wild type .\",\"char_start\":509,\"char_end\":568,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592857\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:-1225552525\"},\"value\":{\"amount\":\"70\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":509,\"char_end\":511,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592857\"}}],\"groundings\":[{\"grounding_text\":\"AdCOVID\",\"grounding_id\":\"vo:0005153\",\"source\":[],\"score\":0.8080059289932251,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.592865\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1957664339\"},\"mentions\":[{\"id\":{\"id\":\"T:662304642\"},\"name\":\"25% and 50% for two doses of Pfizer and AstraZeneca\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"To gain insights , we simulate a dangerous hypothetical variant , which we refer to as `` Neos .\\n'' Neos is designed to be deadlier by increasing its ( i ) infectivity ( 14 % higher than the Delta variant ) , ( ii ) vaccine escape rate ( 70 % for one dose of Pfizer or AstraZeneca , similar to Delta which is 67 % ; 25 % and 50 % for two doses of Pfizer and AstraZeneca , respectively ; compared to 12 % and 40 % for Delta ) , and ( iii ) fraction of asymptomatic infections ( 55 % instead of 50 % ) .\\nRecovery rate , mortality rate , and other clinical features are assumed to be the same as the wild type .\",\"char_start\":583,\"char_end\":634,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592910\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:1339476510\"},\"value\":{\"amount\":\"50\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":591,\"char_end\":593,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592910\"}}],\"groundings\":[{\"grounding_text\":\"M-M-Vax\",\"grounding_id\":\"vo:0000070\",\"source\":[],\"score\":0.7544083595275879,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.592918\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:428284098\"},\"mentions\":[{\"id\":{\"id\":\"T:-306035968\"},\"name\":\"Fig.9f\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"After its introduction , Neos quickly takes hold due to its high transmissivity , and by the end of 2021 , it has overtaken Delta to account for the majority of new infections ( Fig.9c ) .\\nBy mid 2022 , the infected individuals would account for 1 % of the entire population ( Fig.9f ) , despite nearly 80 % of the population having been vaccinated .\\nMore than 6.6K would have died from Neos ( Fig.9g ) ; that is likely an underestimate , since the number of severe cases might overwhelm the hospitals , elevating the mortality rate .\",\"char_start\":1290,\"char_end\":1296,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592966\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:509967361\"},\"description\":\"mid 2022, the infected individuals would account for 1% of the entire population\",\"grounding\":[{\"grounding_text\":\"rate of cases with at least one comorbidity\",\"grounding_id\":\"cemo:rate_of_cases_with_at_least_one_comorbidity\",\"source\":[],\"score\":0.8129532337188721,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.592981\"}}],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":1208,\"char_end\":1288,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.592966\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:2008329411\"},\"mentions\":[{\"id\":{\"id\":\"T:-1759904592\"},\"name\":\"NPI\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"Two potential measures are investigated .\\nFirst , we consider more stringent NPI , perhaps a provincial lockdown .\\nAs noted above , the baseline model includes some NPI that are assumed to lower social contacts by at least 60 % .\",\"char_start\":2575,\"char_end\":2578,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593016\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1362700265\"},\"description\":\"provincial lockdown\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":2590,\"char_end\":2609,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593016\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-491568125\"},\"mentions\":[{\"id\":{\"id\":\"T:-480736182\"},\"name\":\"Fig.9c\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"The predicted population dynamics that describe its spread , from August 1 2021 to June 30 2022 , is shown in Fig.9 .\\nAfter its introduction , Neos quickly takes hold due to its high transmissivity , and by the end of 2021 , it has overtaken Delta to account for the majority of new infections ( Fig.9c ) .\\nBy mid 2022 , the infected individuals would account for 1 % of the entire population ( Fig.9f ) , despite nearly 80 % of the population having been vaccinated .\",\"char_start\":1196,\"char_end\":1202,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593082\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1247709526\"},\"description\":\"account for the majority of new infections\",\"grounding\":[{\"grounding_text\":\"number of cases by testing\",\"grounding_id\":\"cemo:number_of_cases_by_testing\",\"source\":[],\"score\":0.8191622495651245,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.593100\"}}],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":1152,\"char_end\":1194,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593082\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:860821778\"},\"mentions\":[{\"id\":{\"id\":\"T:-1164225066\"},\"name\":\"Neos\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"The predicted population dynamics that describe its spread , from August 1 2021 to June 30 2022 , is shown in Fig.9 .\\nAfter its introduction , Neos quickly takes hold due to its high transmissivity , and by the end of 2021 , it has overtaken Delta to account for the majority of new infections ( Fig.9c ) .\\nBy mid 2022 , the infected individuals would account for 1 % of the entire population ( Fig.9f ) , despite nearly 80 % of the population having been vaccinated .\",\"char_start\":1046,\"char_end\":1050,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593135\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:2127064530\"},\"description\":\"introduction\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":1032,\"char_end\":1044,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593135\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1468322701\"},\"mentions\":[{\"id\":{\"id\":\"T:-216664730\"},\"name\":\"V3\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"In this simulation , we assume that a third dose of either the Pfizer or AstraZeneca vaccine would reduce vaccine breakthrough of Neos to 10 % and 20 % , respectively ( compared to 25 % and 50 % , respectively , with two doses ) , and also double M that has the protection against Alpha and Delta .\\nTo model a third vaccine dose , we add a new population V3 received three vaccine shots .\",\"char_start\":4153,\"char_end\":4155,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593205\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1776097829\"},\"description\":\"new population\",\"grounding\":[{\"grounding_text\":\"New Stuyahok\",\"grounding_id\":\"ncit:C44612\",\"source\":[],\"score\":0.8070313334465027,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.593226\"}}],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":4138,\"char_end\":4152,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593205\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:211817700\"},\"mentions\":[{\"id\":{\"id\":\"T:333027162\"},\"name\":\"lambda\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"That is , ( i ) if 60 % of the vaccines are AstraZeneca , ( ii ) if vaccination deployment is slower , and ( iii ) if NPI are relaxed .\\nIf the vaccination rate is 20 % lower , the model predicts that the total number of Neos infections would be 3 times the original value ; with 60 % AstraZeneca vaccines , 4.6 times ; fewer restrictions ( lambda = 0.5 instead of 0.4 ) , 5 times .\\nSee fig.10b .\",\"char_start\":2057,\"char_end\":2063,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593314\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:1405952390\"},\"value\":{\"amount\":\"0.5\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":2066,\"char_end\":2069,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593314\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-963867388\"},\"mentions\":[{\"id\":{\"id\":\"T:333027162\"},\"name\":\"lambda\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"That is , ( i ) if 60 % of the vaccines are AstraZeneca , ( ii ) if vaccination deployment is slower , and ( iii ) if NPI are relaxed .\\nIf the vaccination rate is 20 % lower , the model predicts that the total number of Neos infections would be 3 times the original value ; with 60 % AstraZeneca vaccines , 4.6 times ; fewer restrictions ( lambda = 0.5 instead of 0.4 ) , 5 times .\\nSee fig.10b .\",\"char_start\":2057,\"char_end\":2063,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593428\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1405326093\"},\"description\":\"lambda\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":2057,\"char_end\":2063,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593428\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:514068618\"},\"mentions\":[{\"id\":{\"id\":\"T:333027162\"},\"name\":\"lambda\",\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":\"That is , ( i ) if 60 % of the vaccines are AstraZeneca , ( ii ) if vaccination deployment is slower , and ( iii ) if NPI are relaxed .\\nIf the vaccination rate is 20 % lower , the model predicts that the total number of Neos infections would be 3 times the original value ; with 60 % AstraZeneca vaccines , 4.6 times ; fewer restrictions ( lambda = 0.5 instead of 0.4 ) , 5 times .\\nSee fig.10b .\",\"char_start\":2057,\"char_end\":2063,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593513\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1405326093\"},\"description\":\"lambda\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":2057,\"char_end\":2063,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593513\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:1405952390\"},\"value\":{\"amount\":\"0.5\",\"grounding\":[],\"extraction_source\":{\"page\":8,\"block\":4,\"surrounding_passage\":null,\"char_start\":2066,\"char_end\":2069,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.593513\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:34958215\"},\"mentions\":[{\"id\":{\"id\":\"T:989106688\"},\"name\":\"Fig.9\",\"extraction_source\":{\"page\":11,\"block\":11,\"surrounding_passage\":\"Unfortunately , our model simulation suggests that the answer is no .\\nWithout additional interventions , such a VOC would infect many more and likely overwhelm the health care system ( Fig.9 ) .\\nThe situation would likely be worse in another region that has a lower rate of vaccination or less effective vaccines ( Fig.10 ) .\",\"char_start\":1381,\"char_end\":1386,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594173\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:94813290\"},\"description\":\"health care system\",\"grounding\":[{\"grounding_text\":\"Health Care Organization\",\"grounding_id\":\"ncit:C43960\",\"source\":[],\"score\":0.8675731420516968,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.594196\"}}],\"extraction_source\":{\"page\":11,\"block\":11,\"surrounding_passage\":null,\"char_start\":1361,\"char_end\":1379,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594173\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1290099843\"},\"mentions\":[{\"id\":{\"id\":\"T:664216289\"},\"name\":\"Fig.7\",\"extraction_source\":{\"page\":11,\"block\":11,\"surrounding_passage\":\"While the Delta strain is undoubtedly wreaking havoc globally , severity differs among countries .\\nOur analysis suggests that how fast Delta spreads depends not only on the NPI and on the fraction of the population who are vaccinated , but also on the types of the vaccines distributed ( Fig.7 ) .\\n4 .\",\"char_start\":667,\"char_end\":672,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594247\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2117503504\"},\"description\":\"distributed\",\"grounding\":[],\"extraction_source\":{\"page\":11,\"block\":11,\"surrounding_passage\":null,\"char_start\":654,\"char_end\":665,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594247\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1659964566\"},\"mentions\":[{\"id\":{\"id\":\"T:-1987709851\"},\"name\":\"Fig.8\",\"extraction_source\":{\"page\":11,\"block\":11,\"surrounding_passage\":\"Vaccinated individuals have a significant chance of suffering a vaccine breakthrough with Delta .\\nModel analysis points to a significant role of the vaccinated individuals in the spread of Delta , particularly in a community where most of the vaccines are AstraZeneca ( Fig.8 ) .\\n5 .\",\"char_start\":945,\"char_end\":950,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594303\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1457565764\"},\"description\":\"community where most of the vaccines are AstraZeneca\",\"grounding\":[{\"grounding_text\":\"COVAXIN\",\"grounding_id\":\"vo:0004991\",\"source\":[],\"score\":0.8213240504264832,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.594324\"}}],\"extraction_source\":{\"page\":11,\"block\":11,\"surrounding_passage\":null,\"char_start\":891,\"char_end\":943,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594303\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-856046416\"},\"mentions\":[{\"id\":{\"id\":\"T:1740553002\"},\"name\":\"Fig.10\",\"extraction_source\":{\"page\":11,\"block\":11,\"surrounding_passage\":\"Without additional interventions , such a VOC would infect many more and likely overwhelm the health care system ( Fig.9 ) .\\nThe situation would likely be worse in another region that has a lower rate of vaccination or less effective vaccines ( Fig.10 ) .\",\"char_start\":1508,\"char_end\":1514,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594380\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-681188948\"},\"description\":\"less effective vaccines\",\"grounding\":[{\"grounding_text\":\"effective\",\"grounding_id\":\"vo:0000805\",\"source\":[],\"score\":0.7866713404655457,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.594408\"}}],\"extraction_source\":{\"page\":11,\"block\":11,\"surrounding_passage\":null,\"char_start\":1483,\"char_end\":1506,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594380\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-598133204\"},\"mentions\":[{\"id\":{\"id\":\"T:-248854092\"},\"name\":\"epsilon\",\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\nThese models can be a valuable decision-support tool for public health .\",\"char_start\":1505,\"char_end\":1512,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594645\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:539099570\"},\"description\":\"vaccine type\",\"grounding\":[{\"grounding_text\":\"Canine Distemper-Adenovirus Type 2-Parvovirus-Rabies Vaccine\",\"grounding_id\":\"vo:0002414\",\"source\":[],\"score\":0.8904863595962524,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.594669\"}}],\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":null,\"char_start\":1492,\"char_end\":1504,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594645\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-77644022\"},\"mentions\":[{\"id\":{\"id\":\"T:-248854092\"},\"name\":\"epsilon\",\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\nThese models can be a valuable decision-support tool for public health .\",\"char_start\":1505,\"char_end\":1512,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594716\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1165854661\"},\"description\":\"COVID-19 mortality rate muX\",\"grounding\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"apollosv:00000445\",\"source\":[],\"score\":0.8332589864730835,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.594738\"}}],\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":null,\"char_start\":1514,\"char_end\":1541,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594716\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1160080482\"},\"mentions\":[{\"id\":{\"id\":\"T:-248854092\"},\"name\":\"epsilon\",\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\nThese models can be a valuable decision-support tool for public health .\",\"char_start\":1505,\"char_end\":1512,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594790\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1165854661\"},\"description\":\"COVID-19 mortality rate muX\",\"grounding\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"apollosv:00000445\",\"source\":[],\"score\":0.8332589864730835,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.594812\"}}],\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":null,\"char_start\":1514,\"char_end\":1541,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594790\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-752128713\"},\"mentions\":[{\"id\":{\"id\":\"T:-810248146\"},\"name\":\"muX\",\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\nThese models can be a valuable decision-support tool for public health .\",\"char_start\":1538,\"char_end\":1541,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594857\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1583784791\"},\"description\":\"COVID-19 mortality rate\",\"grounding\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"apollosv:00000445\",\"source\":[],\"score\":0.9101454615592957,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.594883\"}}],\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":null,\"char_start\":1514,\"char_end\":1537,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594857\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Saxman\",\"grounding_id\":\"ncit:C44726\",\"source\":[],\"score\":0.7636157870292664,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.594865\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-629925471\"},\"mentions\":[{\"id\":{\"id\":\"T:680344900\"},\"name\":\"NPI lambda)\",\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\nThese models can be a valuable decision-support tool for public health .\",\"char_start\":1543,\"char_end\":1554,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594928\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1165854661\"},\"description\":\"COVID-19 mortality rate muX\",\"grounding\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"apollosv:00000445\",\"source\":[],\"score\":0.8332589864730835,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.594992\"}}],\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":null,\"char_start\":1514,\"char_end\":1541,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.594928\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1084065351\"},\"mentions\":[{\"id\":{\"id\":\"T:680344900\"},\"name\":\"NPI lambda)\",\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\nThese models can be a valuable decision-support tool for public health .\",\"char_start\":1543,\"char_end\":1554,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595038\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1066303140\"},\"description\":\"beta\",\"grounding\":[{\"grounding_text\":\"beta distribution\",\"grounding_id\":\"apollosv:00000078\",\"source\":[],\"score\":0.807852566242218,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595061\"}}],\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":null,\"char_start\":1486,\"char_end\":1490,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595038\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1751229178\"},\"mentions\":[{\"id\":{\"id\":\"T:680344900\"},\"name\":\"NPI lambda)\",\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\nThese models can be a valuable decision-support tool for public health .\",\"char_start\":1543,\"char_end\":1554,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595108\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1066303140\"},\"description\":\"beta\",\"grounding\":[{\"grounding_text\":\"beta distribution\",\"grounding_id\":\"apollosv:00000078\",\"source\":[],\"score\":0.807852566242218,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595129\"}}],\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":null,\"char_start\":1486,\"char_end\":1490,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595108\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1086028280\"},\"mentions\":[{\"id\":{\"id\":\"T:680344900\"},\"name\":\"NPI lambda)\",\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\nThese models can be a valuable decision-support tool for public health .\",\"char_start\":1543,\"char_end\":1554,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595175\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1066303140\"},\"description\":\"beta\",\"grounding\":[{\"grounding_text\":\"beta distribution\",\"grounding_id\":\"apollosv:00000078\",\"source\":[],\"score\":0.807852566242218,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595202\"}}],\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":null,\"char_start\":1486,\"char_end\":1490,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595175\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1225515740\"},\"mentions\":[{\"id\":{\"id\":\"T:-114903013\"},\"name\":\"beta\",\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\nThese models can be a valuable decision-support tool for public health .\",\"char_start\":1486,\"char_end\":1490,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595246\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1989796303\"},\"description\":\"e.g., infectivity\",\"grounding\":[],\"extraction_source\":{\"page\":13,\"block\":6,\"surrounding_passage\":null,\"char_start\":1468,\"char_end\":1485,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595246\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"beta distribution\",\"grounding_id\":\"apollosv:00000078\",\"source\":[],\"score\":0.807852566242218,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595254\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:2043881519\"},\"mentions\":[{\"id\":{\"id\":\"T:109668800\"},\"name\":\"SVR\",\"extraction_source\":{\"page\":14,\"block\":1,\"surrounding_passage\":\"Population in the province is divided into several classes based on their health and vaccination status .\\nTwo `` susceptible '' populations are tracked : the original susceptible individuals ( denoted ' S ' ) , who are unvaccinated and have never been infected , and those who become susceptible again after losing their immunity from either vaccination or infection ( denoted ' SVR ' ; more about loss of immunity M class .\\nTwo below ) .\",\"char_start\":518,\"char_end\":521,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595487\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2084842899\"},\"description\":\"denoted '\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":1,\"surrounding_passage\":null,\"char_start\":509,\"char_end\":518,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595487\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1942444907\"},\"mentions\":[{\"id\":{\"id\":\"T:90135231\"},\"name\":\"spread\",\"extraction_source\":{\"page\":14,\"block\":1,\"surrounding_passage\":\"Methods Computational model description .\\nThe SV2 ( AIR ) 3 model simulates the spread of three SARS-CoV-2 strains in Ontario : wild type , Alpha , and Delta .\\nPopulation in the province is divided into several classes based on their health and vaccination status .\",\"char_start\":75,\"char_end\":81,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595536\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:2022960899\"},\"value\":{\"amount\":\"SARS-CoV-2 strains\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":1,\"surrounding_passage\":null,\"char_start\":91,\"char_end\":109,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595536\"}}],\"groundings\":[{\"grounding_text\":\"droplet spread transmission\",\"grounding_id\":\"trans:0000008\",\"source\":[],\"score\":0.8682812452316284,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595545\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1027255289\"},\"mentions\":[{\"id\":{\"id\":\"T:1768699793\"},\"name\":\"sigmaX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"An infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\nWe assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\nSymptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\",\"char_start\":775,\"char_end\":781,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595715\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1260547704\"},\"description\":\"virus type\",\"grounding\":[{\"grounding_text\":\"Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus-Rabies Virus Vaccine\",\"grounding_id\":\"vo:0002466\",\"source\":[],\"score\":0.8640658855438232,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595737\"}}],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":750,\"char_end\":760,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595715\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Snoqualmie\",\"grounding_id\":\"ncit:C44815\",\"source\":[],\"score\":0.7998793125152588,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595723\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-933677463\"},\"mentions\":[{\"id\":{\"id\":\"T:1768699793\"},\"name\":\"sigmaX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"An infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\nWe assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\nSymptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\",\"char_start\":775,\"char_end\":781,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595762\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:697409747\"},\"description\":\"fraction\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":766,\"char_end\":774,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595762\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Snoqualmie\",\"grounding_id\":\"ncit:C44815\",\"source\":[],\"score\":0.7998793125152588,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595770\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-960278729\"},\"mentions\":[{\"id\":{\"id\":\"T:1768699793\"},\"name\":\"sigmaX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"An infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\nWe assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\nSymptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\",\"char_start\":775,\"char_end\":781,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595807\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:697409747\"},\"description\":\"fraction\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":766,\"char_end\":774,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595807\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Snoqualmie\",\"grounding_id\":\"ncit:C44815\",\"source\":[],\"score\":0.7998793125152588,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595816\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1961690714\"},\"mentions\":[{\"id\":{\"id\":\"T:-977150681\"},\"name\":\"muX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"We assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\nSymptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\\nVaccinated individuals may be infected as well , at a reduced rate of betaX VM ( < betaX ) , where V is either V1 or V2 , and M denotes the vaccine type .\",\"char_start\":877,\"char_end\":880,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595853\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1186019931\"},\"description\":\"mortality rate\",\"grounding\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"apollosv:00000445\",\"source\":[],\"score\":0.9990238547325134,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595875\"}}],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":861,\"char_end\":875,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595853\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Saxman\",\"grounding_id\":\"ncit:C44726\",\"source\":[],\"score\":0.7636157870292664,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595861\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:702864283\"},\"mentions\":[{\"id\":{\"id\":\"T:854818942\"},\"name\":\"mu\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"We assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\nSymptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\\nVaccinated individuals may be infected as well , at a reduced rate of betaX VM ( < betaX ) , where V is either V1 or V2 , and M denotes the vaccine type .\",\"char_start\":909,\"char_end\":911,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595897\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:2100133414\"},\"description\":\"natural death\",\"grounding\":[{\"grounding_text\":\"Death by Natural Cause\",\"grounding_id\":\"ncit:C82465\",\"source\":[],\"score\":0.8426523208618164,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595918\"}}],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":894,\"char_end\":907,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595897\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:604822229\"},\"mentions\":[{\"id\":{\"id\":\"T:-1369001096\"},\"name\":\"muX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"Asymptomatic infections of vaccinated individuals enter AX class , same as infections of unvaccinated individuals .\\nIn contrast , symptomatic infections of vaccinated individuals are assumed to have a better survival rate ( with a mortality rate muX V < muX ) , and are represented as a separate infected class IX V. Unvaccinated asymptomatic patients vaccinate at the same rate as the susceptible population ( omega1 ) .\",\"char_start\":1372,\"char_end\":1375,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595944\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1900234311\"},\"description\":\"mortality rate\",\"grounding\":[{\"grounding_text\":\"mortality rate\",\"grounding_id\":\"apollosv:00000445\",\"source\":[],\"score\":0.9990238547325134,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595966\"}}],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":1357,\"char_end\":1371,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.595944\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Saxman\",\"grounding_id\":\"ncit:C44726\",\"source\":[],\"score\":0.7636157870292664,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.595952\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1847156755\"},\"mentions\":[{\"id\":{\"id\":\"T:1859364483\"},\"name\":\"betaX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"Symptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\\nVaccinated individuals may be infected as well , at a reduced rate of betaX VM ( < betaX ) , where V is either V1 or V2 , and M denotes the vaccine type .\\nAsymptomatic infections of vaccinated individuals enter AX class , same as infections of unvaccinated individuals .\",\"char_start\":1062,\"char_end\":1067,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596079\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:2056794527\"},\"description\":\"may be infected as well, at a reduced rate of betaX VM\",\"grounding\":[{\"grounding_text\":\"rate of cases with at least one comorbidity\",\"grounding_id\":\"cemo:rate_of_cases_with_at_least_one_comorbidity\",\"source\":[],\"score\":0.804816484451294,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.596099\"}}],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":1004,\"char_end\":1058,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596079\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:491930989\"},\"mentions\":[{\"id\":{\"id\":\"T:-1136418701\"},\"name\":\"betaX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"R + alphaX ( CID :31 ) AX + AX R ( CID :30 ) .\\nExcept for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\",\"char_start\":309,\"char_end\":314,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596165\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-582391022\"},\"description\":\"rate\",\"grounding\":[{\"grounding_text\":\"Rate\",\"grounding_id\":\"ncit:C25636\",\"source\":[],\"score\":0.999626636505127,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.596183\"}}],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":304,\"char_end\":308,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596165\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1283479641\"},\"mentions\":[{\"id\":{\"id\":\"T:-1136418701\"},\"name\":\"betaX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"R + alphaX ( CID :31 ) AX + AX R ( CID :30 ) .\\nExcept for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\",\"char_start\":309,\"char_end\":314,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596221\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2042889412\"},\"description\":\"infected by one of the viruses at rate betaX\",\"grounding\":[{\"grounding_text\":\"rate of cases with at least one comorbidity\",\"grounding_id\":\"cemo:rate_of_cases_with_at_least_one_comorbidity\",\"source\":[],\"score\":0.8505942225456238,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.596237\"}}],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":270,\"char_end\":314,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596221\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1291825073\"},\"mentions\":[{\"id\":{\"id\":\"T:-1136418701\"},\"name\":\"betaX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"R + alphaX ( CID :31 ) AX + AX R ( CID :30 ) .\\nExcept for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\",\"char_start\":309,\"char_end\":314,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596274\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2042889412\"},\"description\":\"infected by one of the viruses at rate betaX\",\"grounding\":[{\"grounding_text\":\"rate of cases with at least one comorbidity\",\"grounding_id\":\"cemo:rate_of_cases_with_at_least_one_comorbidity\",\"source\":[],\"score\":0.8505942225456238,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.596288\"}}],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":270,\"char_end\":314,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596274\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1542387382\"},\"mentions\":[{\"id\":{\"id\":\"T:-309769174\"},\"name\":\"IX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"R + alphaX ( CID :31 ) AX + AX R ( CID :30 ) .\\nExcept for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\",\"char_start\":397,\"char_end\":399,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596327\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-544155356\"},\"description\":\"denoted IX\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":389,\"char_end\":399,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596327\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1477307630\"},\"mentions\":[{\"id\":{\"id\":\"T:-6512288\"},\"name\":\"X\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"R + alphaX ( CID :31 ) AX + AX R ( CID :30 ) .\\nExcept for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\",\"char_start\":421,\"char_end\":422,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596381\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:661514884\"},\"description\":\"one of the SARS-CoV-2 viruses\",\"grounding\":[{\"grounding_text\":\"WIBP-CorV\",\"grounding_id\":\"vo:0005160\",\"source\":[],\"score\":0.8196014165878296,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.596405\"}}],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":432,\"char_end\":461,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596381\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1386308471\"},\"mentions\":[{\"id\":{\"id\":\"T:-880206136\"},\"name\":\"alphaX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"Except for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\nWe assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\",\"char_start\":642,\"char_end\":648,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596442\"}}],\"text_descriptions\":[],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1964283175\"},\"mentions\":[{\"id\":{\"id\":\"T:-959922248\"},\"name\":\"AX\",\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":\"Except for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\nWe assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\",\"char_start\":596,\"char_end\":598,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596472\"}},{\"id\":{\"id\":\"mit44\"},\"name\":\"A\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-377704025\"},\"description\":\"denoted\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":7,\"surrounding_passage\":null,\"char_start\":588,\"char_end\":595,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596472\"}},{\"id\":{\"id\":\"mit44\"},\"description\":\"class for recovered individuals with partial immunity to a different variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:346088061\"},\"mentions\":[{\"id\":{\"id\":\"T:1820723565\"},\"name\":\"RX\",\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":\"The model assumes that an individuated infected by one variant cannot be infected by a second variant .\\nInfected individuals recover and enter class RX at a rate of gammaX .\\nRecovered individuals are entirely protected from the variant that they were infected with , but may be infected by a different variant at rate betaY R , where Y !\",\"char_start\":148,\"char_end\":150,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596674\"}},{\"id\":{\"id\":\"mit45\"},\"name\":\"D\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1197916351\"},\"description\":\"class\",\"grounding\":[{\"grounding_text\":\"obsolete class\",\"grounding_id\":\"vo:0000597\",\"source\":[],\"score\":0.8032230734825134,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.596691\"}}],\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":null,\"char_start\":142,\"char_end\":147,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596674\"}},{\"id\":{\"id\":\"mit45\"},\"description\":\"class for recovered individuals with partial immunity to a different variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1153919973\"},\"mentions\":[{\"id\":{\"id\":\"T:1498101629\"},\"name\":\"R\",\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":\"Infected individuals recover and enter class RX at a rate of gammaX .\\nRecovered individuals are entirely protected from the variant that they were infected with , but may be infected by a different variant at rate betaY R , where Y !\\n= X, and betaY R < betaY to represent some degree of protection .\",\"char_start\":321,\"char_end\":322,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596781\"}},{\"id\":{\"id\":\"mit46\"},\"name\":\"PZ\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-487650874\"},\"description\":\"rate betaY\",\"grounding\":[{\"grounding_text\":\"Rate\",\"grounding_id\":\"ncit:C25636\",\"source\":[],\"score\":0.999626636505127,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.596800\"}}],\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":null,\"char_start\":310,\"char_end\":320,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596781\"}},{\"id\":{\"id\":\"mit46\"},\"description\":\"class for recovered individuals with immunity to all three viruses\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1969515142\"},\"mentions\":[{\"id\":{\"id\":\"T:763804929\"},\"name\":\"betaY\",\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":\"Infected individuals recover and enter class RX at a rate of gammaX .\\nRecovered individuals are entirely protected from the variant that they were infected with , but may be infected by a different variant at rate betaY R , where Y !\\n= X, and betaY R < betaY to represent some degree of protection .\",\"char_start\":315,\"char_end\":320,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596846\"}},{\"id\":{\"id\":\"mit47\"},\"name\":\"AZ\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:50919761\"},\"description\":\"may be infected by a different variant at rate betaY R\",\"grounding\":[{\"grounding_text\":\"number of cases exposed by local (one or cluster) case\",\"grounding_id\":\"cemo:number_of_cases_exposed_by_local_one_or_cluster_case\",\"source\":[],\"score\":0.7855899930000305,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.596861\"}}],\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":null,\"char_start\":268,\"char_end\":322,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596846\"}},{\"id\":{\"id\":\"mit47\"},\"description\":\"class for recovered individuals with immunity to all three viruses\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1220406750\"},\"mentions\":[{\"id\":{\"id\":\"T:763804929\"},\"name\":\"betaY\",\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":\"Infected individuals recover and enter class RX at a rate of gammaX .\\nRecovered individuals are entirely protected from the variant that they were infected with , but may be infected by a different variant at rate betaY R , where Y !\\n= X, and betaY R < betaY to represent some degree of protection .\",\"char_start\":315,\"char_end\":320,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596945\"}},{\"id\":{\"id\":\"mit48\"},\"name\":\"γ\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1070158172\"},\"description\":\"different variant at rate\",\"grounding\":[{\"grounding_text\":\"rate of cases with at least one comorbidity\",\"grounding_id\":\"cemo:rate_of_cases_with_at_least_one_comorbidity\",\"source\":[],\"score\":0.7559011578559875,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.596962\"}}],\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":null,\"char_start\":289,\"char_end\":314,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.596945\"}},{\"id\":{\"id\":\"mit48\"},\"description\":\"rate of recovery for infected individuals\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"recovery rate\",\"grounding_id\":\"askemo:0000013\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"AE recovery rate\",\"grounding_id\":\"oae:0001869\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1422446413\"},\"mentions\":[{\"id\":{\"id\":\"T:763804929\"},\"name\":\"betaY\",\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":\"Infected individuals recover and enter class RX at a rate of gammaX .\\nRecovered individuals are entirely protected from the variant that they were infected with , but may be infected by a different variant at rate betaY R , where Y !\\n= X, and betaY R < betaY to represent some degree of protection .\",\"char_start\":315,\"char_end\":320,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597009\"}},{\"id\":{\"id\":\"mit49\"},\"name\":\"dAX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1070158172\"},\"description\":\"different variant at rate\",\"grounding\":[{\"grounding_text\":\"rate of cases with at least one comorbidity\",\"grounding_id\":\"cemo:rate_of_cases_with_at_least_one_comorbidity\",\"source\":[],\"score\":0.7559011578559875,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597027\"}}],\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":null,\"char_start\":289,\"char_end\":314,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597009\"}},{\"id\":{\"id\":\"mit49\"},\"description\":\"change in the number of asymptomatic infections over time\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"relative change in new infections\",\"grounding_id\":\"cemo:relative_change_in_new_infections\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"epstein-barr virus infection AE\",\"grounding_id\":\"oae:0007029\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1754528603\"},\"mentions\":[{\"id\":{\"id\":\"T:1513298016\"},\"name\":\"muX\",\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":\"= X, and betaY R < betaY to represent some degree of protection .\\nInfected recovered individuals are denoted IX R , which like IX V are associated with a better survival rate ( muX R < muX ) .\\nRecovered individuals lose their partial immunity and enter SVR at a rate of etaR .\",\"char_start\":515,\"char_end\":518,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597072\"}},{\"id\":{\"id\":\"mit50\"},\"name\":\"S\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-523860896\"},\"description\":\"muX R <\",\"grounding\":[],\"extraction_source\":{\"page\":15,\"block\":1,\"surrounding_passage\":null,\"char_start\":507,\"char_end\":514,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597072\"}},{\"id\":{\"id\":\"mit50\"},\"description\":\"susceptible population\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Saxman\",\"grounding_id\":\"ncit:C44726\",\"source\":[],\"score\":0.7636157870292664,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597081\"}},{\"grounding_text\":\"susceptible population\",\"grounding_id\":\"apollosv:00000234\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"count of susceptible population\",\"grounding_id\":\"apollosv:00000087\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-917712060\"},\"mentions\":[{\"id\":{\"id\":\"T:1567742145\"},\"name\":\"s\",\"extraction_source\":{\"page\":16,\"block\":8,\"surrounding_passage\":\"( C ) the author ( s ) 2022 .\",\"char_start\":15,\"char_end\":16,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597247\"}},{\"id\":{\"id\":\"mit51\"},\"name\":\"SVR\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:2032409614\"},\"description\":\"author\",\"grounding\":[{\"grounding_text\":\"author list\",\"grounding_id\":\"apollosv:00000329\",\"source\":[],\"score\":0.8084220290184021,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597270\"}}],\"extraction_source\":{\"page\":16,\"block\":8,\"surrounding_passage\":null,\"char_start\":8,\"char_end\":14,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597247\"}},{\"id\":{\"id\":\"mit51\"},\"description\":\"class for recovered individuals with partial immunity\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Meruvax I\",\"grounding_id\":\"vo:0003109\",\"source\":[],\"score\":0.7847759127616882,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597257\"}},{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1930130592\"},\"mentions\":[{\"id\":{\"id\":\"T:-44815477\"},\"name\":\"betaW\",\"extraction_source\":{\"page\":2,\"block\":3,\"surrounding_passage\":\"To identify the strongest determinants of the pandemic severity , we assess the sensitivity of model predictions to variations in key model parameters .\\nWe first conduct a sensitivity analysis in a simplified model that represents only the wild-type SARS-CoV-2 , for the year 2020 , but with infectivity betaW elevated .\",\"char_start\":322,\"char_end\":327,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597294\"}},{\"id\":{\"id\":\"mit52\"},\"name\":\"RY\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-678680227\"},\"description\":\"infectivity\",\"grounding\":[],\"extraction_source\":{\"page\":2,\"block\":3,\"surrounding_passage\":null,\"char_start\":310,\"char_end\":321,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597294\"}},{\"id\":{\"id\":\"mit52\"},\"description\":\"class for recovered individuals with immunity to a different variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:716487493\"},\"mentions\":[{\"id\":{\"id\":\"T:-1311637267\"},\"name\":\"n\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"Rates are indicated on the arrows .\\nbeta , infection rate ; , recovery rate ; n , rate of immunity loss ; mu , death rate ; omega , vaccination rate .\\nFor a complete definition of the variables , superscripts , and subscripts , see text .\",\"char_start\":502,\"char_end\":503,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597377\"}},{\"id\":{\"id\":\"mit53\"},\"name\":\"RF\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1113309935\"},\"description\":\"rate of immunity loss\",\"grounding\":[{\"grounding_text\":\"period of persistence of vaccine induced immune response\",\"grounding_id\":\"vo:0000426\",\"source\":[],\"score\":0.7852755784988403,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597401\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":505,\"char_end\":526,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597377\"}},{\"id\":{\"id\":\"mit53\"},\"description\":\"class for recovered individuals with immunity to all three viruses\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"V-LSG/N\",\"grounding_id\":\"vo:0004083\",\"source\":[],\"score\":1.0000001192092896,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597385\"}},{\"grounding_text\":\"Recovered from Adverse Event\",\"grounding_id\":\"ncit:C49498\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"recovered population\",\"grounding_id\":\"apollosv:00000163\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1780919070\"},\"mentions\":[{\"id\":{\"id\":\"T:-1591957904\"},\"name\":\"omega\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"Rates are indicated on the arrows .\\nbeta , infection rate ; , recovery rate ; n , rate of immunity loss ; mu , death rate ; omega , vaccination rate .\\nFor a complete definition of the variables , superscripts , and subscripts , see text .\",\"char_start\":544,\"char_end\":549,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597437\"}},{\"id\":{\"id\":\"mit54\"},\"name\":\"dRF\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:262029104\"},\"description\":\"vaccination rate\",\"grounding\":[{\"grounding_text\":\"vaccine effectiveness rate\",\"grounding_id\":\"vo:0000443\",\"source\":[],\"score\":0.8607025742530823,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597460\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":551,\"char_end\":567,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597437\"}},{\"id\":{\"id\":\"mit54\"},\"description\":\"change in the number of individuals in RF class over time\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Class\",\"grounding_id\":\"rdfs:Class\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Class\",\"grounding_id\":\"owl:Class\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:2056695833\"},\"mentions\":[{\"id\":{\"id\":\"T:476109798\"},\"name\":\"mu\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"Rates are indicated on the arrows .\\nbeta , infection rate ; , recovery rate ; n , rate of immunity loss ; mu , death rate ; omega , vaccination rate .\\nFor a complete definition of the variables , superscripts , and subscripts , see text .\",\"char_start\":528,\"char_end\":530,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597494\"}},{\"id\":{\"id\":\"mit55\"},\"name\":\"dRX\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1370260727\"},\"description\":\"death rate\",\"grounding\":[{\"grounding_text\":\"cumulative death rates\",\"grounding_id\":\"cemo:cumulative_death_rates\",\"source\":[],\"score\":0.9054759740829468,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597515\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":532,\"char_end\":542,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597494\"}},{\"id\":{\"id\":\"mit55\"},\"description\":\"change in the number of individuals in RX class over time\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Class\",\"grounding_id\":\"owl:Class\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"Class\",\"grounding_id\":\"rdfs:Class\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1341709601\"},\"mentions\":[{\"id\":{\"id\":\"T:-1637930573\"},\"name\":\"beta\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"Rates are indicated on the arrows .\\nbeta , infection rate ; , recovery rate ; n , rate of immunity loss ; mu , death rate ; omega , vaccination rate .\\nFor a complete definition of the variables , superscripts , and subscripts , see text .\",\"char_start\":462,\"char_end\":466,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597551\"}},{\"id\":{\"id\":\"mit56\"},\"name\":\"IY\",\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:441272718\"},\"description\":\"infection rate\",\"grounding\":[{\"grounding_text\":\"Infection Fatality Rate\",\"grounding_id\":\"ncit:C173780\",\"source\":[],\"score\":0.9256949424743652,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597573\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":468,\"char_end\":482,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597551\"}},{\"id\":{\"id\":\"mit56\"},\"description\":\"infected individuals of a different variant\",\"grounding\":null,\"extraction_source\":null,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"beta distribution\",\"grounding_id\":\"apollosv:00000078\",\"source\":[],\"score\":0.807852566242218,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597560\"}},{\"grounding_text\":\"human infected by SARS-CoV-2\",\"grounding_id\":\"cido:0000292\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}},{\"grounding_text\":\"transmission coefficient\",\"grounding_id\":\"apollosv:00000191\",\"source\":[],\"score\":1.0,\"provenance\":{\"method\":\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\",\"timestamp\":\"2023-10-31T20:46:33.801844\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:825197191\"},\"mentions\":[{\"id\":{\"id\":\"T:-1458421397\"},\"name\":\"A\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"Figure1 .\\nPanel ( A ) , schematic diagram for a simplified version of the SV2 ( AIR ) 3 model , representing only one V and IW R , symptomatic infected class ; AW and virus and one vaccine type .\\nS and SVR , susceptible class ; IW , IW AW R , asymptomatic infected class ; RW and RF recovered class .\",\"char_start\":17,\"char_end\":18,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597611\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2137874468\"},\"description\":\"Panel\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":10,\"char_end\":15,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597611\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1978344876\"},\"mentions\":[{\"id\":{\"id\":\"T:2059913967\"},\"name\":\"S.\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"Deaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\\nPanel ( B ) shows the full connections associated with the susceptible class S. Arrows indicate movement of S into one of the six infected classes ( the A 's and I 's ) or one of the two vaccinated classes ( V1 's ) .\\nMovements from one of these infected or vaccinated into another class are not shown .\",\"char_start\":1005,\"char_end\":1007,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597677\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1818973716\"},\"description\":\"susceptible class\",\"grounding\":[{\"grounding_text\":\"susceptible individuals\",\"grounding_id\":\"cemo:susceptible_individuals\",\"source\":[],\"score\":0.7851424217224121,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597704\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":987,\"char_end\":1004,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597677\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"S. typimurium Vi4072\",\"grounding_id\":\"vo:0004186\",\"source\":[],\"score\":0.9999999403953552,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597686\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:2127044537\"},\"mentions\":[{\"id\":{\"id\":\"T:1518139039\"},\"name\":\"B\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"Deaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\\nPanel ( B ) shows the full connections associated with the susceptible class S. Arrows indicate movement of S into one of the six infected classes ( the A 's and I 's ) or one of the two vaccinated classes ( V1 's ) .\\nMovements from one of these infected or vaccinated into another class are not shown .\",\"char_start\":937,\"char_end\":938,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597728\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:999358760\"},\"description\":\"Panel\",\"grounding\":[],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":930,\"char_end\":935,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597728\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"AIDSVAX B/B\",\"grounding_id\":\"vo:0000405\",\"source\":[],\"score\":0.8989673256874084,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597738\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-58983686\"},\"mentions\":[{\"id\":{\"id\":\"T:-801290668\"},\"name\":\"IW\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"Panel ( A ) , schematic diagram for a simplified version of the SV2 ( AIR ) 3 model , representing only one V and IW R , symptomatic infected class ; AW and virus and one vaccine type .\\nS and SVR , susceptible class ; IW , IW AW R , asymptomatic infected class ; RW and RF recovered class .\\nArrows denote the movement from one class to another , via infection ( red arrows ) , vaccination ( blue arrows ) , recovery , or loss of immunity .\",\"char_start\":217,\"char_end\":219,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597810\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1013283370\"},\"description\":\"asymptomatic infected class\",\"grounding\":[{\"grounding_text\":\"infected population\",\"grounding_id\":\"apollosv:00000233\",\"source\":[],\"score\":0.7838175892829895,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597833\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":230,\"char_end\":257,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597810\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-2029925287\"},\"mentions\":[{\"id\":{\"id\":\"T:1940093386\"},\"name\":\"A\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"For a complete definition of the variables , superscripts , and subscripts , see text .\\nIn the complete model , three viruses ( W = wild type , A = Alpha , D = Delta ) and two vaccine types ( PZ = Pfizer and AZ = AstraZeneca ) are represented .\\nDeaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\",\"char_start\":706,\"char_end\":707,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597879\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1291450413\"},\"description\":\"wild type\",\"grounding\":[{\"grounding_text\":\"Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.1A)\",\"grounding_id\":\"vo:0002166\",\"source\":[],\"score\":0.784527063369751,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597905\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":695,\"char_end\":704,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597879\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1254443348\"},\"mentions\":[{\"id\":{\"id\":\"T:-50685911\"},\"name\":\"D\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"For a complete definition of the variables , superscripts , and subscripts , see text .\\nIn the complete model , three viruses ( W = wild type , A = Alpha , D = Delta ) and two vaccine types ( PZ = Pfizer and AZ = AstraZeneca ) are represented .\\nDeaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\",\"char_start\":717,\"char_end\":718,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597928\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1291450413\"},\"description\":\"wild type\",\"grounding\":[{\"grounding_text\":\"Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.1A)\",\"grounding_id\":\"vo:0002166\",\"source\":[],\"score\":0.784527063369751,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597951\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":695,\"char_end\":704,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597928\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-283348533\"},\"mentions\":[{\"id\":{\"id\":\"T:-1988267369\"},\"name\":\"W\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"For a complete definition of the variables , superscripts , and subscripts , see text .\\nIn the complete model , three viruses ( W = wild type , A = Alpha , D = Delta ) and two vaccine types ( PZ = Pfizer and AZ = AstraZeneca ) are represented .\\nDeaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\",\"char_start\":691,\"char_end\":692,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597976\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-622537451\"},\"description\":\"wild type\",\"grounding\":[{\"grounding_text\":\"Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.1A)\",\"grounding_id\":\"vo:0002166\",\"source\":[],\"score\":0.784527063369751,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.597990\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":695,\"char_end\":704,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.597976\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1472238765\"},\"mentions\":[{\"id\":{\"id\":\"T:717663234\"},\"name\":\"AZ\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"For a complete definition of the variables , superscripts , and subscripts , see text .\\nIn the complete model , three viruses ( W = wild type , A = Alpha , D = Delta ) and two vaccine types ( PZ = Pfizer and AZ = AstraZeneca ) are represented .\\nDeaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\",\"char_start\":767,\"char_end\":769,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598011\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:265642334\"},\"description\":\"AstraZeneca\",\"grounding\":[{\"grounding_text\":\"AstraZeneca\",\"grounding_id\":\"ncit:C177125\",\"source\":[],\"score\":0.9995855689048767,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598033\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":772,\"char_end\":783,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598011\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1385936192\"},\"mentions\":[{\"id\":{\"id\":\"T:56437613\"},\"name\":\"PZ\",\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":\"For a complete definition of the variables , superscripts , and subscripts , see text .\\nIn the complete model , three viruses ( W = wild type , A = Alpha , D = Delta ) and two vaccine types ( PZ = Pfizer and AZ = AstraZeneca ) are represented .\\nDeaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\",\"char_start\":751,\"char_end\":753,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598053\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-760162990\"},\"description\":\"Pfizer and AZ =\",\"grounding\":[{\"grounding_text\":\"Pfizer Inc.\",\"grounding_id\":\"vo:0004947\",\"source\":[],\"score\":0.7525688409805298,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598069\"}}],\"extraction_source\":{\"page\":3,\"block\":4,\"surrounding_passage\":null,\"char_start\":756,\"char_end\":771,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598053\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:611615583\"},\"mentions\":[{\"id\":{\"id\":\"T:1777265395\"},\"name\":\"betaV\",\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\",\"char_start\":522,\"char_end\":527,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598223\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1725396255\"},\"description\":\"rate\",\"grounding\":[{\"grounding_text\":\"Rate\",\"grounding_id\":\"ncit:C25636\",\"source\":[],\"score\":0.999626636505127,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598238\"}}],\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":null,\"char_start\":516,\"char_end\":520,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598223\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:814952678\"},\"mentions\":[{\"id\":{\"id\":\"T:1115964660\"},\"name\":\"muI\",\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\",\"char_start\":464,\"char_end\":467,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598273\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:2132818818\"},\"description\":\"rate of infected individuals\",\"grounding\":[{\"grounding_text\":\"average rate of infectious contacts\",\"grounding_id\":\"cemo:average_rate_of_infectious_contacts\",\"source\":[],\"score\":0.8620831966400146,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598296\"}}],\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":null,\"char_start\":434,\"char_end\":462,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598273\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:576858469\"},\"mentions\":[{\"id\":{\"id\":\"T:96077972\"},\"name\":\"lambda\",\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\",\"char_start\":546,\"char_end\":552,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598330\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1273803626\"},\"description\":\"stringency\",\"grounding\":[],\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":null,\"char_start\":534,\"char_end\":544,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598330\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1695453225\"},\"mentions\":[{\"id\":{\"id\":\"T:-957289098\"},\"name\":\"beta\",\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\",\"char_start\":334,\"char_end\":338,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598392\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2065961831\"},\"description\":\"infectivity\",\"grounding\":[],\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":null,\"char_start\":322,\"char_end\":333,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598392\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"beta distribution\",\"grounding_id\":\"apollosv:00000078\",\"source\":[],\"score\":0.807852566242218,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598400\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-2089543753\"},\"mentions\":[{\"id\":{\"id\":\"T:-1242538179\"},\"name\":\"gamma\",\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\",\"char_start\":493,\"char_end\":498,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598449\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:376106397\"},\"description\":\"disease recovery rate\",\"grounding\":[{\"grounding_text\":\"Death due to Disease Progression\",\"grounding_id\":\"ncit:C168970\",\"source\":[],\"score\":0.8151561617851257,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598471\"}}],\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":null,\"char_start\":470,\"char_end\":491,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598449\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"gamma distribution\",\"grounding_id\":\"apollosv:00000255\",\"source\":[],\"score\":0.8174800872802734,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598458\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-146210857\"},\"mentions\":[{\"id\":{\"id\":\"T:2030986905\"},\"name\":\"sigma\",\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\",\"char_start\":294,\"char_end\":299,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598506\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-995615771\"},\"description\":\"ratio of asymptomatic versus symptomatic infections\",\"grounding\":[],\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":null,\"char_start\":241,\"char_end\":292,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598506\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-230919232\"},\"mentions\":[{\"id\":{\"id\":\"T:692333997\"},\"name\":\"beta\",\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\",\"char_start\":234,\"char_end\":238,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598560\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:95196513\"},\"description\":\"virus infectivity\",\"grounding\":[{\"grounding_text\":\"Sindbis virus vaccine\",\"grounding_id\":\"vo:0003043\",\"source\":[],\"score\":0.7953133583068848,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598599\"}}],\"extraction_source\":{\"page\":6,\"block\":2,\"surrounding_passage\":null,\"char_start\":215,\"char_end\":232,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598560\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"beta distribution\",\"grounding_id\":\"apollosv:00000078\",\"source\":[],\"score\":0.807852566242218,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598568\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1759113608\"},\"mentions\":[{\"id\":{\"id\":\"T:-659649705\"},\"name\":\"lambda\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\",\"char_start\":906,\"char_end\":912,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598686\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:2102379480\"},\"description\":\"stringency\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":894,\"char_end\":904,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598686\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-868577489\"},\"mentions\":[{\"id\":{\"id\":\"T:740455928\"},\"name\":\"beta\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\",\"char_start\":644,\"char_end\":648,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598813\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1980366916\"},\"description\":\"infectivity\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":632,\"char_end\":643,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598813\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"beta distribution\",\"grounding_id\":\"apollosv:00000078\",\"source\":[],\"score\":0.807852566242218,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598822\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-869823682\"},\"mentions\":[{\"id\":{\"id\":\"T:-1637236798\"},\"name\":\"gamma\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\",\"char_start\":803,\"char_end\":808,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598902\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-763748697\"},\"description\":\"disease recovery rate\",\"grounding\":[{\"grounding_text\":\"Death due to Disease Progression\",\"grounding_id\":\"ncit:C168970\",\"source\":[],\"score\":0.8151561617851257,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598928\"}}],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":780,\"char_end\":801,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598902\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"gamma distribution\",\"grounding_id\":\"apollosv:00000255\",\"source\":[],\"score\":0.8174800872802734,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.598910\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1297286117\"},\"mentions\":[{\"id\":{\"id\":\"T:609904275\"},\"name\":\"etaR\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\",\"char_start\":854,\"char_end\":858,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598995\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:2073665918\"},\"description\":\"infection\",\"grounding\":[{\"grounding_text\":\"infection\",\"grounding_id\":\"apollosv:00000114\",\"source\":[],\"score\":0.9989686012268066,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.599017\"}}],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":843,\"char_end\":852,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.598995\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-438207695\"},\"mentions\":[{\"id\":{\"id\":\"T:-1500361573\"},\"name\":\"sigma\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\",\"char_start\":604,\"char_end\":609,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599084\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1030514774\"},\"description\":\"ratio of asymptomatic versus symptomatic infections\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":551,\"char_end\":602,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599084\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:83314069\"},\"mentions\":[{\"id\":{\"id\":\"T:-44008016\"},\"name\":\"betaV\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\",\"char_start\":882,\"char_end\":887,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599164\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-323266353\"},\"description\":\"vaccine escape rate\",\"grounding\":[{\"grounding_text\":\"vaccine effectiveness rate\",\"grounding_id\":\"vo:0000443\",\"source\":[],\"score\":0.8239560723304749,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.599182\"}}],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":861,\"char_end\":880,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599164\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-634538974\"},\"mentions\":[{\"id\":{\"id\":\"T:-750522701\"},\"name\":\"muI\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\",\"char_start\":774,\"char_end\":777,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599249\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-863487193\"},\"description\":\"rate of infected individuals\",\"grounding\":[{\"grounding_text\":\"average rate of infectious contacts\",\"grounding_id\":\"cemo:average_rate_of_infectious_contacts\",\"source\":[],\"score\":0.8620831966400146,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.599272\"}}],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":744,\"char_end\":772,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599249\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1993378382\"},\"mentions\":[{\"id\":{\"id\":\"T:675843161\"},\"name\":\"beta\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\",\"char_start\":467,\"char_end\":471,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599337\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1412009529\"},\"description\":\"virus infectivity\",\"grounding\":[{\"grounding_text\":\"Sindbis virus vaccine\",\"grounding_id\":\"vo:0003043\",\"source\":[],\"score\":0.7953133583068848,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.599359\"}}],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":448,\"char_end\":465,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599337\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"beta distribution\",\"grounding_id\":\"apollosv:00000078\",\"source\":[],\"score\":0.807852566242218,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.599345\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:800289603\"},\"mentions\":[{\"id\":{\"id\":\"T:-1970682056\"},\"name\":\"c\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to increases in model parameter values , in a two-year simulation interacting VOC dynamics .\\nParameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\",\"char_start\":273,\"char_end\":274,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599461\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-230207360\"},\"description\":\"column\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":266,\"char_end\":272,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599461\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"BoNT/C\",\"grounding_id\":\"vo:0004004\",\"source\":[],\"score\":0.7589514851570129,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.599470\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1558390445\"},\"mentions\":[{\"id\":{\"id\":\"T:106329618\"},\"name\":\"a\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to increases in model parameter values , in a two-year simulation interacting VOC dynamics .\\nParameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\",\"char_start\":233,\"char_end\":234,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599550\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:371412418\"},\"description\":\"column\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":226,\"char_end\":232,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599550\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-2075507652\"},\"mentions\":[{\"id\":{\"id\":\"T:-1292040628\"},\"name\":\"Delta\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to increases in model parameter values , in a two-year simulation interacting VOC dynamics .\\nParameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\",\"char_start\":259,\"char_end\":264,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599631\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2068630805\"},\"description\":\"column c\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":266,\"char_end\":274,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599631\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:721581088\"},\"mentions\":[{\"id\":{\"id\":\"T:1896128896\"},\"name\":\"b\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to increases in model parameter values , in a two-year simulation interacting VOC dynamics .\\nParameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\",\"char_start\":251,\"char_end\":252,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599723\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1644904032\"},\"description\":\"column\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":244,\"char_end\":250,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599723\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"AIDSVAX B/B\",\"grounding_id\":\"vo:0000405\",\"source\":[],\"score\":0.8989673256874084,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.599733\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1895430149\"},\"mentions\":[{\"id\":{\"id\":\"T:-933317352\"},\"name\":\"Alpha\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Sensitivity of model predictions , measured by total infections and deaths , to increases in model parameter values , in a two-year simulation interacting VOC dynamics .\\nParameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\",\"char_start\":237,\"char_end\":242,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599806\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-156709321\"},\"description\":\"column b\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":244,\"char_end\":252,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599806\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1776301662\"},\"mentions\":[{\"id\":{\"id\":\"T:-492448180\"},\"name\":\"Delta\",\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":\"Parameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\",\"char_start\":402,\"char_end\":407,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599895\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1615859808\"},\"description\":\"blue bars\",\"grounding\":[],\"extraction_source\":{\"page\":7,\"block\":7,\"surrounding_passage\":null,\"char_start\":409,\"char_end\":418,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.599895\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1876321384\"},\"mentions\":[{\"id\":{\"id\":\"T:-2028255591\"},\"name\":\"NPI\",\"extraction_source\":{\"page\":9,\"block\":6,\"surrounding_passage\":\"`` Vac rate , '' vaccination rate reduced by 20 % .\\n`` NPI '' , less stringent lockdown measured , with mobility increased by 25 % .\\nAmong these scenarios considered , Delta outbreak is the most severe when the majority of the vaccines are AstraZeneca .\",\"char_start\":391,\"char_end\":394,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600060\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-427152325\"},\"description\":\"stringent lockdown measured, with mobility increased by 25%\",\"grounding\":[],\"extraction_source\":{\"page\":9,\"block\":6,\"surrounding_passage\":null,\"char_start\":403,\"char_end\":462,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600060\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:868023049\"},\"mentions\":[{\"id\":{\"id\":\"T:2020399361\"},\"name\":\"Pfizer\",\"extraction_source\":{\"page\":9,\"block\":6,\"surrounding_passage\":\"Predicted spread of the Delta variant , from March 2021 to March 2022 , obtained for baseline parameters and three alternative scenarios .\\n`` PZ / AZ , '' lower fraction of vaccines being Pfizer ( from 95 to 40 % ) , with the reduction made up with AstraZeneca , which of fers reduced protection from Delta infections and a longer dosing delay .\\n`` Vac rate , '' vaccination rate reduced by 20 % .\",\"char_start\":190,\"char_end\":196,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600162\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:-474620134\"},\"value\":{\"amount\":\"%\",\"grounding\":[],\"extraction_source\":{\"page\":9,\"block\":6,\"surrounding_passage\":null,\"char_start\":211,\"char_end\":212,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600162\"}}],\"groundings\":[{\"grounding_text\":\"Pfizer\",\"grounding_id\":\"ncit:C177123\",\"source\":[],\"score\":0.9995554089546204,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.600170\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-739144679\"},\"mentions\":[{\"id\":{\"id\":\"T:-169454598\"},\"name\":\"Fig.4\",\"extraction_source\":{\"page\":10,\"block\":8,\"surrounding_passage\":\"It is well understood that for any infectious disease , the major factors that determine how fast it spreads include infectivity , the extent of the NPI , and vaccination rate .\\nFor COVID-19 , our sensitivity analysis reveals two additional factors , the prevalence of asymptomatic infections and the enhanced infectivity of asymptomatic patients ( Fig.4 ) .\",\"char_start\":345,\"char_end\":350,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600400\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:674776079\"},\"description\":\"enhanced infectivity of asymptomatic patients\",\"grounding\":[{\"grounding_text\":\"percentage of asymptomatic of confirmed cases\",\"grounding_id\":\"cemo:percentage_of_asymptomatic_of_confirmed_cases\",\"source\":[],\"score\":0.768237292766571,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.600422\"}}],\"extraction_source\":{\"page\":10,\"block\":8,\"surrounding_passage\":null,\"char_start\":298,\"char_end\":343,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600400\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1447664274\"},\"mentions\":[{\"id\":{\"id\":\"T:560216930\"},\"name\":\"PZ\",\"extraction_source\":{\"page\":11,\"block\":10,\"surrounding_passage\":\"( a ) Susceptible individuals , original population and those who lost their immunity acquired either from an infection or vaccination .\\n( b ) Vaccinated with only one dose or both , with either Pfizer ( PZ ) or AstraZeneca ( AZ ) .\\n( C ) new infections per day ( Neos , Alpha , Delta ) since August 1 2021 .\",\"char_start\":293,\"char_end\":295,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600478\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1697504455\"},\"description\":\"either Pfizer\",\"grounding\":[],\"extraction_source\":{\"page\":11,\"block\":10,\"surrounding_passage\":null,\"char_start\":278,\"char_end\":291,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600478\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:937246848\"},\"mentions\":[{\"id\":{\"id\":\"T:1272919843\"},\"name\":\"AZ\",\"extraction_source\":{\"page\":11,\"block\":10,\"surrounding_passage\":\"( a ) Susceptible individuals , original population and those who lost their immunity acquired either from an infection or vaccination .\\n( b ) Vaccinated with only one dose or both , with either Pfizer ( PZ ) or AstraZeneca ( AZ ) .\\n( C ) new infections per day ( Neos , Alpha , Delta ) since August 1 2021 .\",\"char_start\":313,\"char_end\":315,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600516\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-88807827\"},\"description\":\"AstraZeneca\",\"grounding\":[{\"grounding_text\":\"AstraZeneca\",\"grounding_id\":\"ncit:C177125\",\"source\":[],\"score\":0.9995855689048767,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.600537\"}}],\"extraction_source\":{\"page\":11,\"block\":10,\"surrounding_passage\":null,\"char_start\":300,\"char_end\":311,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600516\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-795860774\"},\"mentions\":[{\"id\":{\"id\":\"T:-1746125849\"},\"name\":\"NPI\",\"extraction_source\":{\"page\":12,\"block\":5,\"surrounding_passage\":\"`` Vac rate , '' vaccination rate reduced by 20 % .\\n`` NPI '' , less stringent lockdown measured , with mobility increased by 25 % .\\n( a ) Number of new Neos infections .\",\"char_start\":423,\"char_end\":426,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600641\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1664213421\"},\"description\":\"stringent lockdown measured, with mobility increased by 25%\",\"grounding\":[],\"extraction_source\":{\"page\":12,\"block\":5,\"surrounding_passage\":null,\"char_start\":435,\"char_end\":494,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600641\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:1959808490\"},\"mentions\":[{\"id\":{\"id\":\"T:1065713676\"},\"name\":\"Pfizer\",\"extraction_source\":{\"page\":12,\"block\":5,\"surrounding_passage\":\"Results are obtained for baseline parameters and three alternative scenarios .\\n`` PZ / AZ , '' lower fraction of vaccines being Pfizer ( from 95 to 40 % ) , with the reduction made up with AstraZeneca , which of fers reduced protection from Delta infections and a longer dosing delay .\\n`` Vac rate , '' vaccination rate reduced by 20 % .\",\"char_start\":222,\"char_end\":228,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600728\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:1755210173\"},\"value\":{\"amount\":\"%\",\"grounding\":[],\"extraction_source\":{\"page\":12,\"block\":5,\"surrounding_passage\":null,\"char_start\":243,\"char_end\":244,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600728\"}}],\"groundings\":[{\"grounding_text\":\"Pfizer\",\"grounding_id\":\"ncit:C177123\",\"source\":[],\"score\":0.9995554089546204,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.600737\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1741730311\"},\"mentions\":[{\"id\":{\"id\":\"T:2030280181\"},\"name\":\"70% of the Ontario population\",\"extraction_source\":{\"page\":12,\"block\":7,\"surrounding_passage\":\"As previously noted , a significant number of the Delta infections are caused by vaccinated individuals with asymptomatic infections .\\nConsequently , even with > 70 % of the Ontario population have received at least one vaccine dose , some NPI must remain to prevent the further spread of Delta , or the emergence and rapid spread of the next series of more dangerous VOC .\\nWhen in-person classes resume in public schools and college in September , any Delta outbreak and the emergence of new VOC must be closely monitored , and if necessary , NPI must be reinstated .\",\"char_start\":248,\"char_end\":277,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600880\"}}],\"text_descriptions\":[],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"count of simulated population\",\"grounding_id\":\"apollosv:00000022\",\"source\":[],\"score\":0.7830394506454468,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.600889\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1995693754\"},\"mentions\":[{\"id\":{\"id\":\"T:2085801335\"},\"name\":\"news\",\"extraction_source\":{\"page\":12,\"block\":7,\"surrounding_passage\":\"And for these NPI to be effective , they must begin sufficiently early .\\nThe news that a third ( or fourth ) dose of the Pfizer vaccine enhances one 's protection against VOC is exciting25 .\\nIndeed , the combination of NPI and a booster shot may be necessary in our fight against a future , more transmissible and deadlier VOC .\",\"char_start\":722,\"char_end\":726,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600952\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:-1437501135\"},\"value\":{\"amount\":\"exciting25\",\"grounding\":[],\"extraction_source\":{\"page\":12,\"block\":7,\"surrounding_passage\":null,\"char_start\":820,\"char_end\":830,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.600952\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1128287073\"},\"mentions\":[{\"id\":{\"id\":\"T:993894564\"},\"name\":\"W\",\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\",\"char_start\":71,\"char_end\":72,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601146\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:-681436695\"},\"value\":{\"amount\":\"2\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":null,\"char_start\":47,\"char_end\":48,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601146\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-680787754\"},\"mentions\":[{\"id\":{\"id\":\"T:993894564\"},\"name\":\"W\",\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\",\"char_start\":71,\"char_end\":72,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601235\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:499808299\"},\"description\":\"AZ v m 2  x=W\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":null,\"char_start\":93,\"char_end\":106,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601235\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1717504424\"},\"mentions\":[{\"id\":{\"id\":\"T:993894564\"},\"name\":\"W\",\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\",\"char_start\":71,\"char_end\":72,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601362\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:499808299\"},\"description\":\"AZ v m 2  x=W\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":null,\"char_start\":93,\"char_end\":106,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601362\"}}],\"value_descriptions\":[{\"id\":{\"id\":\"T:-681436695\"},\"value\":{\"amount\":\"2\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":null,\"char_start\":47,\"char_end\":48,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601362\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:513256652\"},\"mentions\":[{\"id\":{\"id\":\"T:-486607980\"},\"name\":\"D\",\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\",\"char_start\":110,\"char_end\":111,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601473\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:1067643941\"},\"value\":{\"amount\":\"1\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":null,\"char_start\":114,\"char_end\":115,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601473\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1599769952\"},\"mentions\":[{\"id\":{\"id\":\"T:812880442\"},\"name\":\"AZ\",\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\",\"char_start\":151,\"char_end\":153,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601573\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1628876281\"},\"description\":\"v i x  - Gamma    M=\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":null,\"char_start\":128,\"char_end\":148,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601573\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1123702885\"},\"mentions\":[{\"id\":{\"id\":\"T:1832677529\"},\"name\":\"DT Total  ry\",\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\",\"char_start\":195,\"char_end\":207,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601673\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:1908242220\"},\"value\":{\"amount\":\"1\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":8,\"surrounding_passage\":null,\"char_start\":211,\"char_end\":212,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601673\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1421467959\"},\"mentions\":[{\"id\":{\"id\":\"T:-2073168936\"},\"name\":\"x RY Beta\",\"extraction_source\":{\"page\":14,\"block\":9,\"surrounding_passage\":\"Y =x - Gamma dAX x x x x x x i x Beta = Sigma v1 + Beta v 1 v 2 DT Total ( CID :29 ) + Sigma ( s + SVR ) ( CID :31 ) ( CID :30 ) x = W , A , D v ( CID :31 ) ( CID :30 ) x = W , a , Dftbeta V2ffI x Total ( CID :29 ) - Ftomega1 + Gamma + microffAX ( 9 ) dAX R x x x RY Beta = Sigma R i x R ( 10 ) DT Total ( CID :31 ) y =x - ( CID :30 ) Gamma + Micro ( CID :29 ) AX .\",\"char_start\":225,\"char_end\":234,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601773\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:725759874\"},\"description\":\"x x RY\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":9,\"surrounding_passage\":null,\"char_start\":223,\"char_end\":229,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601773\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-502448825\"},\"mentions\":[{\"id\":{\"id\":\"T:1599136411\"},\"name\":\"CID\",\"extraction_source\":{\"page\":14,\"block\":9,\"surrounding_passage\":\"Y =x - Gamma dAX x x x x x x i x Beta = Sigma v1 + Beta v 1 v 2 DT Total ( CID :29 ) + Sigma ( s + SVR ) ( CID :31 ) ( CID :30 ) x = W , A , D v ( CID :31 ) ( CID :30 ) x = W , a , Dftbeta V2ffI x Total ( CID :29 ) - Ftomega1 + Gamma + microffAX ( 9 ) dAX R x x x RY Beta = Sigma R i x R ( 10 ) DT Total ( CID :31 ) y =x - ( CID :30 ) Gamma + Micro ( CID :29 ) AX .\",\"char_start\":138,\"char_end\":141,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601871\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:719080638\"},\"description\":\"Dftbeta V2ffI\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":9,\"surrounding_passage\":null,\"char_start\":152,\"char_end\":165,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601871\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-245957849\"},\"mentions\":[{\"id\":{\"id\":\"T:280540233\"},\"name\":\"V2ffI\",\"extraction_source\":{\"page\":14,\"block\":9,\"surrounding_passage\":\"Y =x - Gamma dAX x x x x x x i x Beta = Sigma v1 + Beta v 1 v 2 DT Total ( CID :29 ) + Sigma ( s + SVR ) ( CID :31 ) ( CID :30 ) x = W , A , D v ( CID :31 ) ( CID :30 ) x = W , a , Dftbeta V2ffI x Total ( CID :29 ) - Ftomega1 + Gamma + microffAX ( 9 ) dAX R x x x RY Beta = Sigma R i x R ( 10 ) DT Total ( CID :31 ) y =x - ( CID :30 ) Gamma + Micro ( CID :29 ) AX .\",\"char_start\":160,\"char_end\":165,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601959\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2030978223\"},\"description\":\"Dftbeta\",\"grounding\":[],\"extraction_source\":{\"page\":14,\"block\":9,\"surrounding_passage\":null,\"char_start\":152,\"char_end\":159,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.601959\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:1346749703\"},\"mentions\":[{\"id\":{\"id\":\"T:-405996026\"},\"name\":\"lambda\",\"extraction_source\":{\"page\":15,\"block\":5,\"surrounding_passage\":\"As the number of COVID-19 rose , on March 23 2020 the Ontario government began a number of public health safety measures , which varied in severity over time , including stay-at-home orders , workplace safety measures , restrictions on public events and social gatherings , temporary shutdown of selected businesses , and mandatory mask wearing .\\nThese NPI reduce the transmissivity of COVID-19 , and are represented by scaling all betaX 's and betaX V , M 's simultaneously by a NPI severity index lambda , where 0 < = lambda < = 1 .\\nThe time-varying function lambda is chosen in part based on Ontario COVID-19 lockdown timeline and Google mobility data , and in part to fit the predicted new case numbers against provincial data available prior to July 2021 ; the values of lambda for 2020-2021 are shown in Fig.S1 .\",\"char_start\":521,\"char_end\":527,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.602855\"}}],\"text_descriptions\":[],\"value_descriptions\":[{\"id\":{\"id\":\"T:464742218\"},\"value\":{\"amount\":\"1\",\"grounding\":[],\"extraction_source\":{\"page\":15,\"block\":5,\"surrounding_passage\":null,\"char_start\":531,\"char_end\":532,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}}},\"units\":null,\"type\":null,\"bounds\":null,\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.602855\"}}],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1566681075\"},\"mentions\":[{\"id\":{\"id\":\"T:1414919006\"},\"name\":\"lambda\",\"extraction_source\":{\"page\":15,\"block\":5,\"surrounding_passage\":\"As the number of COVID-19 rose , on March 23 2020 the Ontario government began a number of public health safety measures , which varied in severity over time , including stay-at-home orders , workplace safety measures , restrictions on public events and social gatherings , temporary shutdown of selected businesses , and mandatory mask wearing .\\nThese NPI reduce the transmissivity of COVID-19 , and are represented by scaling all betaX 's and betaX V , M 's simultaneously by a NPI severity index lambda , where 0 < = lambda < = 1 .\\nThe time-varying function lambda is chosen in part based on Ontario COVID-19 lockdown timeline and Google mobility data , and in part to fit the predicted new case numbers against provincial data available prior to July 2021 ; the values of lambda for 2020-2021 are shown in Fig.S1 .\",\"char_start\":502,\"char_end\":508,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.602954\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1219973510\"},\"description\":\"severity index\",\"grounding\":[{\"grounding_text\":\"Breteau Index\",\"grounding_id\":\"apollosv:00000311\",\"source\":[],\"score\":0.808208703994751,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.602978\"}}],\"extraction_source\":{\"page\":15,\"block\":5,\"surrounding_passage\":null,\"char_start\":487,\"char_end\":501,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.602954\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-972044033\"},\"mentions\":[{\"id\":{\"id\":\"T:1609199231\"},\"name\":\"lambda\",\"extraction_source\":{\"page\":15,\"block\":5,\"surrounding_passage\":\"These NPI reduce the transmissivity of COVID-19 , and are represented by scaling all betaX 's and betaX V , M 's simultaneously by a NPI severity index lambda , where 0 < = lambda < = 1 .\\nThe time-varying function lambda is chosen in part based on Ontario COVID-19 lockdown timeline and Google mobility data , and in part to fit the predicted new case numbers against provincial data available prior to July 2021 ; the values of lambda for 2020-2021 are shown in Fig.S1 .\",\"char_start\":560,\"char_end\":566,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603050\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1560584713\"},\"description\":\"time-varying function\",\"grounding\":[{\"grounding_text\":\"seasonal function parameter\",\"grounding_id\":\"apollosv:00000273\",\"source\":[],\"score\":0.8261008858680725,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.603077\"}}],\"extraction_source\":{\"page\":15,\"block\":5,\"surrounding_passage\":null,\"char_start\":538,\"char_end\":559,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603050\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:431433590\"},\"mentions\":[{\"id\":{\"id\":\"T:-1166198558\"},\"name\":\"A.T.L\",\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":\"Author contributions conceptualization , A.T.L .\\nand M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\nand M.S .; writing - - original draft preparation , A.T.L .; writing - - review and editing , M.S. and A.T.L .; visualization , A.T.L .; project administration and funding acquisition , A.T.L .\",\"char_start\":130,\"char_end\":135,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603273\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-1180241410\"},\"description\":\"M.S.; methodology\",\"grounding\":[],\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":null,\"char_start\":51,\"char_end\":68,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603273\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:622838043\"},\"mentions\":[{\"id\":{\"id\":\"T:-1166198558\"},\"name\":\"A.T.L\",\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":\"Author contributions conceptualization , A.T.L .\\nand M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\nand M.S .; writing - - original draft preparation , A.T.L .; writing - - review and editing , M.S. and A.T.L .; visualization , A.T.L .; project administration and funding acquisition , A.T.L .\",\"char_start\":130,\"char_end\":135,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603366\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-798456128\"},\"description\":\"A.T.L.; data curation\",\"grounding\":[{\"grounding_text\":\"data parsing\",\"grounding_id\":\"apollosv:00000566\",\"source\":[],\"score\":0.8749537467956543,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.603381\"}}],\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":null,\"char_start\":107,\"char_end\":128,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603366\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-303100857\"},\"mentions\":[{\"id\":{\"id\":\"T:-1166198558\"},\"name\":\"A.T.L\",\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":\"Author contributions conceptualization , A.T.L .\\nand M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\nand M.S .; writing - - original draft preparation , A.T.L .; writing - - review and editing , M.S. and A.T.L .; visualization , A.T.L .; project administration and funding acquisition , A.T.L .\",\"char_start\":130,\"char_end\":135,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603461\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-798456128\"},\"description\":\"A.T.L.; data curation\",\"grounding\":[{\"grounding_text\":\"data parsing\",\"grounding_id\":\"apollosv:00000566\",\"source\":[],\"score\":0.8749537467956543,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.603476\"}}],\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":null,\"char_start\":107,\"char_end\":128,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603461\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-1713386033\"},\"mentions\":[{\"id\":{\"id\":\"T:446109225\"},\"name\":\"M.S.\",\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":\"and M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\nand M.S .; writing - - original draft preparation , A.T.L .; writing - - review and editing , M.S. and A.T.L .; visualization , A.T.L .; project administration and funding acquisition , A.T.L .\\nAll authors have read and agreed to the published version of the manuscript .\",\"char_start\":221,\"char_end\":225,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603553\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1503915347\"},\"description\":\"editing\",\"grounding\":[],\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":null,\"char_start\":212,\"char_end\":219,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603553\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-627640234\"},\"mentions\":[{\"id\":{\"id\":\"T:1856363209\"},\"name\":\"A.T.L\",\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":\"and M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\nand M.S .; writing - - original draft preparation , A.T.L .; writing - - review and editing , M.S. and A.T.L .; visualization , A.T.L .; project administration and funding acquisition , A.T.L .\\nAll authors have read and agreed to the published version of the manuscript .\",\"char_start\":309,\"char_end\":314,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603682\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2070179544\"},\"description\":\"funding acquisition\",\"grounding\":[],\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":null,\"char_start\":288,\"char_end\":307,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603682\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"E:-1848496646\"},\"mentions\":[{\"id\":{\"id\":\"T:-229313771\"},\"name\":\"A.T.L\",\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":\"Author contributions conceptualization , A.T.L .\\nand M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\",\"char_start\":40,\"char_end\":45,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603775\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-982351631\"},\"description\":\"Author contributions conceptualization\",\"grounding\":[],\"extraction_source\":{\"page\":16,\"block\":3,\"surrounding_passage\":null,\"char_start\":0,\"char_end\":38,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603775\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-62286782\"},\"mentions\":[{\"id\":{\"id\":\"T:1130222314\"},\"name\":\"s\",\"extraction_source\":{\"page\":16,\"block\":7,\"surrounding_passage\":\"Open Access This article is licensed under a Creative Commons Attribution 4.0 International License , which permits use , sharing , adaptation , distribution and reproduction in any medium or format , as long as you give appropriate credit to the original author ( s ) and the source , provide a link to the Creative Commons licence , and indicate if changes were made .\\nThe images or other third party material in this article are included in the article 's Creative Commons licence , unless indicated otherwise in a credit line to the material .\",\"char_start\":259,\"char_end\":260,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603874\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:-2107321472\"},\"description\":\"original author\",\"grounding\":[{\"grounding_text\":\"author list\",\"grounding_id\":\"apollosv:00000329\",\"source\":[],\"score\":0.7829368710517883,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.603899\"}}],\"extraction_source\":{\"page\":16,\"block\":7,\"surrounding_passage\":null,\"char_start\":243,\"char_end\":258,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603874\"}}],\"value_descriptions\":[],\"groundings\":[{\"grounding_text\":\"Meruvax I\",\"grounding_id\":\"vo:0003109\",\"source\":[],\"score\":0.7847759127616882,\"provenance\":{\"method\":\"SKEMA-TR-Embedding\",\"timestamp\":\"2023-10-29T20:32:10.603882\"}}],\"data_columns\":null}},{\"type\":\"anchored_entity\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"R:-561348916\"},\"mentions\":[{\"id\":{\"id\":\"T:644227346\"},\"name\":\"mmons\",\"extraction_source\":{\"page\":16,\"block\":7,\"surrounding_passage\":\"If material is not included in the article 's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use , you will need to obtain permission directly from the copyright holder .\\nTo view a copy of this licence , visit http :// creat iveco mmons .\\norg / licen ses / by / 4 .\",\"char_start\":827,\"char_end\":832,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603933\"}}],\"text_descriptions\":[{\"id\":{\"id\":\"T:1629415388\"},\"description\":\"creat iveco\",\"grounding\":[],\"extraction_source\":{\"page\":16,\"block\":7,\"surrounding_passage\":null,\"char_start\":815,\"char_end\":826,\"document_reference\":{\"id\":\"s41598-022-06159-x (1).pdf\"}},\"provenance\":{\"method\":\"Skema TR Pipeline rules\",\"timestamp\":\"2023-10-29T20:32:10.603933\"}}],\"value_descriptions\":[],\"groundings\":[],\"data_columns\":null}},{\"type\":\"document_collection\",\"amr_element_id\":null,\"payload\":{\"documents\":[{\"id\":{\"id\":\"s41598-022-06159-x (1).pdf\"},\"source_file\":\"s41598-022-06159-x (1).pdf\",\"doi\":\"\"},{\"id\":{\"id\":\"1\"},\"source_file\":\"44b9158cad9a3098e5272cf906ef88a2__filename\",\"doi\":\"\"}]}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1687473227\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585404\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:-1687473227\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585437\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-1687473227\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585448\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:1099021099\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585523\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:1099021099\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585536\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:1012021369\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585599\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:1012021369\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585611\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1111183205321914260\"},\"extractions\":[{\"id\":\"E:1012021369\"}],\"location\":{\"location\":\"World Health Organization\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585622\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:-779055136\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585686\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:-779055136\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585698\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1111183205321914260\"},\"extractions\":[{\"id\":\"E:-779055136\"}],\"location\":{\"location\":\"World Health Organization\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585707\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"E:-779055136\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585717\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"E:-657071160\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585872\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:-657071160\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585882\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-657071160\"}],\"location\":null,\"time\":{\"datetime\":\"April 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585892\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-657071160\"}],\"location\":null,\"time\":{\"datetime\":\"3 June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585906\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-657071160\"}],\"location\":null,\"time\":{\"datetime\":\"July 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585921\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1574680068\"}],\"location\":null,\"time\":{\"datetime\":\"July 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585982\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"7595783505243143026\"},\"extractions\":[{\"id\":\"R:-1574680068\"}],\"location\":{\"location\":\"WHO\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.585995\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5177116372746314001\"},\"extractions\":[{\"id\":\"R:-1574680068\"}],\"location\":{\"location\":\"North America\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586004\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2730056309469988308\"},\"extractions\":[{\"id\":\"R:-1574680068\"}],\"location\":{\"location\":\"Oxford-AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586017\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-627600896\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586079\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-627600896\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586090\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1111183205321914260\"},\"extractions\":[{\"id\":\"R:-627600896\"}],\"location\":{\"location\":\"World Health Organization\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586101\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:-627600896\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586112\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-627600896\"}],\"location\":null,\"time\":{\"datetime\":\"April 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586122\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-1894470453\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586228\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:183719204\"}],\"location\":null,\"time\":{\"datetime\":\"3 June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586294\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:183719204\"}],\"location\":null,\"time\":{\"datetime\":\"July 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586305\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1111183205321914260\"},\"extractions\":[{\"id\":\"E:-320992724\"}],\"location\":{\"location\":\"World Health Organization\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586367\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"E:-320992724\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586377\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:-320992724\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586388\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-320992724\"}],\"location\":null,\"time\":{\"datetime\":\"April 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586397\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-320992724\"}],\"location\":null,\"time\":{\"datetime\":\"3 June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586407\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-380273488\"}],\"location\":null,\"time\":{\"datetime\":\"3 June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586466\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-380273488\"}],\"location\":null,\"time\":{\"datetime\":\"July 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586477\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"7595783505243143026\"},\"extractions\":[{\"id\":\"R:-380273488\"}],\"location\":{\"location\":\"WHO\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.586487\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-308499566\"}],\"location\":null,\"time\":{\"datetime\":\"March 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587189\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-308499566\"}],\"location\":null,\"time\":{\"datetime\":\"December 2020\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587203\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-308499566\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587213\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-308499566\"}],\"location\":null,\"time\":{\"datetime\":\"July 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587228\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-308499566\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587238\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1672592981\"}],\"location\":null,\"time\":{\"datetime\":\"March 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587297\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1672592981\"}],\"location\":null,\"time\":{\"datetime\":\"December 2020\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587307\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1672592981\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587317\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-3540222956639707560\"},\"extractions\":[{\"id\":\"R:-1672592981\"}],\"location\":{\"location\":\"COVID\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587327\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1676757554\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587401\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1676757554\"}],\"location\":null,\"time\":{\"datetime\":\"December 2020\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587414\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1676757554\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587425\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1511085452\"}],\"location\":null,\"time\":{\"datetime\":\"March 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587480\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1511085452\"}],\"location\":null,\"time\":{\"datetime\":\"December 2020\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587491\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1511085452\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587501\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-3540222956639707560\"},\"extractions\":[{\"id\":\"R:-1511085452\"}],\"location\":{\"location\":\"COVID\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587552\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-303059524\"}],\"location\":null,\"time\":{\"datetime\":\"December 2020\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587615\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-303059524\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587625\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-303059524\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587635\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:527532433\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587689\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-3540222956639707560\"},\"extractions\":[{\"id\":\"E:527532433\"}],\"location\":{\"location\":\"COVID\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587702\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:527532433\"}],\"location\":null,\"time\":{\"datetime\":\"March 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587713\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:527532433\"}],\"location\":null,\"time\":{\"datetime\":\"December 2020\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587722\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:527532433\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587731\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:1952535670\"}],\"location\":null,\"time\":{\"datetime\":\"March 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587792\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:1952535670\"}],\"location\":null,\"time\":{\"datetime\":\"December 2020\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587801\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:1952535670\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587811\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:1952535670\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587822\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-3540222956639707560\"},\"extractions\":[{\"id\":\"E:1952535670\"}],\"location\":{\"location\":\"COVID\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587831\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:-1550505153\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587898\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-3540222956639707560\"},\"extractions\":[{\"id\":\"E:-1550505153\"}],\"location\":{\"location\":\"COVID\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587908\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-1550505153\"}],\"location\":null,\"time\":{\"datetime\":\"March 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587918\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-1550505153\"}],\"location\":null,\"time\":{\"datetime\":\"December 2020\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587928\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-1550505153\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.587939\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:44342288\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588003\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"E:44342288\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588013\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:1960087092\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588076\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"R:1960087092\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588086\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:1580628517\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588590\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"E:1580628517\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588602\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:1580628517\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588612\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-1846480138\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588672\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-1846480138\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588719\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-1846480138\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588730\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:-1532099766\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588790\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"E:-1532099766\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588806\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:-1532099766\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588817\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"E:1960993140\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588870\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:1960993140\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588880\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:332339292\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.588986\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-302164219\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.589038\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-1790727618\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.589096\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-1790727618\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.589109\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-1790727618\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.589119\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:615518326\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.589179\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:615518326\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.589189\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:615518326\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.589200\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:-1662231047\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.589416\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"E:-1430855057\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.590130\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"E:2134716306\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.590190\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"E:1308192125\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.590244\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:795884335\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.590348\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:1041191212\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.590407\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-535082164\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591253\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-1637552708\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591313\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"R:-1637552708\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591324\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1637552708\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591335\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-1637552708\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591344\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1637552708\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591356\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:1830320991\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591416\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:1830320991\"}],\"location\":null,\"time\":{\"datetime\":\"March 2022\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591427\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:1864118410\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591488\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:1864118410\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591498\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:1864118410\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591511\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"E:1864118410\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591520\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"E:1864118410\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591530\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-1461588612\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591590\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:1956562617\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591687\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:1164908205\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591749\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:1164908205\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591759\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"R:1164908205\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591771\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:1164908205\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591781\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:1164908205\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591794\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:1822299949\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591853\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:1822299949\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591864\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"E:1822299949\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591874\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"E:1822299949\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591883\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:1839289179\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591939\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:1839289179\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591951\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"E:1839289179\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591961\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"E:1839289179\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.591970\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:390122022\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592038\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:390122022\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592049\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"E:390122022\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592058\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"E:390122022\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592069\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"R:1137065363\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592128\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:1137065363\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592140\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:1137065363\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592151\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:1137065363\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592161\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:1311518691\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592220\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"R:1311518691\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592231\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:1311518691\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592241\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:1311518691\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592251\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"E:-1669100175\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592310\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:-1669100175\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592320\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:-1669100175\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592366\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-1669100175\"}],\"location\":null,\"time\":{\"datetime\":\"June 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592376\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"R:786071264\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592780\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"R:-1015129557\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592840\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"R:847069629\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592895\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"R:1957664339\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.592950\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"R:428284098\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593003\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:2008329411\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593059\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"E:2008329411\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593069\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"R:-491568125\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593121\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"R:860821778\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593191\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-1468322701\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593246\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-1468322701\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593258\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"9196459189987031493\"},\"extractions\":[{\"id\":\"R:-1468322701\"}],\"location\":{\"location\":\"which\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593267\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"R:-1468322701\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593277\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1468322701\"}],\"location\":null,\"time\":{\"datetime\":\"March 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593289\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1468322701\"}],\"location\":null,\"time\":{\"datetime\":\"March 2022\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593299\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:211817700\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593359\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"E:211817700\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593368\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:211817700\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593378\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:-963867388\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593476\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"E:-963867388\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593488\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:-963867388\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593498\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:514068618\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593569\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"E:514068618\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593580\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:514068618\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.593589\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:34958215\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594218\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:34958215\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594231\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:1290099843\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594290\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:1659964566\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594347\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:1659964566\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594357\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:1659964566\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594366\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-598133204\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594691\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:-598133204\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594702\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-77644022\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594763\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:-77644022\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594774\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:1160080482\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594833\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:1160080482\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594845\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-752128713\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594904\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:-752128713\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.594914\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-629925471\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595013\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:-629925471\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595023\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:-1084065351\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595082\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"E:-1084065351\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595094\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:-1751229178\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595151\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"E:-1751229178\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595163\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1086028280\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595222\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:-1086028280\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595232\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1225515740\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595291\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"R:-1225515740\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595302\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:2043881519\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595523\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6656807016960893394\"},\"extractions\":[{\"id\":\"E:1942444907\"}],\"location\":{\"location\":\"Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595589\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:1942444907\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.595600\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"R:604822229\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596023\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"R:604822229\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596036\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"R:604822229\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596046\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"R:604822229\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596057\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:604822229\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596066\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"E:1847156755\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596118\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"E:1847156755\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596130\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"E:1847156755\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596141\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"E:1847156755\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596150\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:491930989\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596206\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:1283479641\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596259\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:-1291825073\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596311\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:-1542387382\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596367\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"E:-1477307630\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596428\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"R:346088061\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596713\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"R:346088061\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596725\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"R:346088061\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596736\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"R:346088061\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596747\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:346088061\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596764\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:-1153919973\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596823\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"R:-1153919973\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596833\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:1969515142\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596921\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"R:1969515142\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596932\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:-1220406750\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596987\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"R:-1220406750\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.596997\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:-1422446413\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597047\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"R:-1422446413\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597058\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"R:-1754528603\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597116\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:1930130592\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597331\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"E:716487493\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597425\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"E:-1780919070\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597480\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"E:2056695833\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597539\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"E:1341709601\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597596\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"E:825197191\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597651\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"E:825197191\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597663\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6143938794794778449\"},\"extractions\":[{\"id\":\"E:-58983686\"}],\"location\":{\"location\":\"VOC\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597853\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-5756132935071079135\"},\"extractions\":[{\"id\":\"E:-58983686\"}],\"location\":{\"location\":\"SVR\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.597865\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:611615583\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598259\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:814952678\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598316\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:576858469\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598377\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:1695453225\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598436\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-2089543753\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598492\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-146210857\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598545\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-230919232\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598622\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-1759113608\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598764\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1759113608\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598777\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-1759113608\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598787\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-1759113608\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598798\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-868577489\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598857\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-868577489\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598867\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-868577489\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598876\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-868577489\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598889\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-869823682\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598950\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-869823682\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598961\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-869823682\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598972\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-869823682\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.598982\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:-1297286117\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599038\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:-1297286117\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599049\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:-1297286117\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599060\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"E:-1297286117\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599069\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-438207695\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599122\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-438207695\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599133\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-438207695\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599142\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-438207695\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599151\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:83314069\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599201\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:83314069\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599214\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:83314069\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599227\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:83314069\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599236\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-634538974\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599295\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-634538974\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599304\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-634538974\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599313\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-634538974\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599323\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-1993378382\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599382\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1993378382\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599394\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-1993378382\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599437\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-1993378382\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599447\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:800289603\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599501\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:800289603\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599511\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:800289603\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599525\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:800289603\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599537\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-1558390445\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599588\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1558390445\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599599\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-1558390445\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599609\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-1558390445\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599618\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-2075507652\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599679\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-2075507652\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599689\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-2075507652\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599700\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-2075507652\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599710\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:721581088\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599761\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:721581088\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599772\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:721581088\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599781\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:721581088\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599790\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:1895430149\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599850\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:1895430149\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599860\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:1895430149\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599869\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:1895430149\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599879\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-1776301662\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599935\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1776301662\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599946\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:-1776301662\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599956\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-2902571932492443446\"},\"extractions\":[{\"id\":\"R:-1776301662\"}],\"location\":{\"location\":\"Pfizer\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.599966\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-1876321384\"}],\"location\":null,\"time\":{\"datetime\":\"March 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600103\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:-1876321384\"}],\"location\":null,\"time\":{\"datetime\":\"March 2022\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600114\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"9196459189987031493\"},\"extractions\":[{\"id\":\"E:-1876321384\"}],\"location\":{\"location\":\"which\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600124\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"E:-1876321384\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600134\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:-1876321384\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600147\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:868023049\"}],\"location\":null,\"time\":{\"datetime\":\"March 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600238\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:868023049\"}],\"location\":null,\"time\":{\"datetime\":\"March 2022\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600248\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"9196459189987031493\"},\"extractions\":[{\"id\":\"R:868023049\"}],\"location\":{\"location\":\"which\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600260\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"R:868023049\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600271\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:868023049\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600280\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-739144679\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600442\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"9196459189987031493\"},\"extractions\":[{\"id\":\"E:-795860774\"}],\"location\":{\"location\":\"which\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600682\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"E:-795860774\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600694\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"E:-795860774\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600704\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"E:-795860774\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600713\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"9196459189987031493\"},\"extractions\":[{\"id\":\"R:1959808490\"}],\"location\":{\"location\":\"which\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600779\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"R:1959808490\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600790\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4465670777268672531\"},\"extractions\":[{\"id\":\"R:1959808490\"}],\"location\":{\"location\":\"AstraZeneca\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600799\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"5649036413160770716\"},\"extractions\":[{\"id\":\"E:1741730311\"}],\"location\":{\"location\":\"Neos\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600915\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:1741730311\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600926\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:1741730311\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600938\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:1995693754\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.600992\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:1995693754\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601006\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"E:-1128287073\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601178\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"E:-1128287073\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601188\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"E:-1128287073\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601197\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"E:-1128287073\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601208\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"E:-1128287073\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601221\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"E:-680787754\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601272\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"E:-680787754\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601282\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"E:-680787754\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601293\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"E:-680787754\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601304\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"E:-680787754\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601349\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"E:-1717504424\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601415\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"E:-1717504424\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601429\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"E:-1717504424\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601440\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"E:-1717504424\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601449\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"E:-1717504424\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601460\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"E:513256652\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601517\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"E:513256652\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601530\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"E:513256652\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601540\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"E:513256652\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601549\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"E:513256652\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601560\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"E:-1599769952\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601616\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"E:-1599769952\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601627\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"E:-1599769952\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601637\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"E:-1599769952\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601646\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"E:-1599769952\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601656\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"E:1123702885\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601711\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"E:1123702885\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601721\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"E:1123702885\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601732\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"E:1123702885\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601741\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"E:1123702885\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601752\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"R:-1421467959\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601817\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"R:-1421467959\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601828\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"R:-1421467959\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601837\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"R:-1421467959\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601849\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:-1421467959\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601858\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"E:-502448825\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601903\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"E:-502448825\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601914\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"E:-502448825\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601925\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"E:-502448825\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601935\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"E:-502448825\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601944\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-7955947886743420174\"},\"extractions\":[{\"id\":\"R:-245957849\"}],\"location\":{\"location\":\"x\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601986\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-942088709085686913\"},\"extractions\":[{\"id\":\"R:-245957849\"}],\"location\":{\"location\":\"Micro\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.601997\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"682249285375859648\"},\"extractions\":[{\"id\":\"R:-245957849\"}],\"location\":{\"location\":\"PZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.602008\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6335243503299725048\"},\"extractions\":[{\"id\":\"R:-245957849\"}],\"location\":{\"location\":\"AZ\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.602778\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1952131805326656659\"},\"extractions\":[{\"id\":\"R:-245957849\"}],\"location\":{\"location\":\"D\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.602789\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"E:1346749703\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.602907\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"E:1346749703\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.602918\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"714152609938435503\"},\"extractions\":[{\"id\":\"E:1346749703\"}],\"location\":{\"location\":\"Google\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.602928\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"E:1346749703\"}],\"location\":null,\"time\":{\"datetime\":\"July 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.602939\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-1566681075\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603001\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-1566681075\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603013\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"714152609938435503\"},\"extractions\":[{\"id\":\"R:-1566681075\"}],\"location\":{\"location\":\"Google\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603025\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-1566681075\"}],\"location\":null,\"time\":{\"datetime\":\"July 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603036\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-4298961581852288150\"},\"extractions\":[{\"id\":\"R:-972044033\"}],\"location\":{\"location\":\"Ontario\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603096\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"1338862567378819490\"},\"extractions\":[{\"id\":\"R:-972044033\"}],\"location\":{\"location\":\"NPI\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603107\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"714152609938435503\"},\"extractions\":[{\"id\":\"R:-972044033\"}],\"location\":{\"location\":\"Google\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603116\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-853588310126217076\"},\"extractions\":[{\"id\":\"R:-972044033\"}],\"location\":{\"location\":\"Natural Sciences and Engineering Research Council of Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603127\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6488996057273214108\"},\"extractions\":[{\"id\":\"R:-972044033\"}],\"location\":{\"location\":\"Nserc Discovery Award\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603136\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6053394954652950638\"},\"extractions\":[{\"id\":\"R:-972044033\"}],\"location\":{\"location\":\"Canada 150 Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603147\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1685434613467854918\"},\"extractions\":[{\"id\":\"R:-972044033\"}],\"location\":{\"location\":\"Canadian Institutes of Health Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603157\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"3185139421556535230\"},\"extractions\":[{\"id\":\"R:-972044033\"}],\"location\":{\"location\":\"Immunity Task Force\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603168\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"8129740313160126952\"},\"extractions\":[{\"id\":\"R:-972044033\"}],\"location\":null,\"time\":{\"datetime\":\"July 2021\",\"start_datetime\":null,\"end_datetime\":null,\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603178\"},\"grounding\":null}}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-853588310126217076\"},\"extractions\":[{\"id\":\"E:431433590\"}],\"location\":{\"location\":\"Natural Sciences and Engineering Research Council of Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603305\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6488996057273214108\"},\"extractions\":[{\"id\":\"E:431433590\"}],\"location\":{\"location\":\"Nserc Discovery Award\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603316\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6053394954652950638\"},\"extractions\":[{\"id\":\"E:431433590\"}],\"location\":{\"location\":\"Canada 150 Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603325\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1685434613467854918\"},\"extractions\":[{\"id\":\"E:431433590\"}],\"location\":{\"location\":\"Canadian Institutes of Health Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603335\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"3185139421556535230\"},\"extractions\":[{\"id\":\"E:431433590\"}],\"location\":{\"location\":\"Immunity Task Force\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603344\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-853588310126217076\"},\"extractions\":[{\"id\":\"R:622838043\"}],\"location\":{\"location\":\"Natural Sciences and Engineering Research Council of Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603405\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6488996057273214108\"},\"extractions\":[{\"id\":\"R:622838043\"}],\"location\":{\"location\":\"Nserc Discovery Award\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603417\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6053394954652950638\"},\"extractions\":[{\"id\":\"R:622838043\"}],\"location\":{\"location\":\"Canada 150 Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603427\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1685434613467854918\"},\"extractions\":[{\"id\":\"R:622838043\"}],\"location\":{\"location\":\"Canadian Institutes of Health Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603436\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"3185139421556535230\"},\"extractions\":[{\"id\":\"R:622838043\"}],\"location\":{\"location\":\"Immunity Task Force\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603447\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-853588310126217076\"},\"extractions\":[{\"id\":\"E:-303100857\"}],\"location\":{\"location\":\"Natural Sciences and Engineering Research Council of Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603497\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6488996057273214108\"},\"extractions\":[{\"id\":\"E:-303100857\"}],\"location\":{\"location\":\"Nserc Discovery Award\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603507\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6053394954652950638\"},\"extractions\":[{\"id\":\"E:-303100857\"}],\"location\":{\"location\":\"Canada 150 Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603519\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1685434613467854918\"},\"extractions\":[{\"id\":\"E:-303100857\"}],\"location\":{\"location\":\"Canadian Institutes of Health Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603528\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"3185139421556535230\"},\"extractions\":[{\"id\":\"E:-303100857\"}],\"location\":{\"location\":\"Immunity Task Force\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603539\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-853588310126217076\"},\"extractions\":[{\"id\":\"R:-1713386033\"}],\"location\":{\"location\":\"Natural Sciences and Engineering Research Council of Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603623\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6488996057273214108\"},\"extractions\":[{\"id\":\"R:-1713386033\"}],\"location\":{\"location\":\"Nserc Discovery Award\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603637\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6053394954652950638\"},\"extractions\":[{\"id\":\"R:-1713386033\"}],\"location\":{\"location\":\"Canada 150 Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603646\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1685434613467854918\"},\"extractions\":[{\"id\":\"R:-1713386033\"}],\"location\":{\"location\":\"Canadian Institutes of Health Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603657\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"3185139421556535230\"},\"extractions\":[{\"id\":\"R:-1713386033\"}],\"location\":{\"location\":\"Immunity Task Force\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603667\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-853588310126217076\"},\"extractions\":[{\"id\":\"R:-627640234\"}],\"location\":{\"location\":\"Natural Sciences and Engineering Research Council of Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603722\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6488996057273214108\"},\"extractions\":[{\"id\":\"R:-627640234\"}],\"location\":{\"location\":\"Nserc Discovery Award\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603733\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6053394954652950638\"},\"extractions\":[{\"id\":\"R:-627640234\"}],\"location\":{\"location\":\"Canada 150 Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603743\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1685434613467854918\"},\"extractions\":[{\"id\":\"R:-627640234\"}],\"location\":{\"location\":\"Canadian Institutes of Health Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603752\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"3185139421556535230\"},\"extractions\":[{\"id\":\"R:-627640234\"}],\"location\":{\"location\":\"Immunity Task Force\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603761\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-853588310126217076\"},\"extractions\":[{\"id\":\"E:-1848496646\"}],\"location\":{\"location\":\"Natural Sciences and Engineering Research Council of Canada\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603812\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-6488996057273214108\"},\"extractions\":[{\"id\":\"E:-1848496646\"}],\"location\":{\"location\":\"Nserc Discovery Award\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603822\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"6053394954652950638\"},\"extractions\":[{\"id\":\"E:-1848496646\"}],\"location\":{\"location\":\"Canada 150 Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603832\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"-1685434613467854918\"},\"extractions\":[{\"id\":\"E:-1848496646\"}],\"location\":{\"location\":\"Canadian Institutes of Health Research\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603842\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"3185139421556535230\"},\"extractions\":[{\"id\":\"E:-1848496646\"}],\"location\":{\"location\":\"Immunity Task Force\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603851\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}},{\"type\":\"scenario_context\",\"amr_element_id\":null,\"payload\":{\"id\":{\"id\":\"7814043800575125331\"},\"extractions\":[{\"id\":\"R:-62286782\"}],\"location\":{\"location\":\"Springer Nature\",\"provenance\":{\"method\":\"SKEMA-TR-Context-1.0\",\"timestamp\":\"2023-10-29T20:32:10.603918\"},\"grounding\":null,\"extraction_source\":null},\"time\":null}}]}\n"
     ]
    }
   ],
   "source": [
    "with open('m_temp_scenario_2.json', 'rb') as f_mit, open('s41598-022-06159.json', 'rb') as f_arizona:\n",
    "    files = { 'mit_file': ('bucky__mit-extraction_id.json', f_mit, 'application/json'),\n",
    "        'arizona_file': ('bucky_arizona_output_example.json', f_arizona, 'application/json')}\n",
    "    params = {\"gpt_key\": GPT_KEY}\n",
    "    response = requests.post(API_ROOT + \"integration/get_mapping\", params=params, files=files)\n",
    "    assert response.status_code == 200, response.text\n",
    "    print(response.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "69af103e",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2023-10-31T20:46:33.933386Z",
     "iopub.status.busy": "2023-10-31T20:46:33.933280Z",
     "iopub.status.idle": "2023-10-31T20:46:33.969813Z",
     "shell.execute_reply": "2023-10-31T20:46:33.969516Z"
    },
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "                <iframe\n",
       "                    id=\"jsonviewer_mbSVczAp\">\n",
       "                </iframe>\n",
       "                <script>\n",
       "                    function init (){\n",
       "                        console.log('within iframe script')\n",
       "\n",
       "                        document.getElementById(\"jsonviewer_mbSVczAp\").onload = () => {\n",
       "                            console.log('loaded iframe')\n",
       "                            let iframe = document.getElementById(\"jsonviewer_mbSVczAp\")\n",
       "                            var iframeWindow = document.getElementById(\"jsonviewer_mbSVczAp\").contentWindow;\n",
       "                            iframe.style.width = \"100%\";\n",
       "                            iframe.style.height = \"630px\";\n",
       "                            let data = {\"json_str\": \"{\\n  \\\"attributes\\\": [\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1687473227\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1909222834\\\"\\n            },\\n            \\\"name\\\": \\\"NPI\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"In Ontario , Canada , the wild type was overtaken first by the Alpha / B1.1.17 variant , and then by the Delta / B.1.617 variant .\\\\nThe principal objective of the present study is to develop and apply a much expanded Susceptible-Infection-Recovered-type model to better understand the spread of multiple VOC , and assess the effectiveness of vaccination and non pharmaceutical interventions ( NPI ) .\\\\nThe model represents competition among VOC , and reveals their mutual inhibitory effects .\\\",\\n              \\\"char_start\\\": 579,\\n              \\\"char_end\\\": 582,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585267\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit0\\\"\\n            },\\n            \\\"name\\\": \\\"ame\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1739817510\\\"\\n            },\\n            \\\"description\\\": \\\"effectiveness of vaccination and non-pharmaceutical interventions\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 512,\\n              \\\"char_end\\\": 577,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585267\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit0\\\"\\n            },\\n            \\\"description\\\": \\\"description\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit0\\\"\\n            },\\n            \\\"description\\\": \\\"description\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit0-value\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"numerical value\\\",\\n              \\\"grounding\\\": null,\\n              \\\"extraction_source\\\": null\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"description\\\",\\n            \\\"grounding_id\\\": \\\"dc:description\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"\\\",\\n            \\\"grounding_id\\\": \\\"fbbt:00045003\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1099021099\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1246793088\\\"\\n            },\\n            \\\"name\\\": \\\"VOC\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"A year after the initial wild-type Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS-CoV-2 ) strains began their devastation of the world , they were supplanted by new variants of concern ( VOC ) .\\\\nIn Ontario , Canada , the wild type was overtaken first by the Alpha / B1.1.17 variant , and then by the Delta / B.1.617 variant .\\\",\\n              \\\"char_start\\\": 191,\\n              \\\"char_end\\\": 194,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585467\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit1\\\"\\n            },\\n            \\\"name\\\": \\\"---\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1660685213\\\"\\n            },\\n            \\\"description\\\": \\\"new variants of concern\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 166,\\n              \\\"char_end\\\": 189,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585467\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit1\\\"\\n            },\\n            \\\"description\\\": \\\"---\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit1\\\"\\n            },\\n            \\\"description\\\": \\\"---\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit1-value\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"---\\\",\\n              \\\"grounding\\\": null,\\n              \\\"extraction_source\\\": null\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"purely intentional entity\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000000\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Bat coronavirus (BtCoV/A910/2005)\\\",\\n            \\\"grounding_id\\\": \\\"ncbitaxon:389159\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1012021369\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1703120071\\\"\\n            },\\n            \\\"name\\\": \\\"VOC\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Furthermore , the severity of a Delta outbreak depends not only on the NPI and vaccination rate but also on the vaccine types .\\\\nAlarmingly , despite Ontario 's existing NPI and relatively successful vaccine rollout , a future , more dangerous VOC could potentially infect a significant fraction of the province 's population and overwhelm the health care system .\\\\nTo stop that VOC , the province may need the simultaneous and rapid deployment of a third booster vaccine and stringent NPI .\\\",\\n              \\\"char_start\\\": 1069,\\n              \\\"char_end\\\": 1072,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585553\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit2\\\"\\n            },\\n            \\\"name\\\": \\\"SARS-CoV-2\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-493884876\\\"\\n            },\\n            \\\"description\\\": \\\"future\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1046,\\n              \\\"char_end\\\": 1052,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585553\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit2\\\"\\n            },\\n            \\\"description\\\": \\\"Severe Acute Respiratory Syndrome Coronavirus 2\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"N gene of severe acute respiratory syndrome coronavirus 2\\\",\\n            \\\"grounding_id\\\": \\\"ogg:3043740575\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"S gene of severe acute respiratory syndrome coronavirus 2\\\",\\n            \\\"grounding_id\\\": \\\"ogg:3043740568\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-779055136\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2007310784\\\"\\n            },\\n            \\\"name\\\": \\\"VOC\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Alarmingly , despite Ontario 's existing NPI and relatively successful vaccine rollout , a future , more dangerous VOC could potentially infect a significant fraction of the province 's population and overwhelm the health care system .\\\\nTo stop that VOC , the province may need the simultaneous and rapid deployment of a third booster vaccine and stringent NPI .\\\",\\n              \\\"char_start\\\": 1201,\\n              \\\"char_end\\\": 1204,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585638\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit3\\\"\\n            },\\n            \\\"name\\\": \\\"VOC\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1802530407\\\"\\n            },\\n            \\\"description\\\": \\\"province\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1210,\\n              \\\"char_end\\\": 1218,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585638\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit3\\\"\\n            },\\n            \\\"description\\\": \\\"Variants of Concern\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Dermatoglyphic variants\\\",\\n            \\\"grounding_id\\\": \\\"hp:0005882\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"EEG with constitutional variants\\\",\\n            \\\"grounding_id\\\": \\\"hp:0011176\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-657071160\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2109284684\\\"\\n            },\\n            \\\"name\\\": \\\"Beta from\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"Around that time , the Delta variant was first reported in the province .\\\\nBy 3 June 2021 , the Alpha variant has been reported from at least 160 countries , Beta from 113 countries , Gamma from 64 countries , and Delta from 62 countries .\\\\nSince then , the Delta variant has rapidly become the dominant circulating lineage .\\\",\\n              \\\"char_start\\\": 894,\\n              \\\"char_end\\\": 903,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585826\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-552097546\\\"\\n            },\\n            \\\"description\\\": \\\"least 160 countries\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 873,\\n              \\\"char_end\\\": 892,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585826\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1574680068\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:115397170\\\"\\n            },\\n            \\\"name\\\": \\\"NPI\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"Initially , no pharmaceutical agents are known to be safe and effective at preventing or treating coronavirus disease 2019 ( COVID-19 ) 4 .\\\\nThis leaves public health authorities with nonpharmaceutical interventions ( NPI ) as the only recourse to reduce disease transmission ; these measures include bans on public gatherings , compulsory stay-at-home policies , mandating closures of schools and nonessential businesses , face mask ordinances , and quarantine .\\\\nEven though the WHO initially expected vaccine development to take 18 months5 , dedicated global efforts resulted in the approval of vaccines first in China6 and Russia7 in the summer of 2020 .\\\",\\n              \\\"char_start\\\": 1398,\\n              \\\"char_end\\\": 1401,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585938\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit4\\\"\\n            },\\n            \\\"name\\\": \\\"NPI\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:600529022\\\"\\n            },\\n            \\\"description\\\": \\\"nonpharmaceutical interventions\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1365,\\n              \\\"char_end\\\": 1396,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585938\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit4\\\"\\n            },\\n            \\\"description\\\": \\\"Non-pharmaceutical interventions\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"non-pharmaceutical interventions\\\",\\n            \\\"grounding_id\\\": \\\"cemo:non-pharmaceutical_interventions\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Pharmaceutical Preparations\\\",\\n            \\\"grounding_id\\\": \\\"ndfrt:N0000000001\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-627600896\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1702094218\\\"\\n            },\\n            \\\"name\\\": \\\"VOC\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"In recent months , severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) variants associated with increased transmissibility have emerged and spread , one after another .\\\\nThe World Health Organization has designated a list of variants of concern ( VOC ) , including Alpha ( B.1.1.7 ) , Beta ( B.1.351 ) , Gamma ( P.1 ) , Delta ( B.1.617.2 ) , and Omicron ( B.1.1.529 ) , as well as multiple variants of interest1 .\\\\nViral lineages carrying the N501Y and / or E484K mutations , i.e ., the Alpha , Beta , and Gamma variants , were first identified in Ontario , Canada in December 20202 .\\\",\\n              \\\"char_start\\\": 251,\\n              \\\"char_end\\\": 254,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586031\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1796743511\\\"\\n            },\\n            \\\"description\\\": \\\"list of variants of concern\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"identifier for species of case\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000485\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7854529023170471,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586057\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 222,\\n              \\\"char_end\\\": 249,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586031\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1894470453\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:430060180\\\"\\n            },\\n            \\\"name\\\": \\\"SIR\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"A schematic diagram of the model is shown in Fig.1 .\\\\nA large number of epidemiological modeling studies have been published11 , many of which are based on the Susceptible-Infected-Recovered ( SIR ) formulation ( e.g ., 12-15 ) .\\\\nA key feature that distinguishes the present study from existing SIR-type models in that it is the first model to represent multiple SARS-CoV-2 VOC and their competition .\\\",\\n              \\\"char_start\\\": 4022,\\n              \\\"char_end\\\": 4025,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586136\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1729392404\\\"\\n            },\\n            \\\"description\\\": \\\"Susceptible-Infected-Recovered\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 3990,\\n              \\\"char_end\\\": 4020,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586136\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:183719204\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:722931979\\\"\\n            },\\n            \\\"name\\\": \\\"Delta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"Since then , the Delta variant has rapidly become the dominant circulating lineage .\\\\nAs of July 2021 , Delta represented the majority of infections in Ontario3 .\\\\nAt the time of this study , Omicron has begun spreading .\\\",\\n              \\\"char_start\\\": 1073,\\n              \\\"char_end\\\": 1078,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586244\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit6\\\"\\n            },\\n            \\\"name\\\": \\\"Delta/B.1.617 variant\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-476419679\\\"\\n            },\\n            \\\"description\\\": \\\"majority of infections in Ontario3\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"number of cases currently in icu\\\",\\n                \\\"grounding_id\\\": \\\"cemo:number_of_cases_currently_in_icu\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8028971552848816,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586272\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1095,\\n              \\\"char_end\\\": 1129,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586244\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit6\\\"\\n            },\\n            \\\"description\\\": \\\"Variant of SARS-CoV-2\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SII B.1.617.2\\\",\\n            \\\"grounding_id\\\": \\\"vo:0005335\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 Alpha variant\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000371\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-320992724\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1613533450\\\"\\n            },\\n            \\\"name\\\": \\\"Alpha\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"Viral lineages carrying the N501Y and / or E484K mutations , i.e ., the Alpha , Beta , and Gamma variants , were first identified in Ontario , Canada in December 20202 .\\\\nThese VOC quickly outcompeted earlier SARS-CoV-2 lineages and , as of late April 2021 , accounted for all new infections in Ontario , with Alpha being the most prevalent lineage1 .\\\\nAround that time , the Delta variant was first reported in the province .\\\",\\n              \\\"char_start\\\": 700,\\n              \\\"char_end\\\": 705,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586319\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit5\\\"\\n            },\\n            \\\"name\\\": \\\"Alpha/B1.1.17 variant\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-934352954\\\"\\n            },\\n            \\\"description\\\": \\\"most prevalent lineage1\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 716,\\n              \\\"char_end\\\": 739,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586319\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit5\\\"\\n            },\\n            \\\"description\\\": \\\"Variant of SARS-CoV-2\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 Alpha variant\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000371\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 Kappa variant\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000383\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-380273488\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:71761250\\\"\\n            },\\n            \\\"name\\\": \\\"Omicron\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"As of July 2021 , Delta represented the majority of infections in Ontario3 .\\\\nAt the time of this study , Omicron has begun spreading .\\\\nInitially , no pharmaceutical agents are known to be safe and effective at preventing or treating coronavirus disease 2019 ( COVID-19 ) 4 .\\\",\\n              \\\"char_start\\\": 1158,\\n              \\\"char_end\\\": 1165,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586422\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit7\\\"\\n            },\\n            \\\"name\\\": \\\"vaccine breakthrough\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-408090461\\\"\\n            },\\n            \\\"description\\\": \\\"time of this study, Omicron has begun spreading\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"data set about Earth's atmosphere or some part of it\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000594\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7653031349182129,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586446\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1138,\\n              \\\"char_end\\\": 1185,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586422\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit7\\\"\\n            },\\n            \\\"description\\\": \\\"Infection with SARS-CoV-2 despite vaccination\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-COV-2 Infection\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001287\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Post-vaccination rotavirus infection\\\",\\n            \\\"grounding_id\\\": \\\"hp:0020091\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-172046428\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1110622832\\\"\\n            },\\n            \\\"name\\\": \\\"A\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"A key feature that distinguishes the present study from existing SIR-type models in that it is the first model to represent multiple SARS-CoV-2 VOC and their competition .\\\\nWe refer to this model as a SV2 ( AIR ) 3 model , for its representation of two vaccine types ( V2 ) , asymptomatic infections ( A ) , and three VOC ( the power ' 3 ' refers to the three instantiations of each infected and recovered class ) .\\\\nThe SV2 ( AIR ) 3 model can answer the question : To what extent do the interactions and competition among VOC impact the spread of COVID-19 ?\\\",\\n              \\\"char_start\\\": 4345,\\n              \\\"char_end\\\": 4346,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586501\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit10\\\"\\n            },\\n            \\\"name\\\": \\\"asymptomatic infections\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2140386664\\\"\\n            },\\n            \\\"description\\\": \\\"asymptomatic infections\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Asymptomatic COVID-19 Infection Laboratory-Confirmed\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C171547\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8376278281211853,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586527\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 4320,\\n              \\\"char_end\\\": 4343,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586501\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit10\\\"\\n            },\\n            \\\"description\\\": \\\"Infections without symptoms\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recurrent infections\\\",\\n            \\\"grounding_id\\\": \\\"hp:0002719\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Recurrent skin infections\\\",\\n            \\\"grounding_id\\\": \\\"hp:0001581\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-805696495\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1209834396\\\"\\n            },\\n            \\\"name\\\": \\\"V2\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"A key feature that distinguishes the present study from existing SIR-type models in that it is the first model to represent multiple SARS-CoV-2 VOC and their competition .\\\\nWe refer to this model as a SV2 ( AIR ) 3 model , for its representation of two vaccine types ( V2 ) , asymptomatic infections ( A ) , and three VOC ( the power ' 3 ' refers to the three instantiations of each infected and recovered class ) .\\\\nThe SV2 ( AIR ) 3 model can answer the question : To what extent do the interactions and competition among VOC impact the spread of COVID-19 ?\\\",\\n              \\\"char_start\\\": 4315,\\n              \\\"char_end\\\": 4317,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586552\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit8\\\"\\n            },\\n            \\\"name\\\": \\\"vaccine types\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1450408391\\\"\\n            },\\n            \\\"description\\\": \\\"refer to this model as a SV2(AIR)3 model, for its representation of two vaccine types\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Semantic_Type\\\",\\n                \\\"grounding_id\\\": \\\"ncit:P106\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8575206995010376,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586576\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 1,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 4228,\\n              \\\"char_end\\\": 4313,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586552\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit8\\\"\\n            },\\n            \\\"description\\\": \\\"Different types of COVID-19 vaccines\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"COVID-19 subunit vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0005202\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"COVID-19 DNA vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0005203\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-308499566\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:87077992\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.2a\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Key measures of the pandemic are illustrated in Fig.2 .\\\\nThe total number of new infections exhibits two peaks ( Fig.2a ) , with the first wave in December 2020 driven by the wild type , and the second around March 2021 driven by Alpha .\\\\nBy mid June 2021 , the new infections are dominated by the Delta variant .\\\",\\n              \\\"char_start\\\": 1291,\\n              \\\"char_end\\\": 1297,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587143\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit11\\\"\\n            },\\n            \\\"name\\\": \\\"symptomatic infections\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1325764302\\\"\\n            },\\n            \\\"description\\\": \\\"peaks\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1284,\\n              \\\"char_end\\\": 1289,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587143\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit11\\\"\\n            },\\n            \\\"description\\\": \\\"Infections with symptoms\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recurrent infections\\\",\\n            \\\"grounding_id\\\": \\\"hp:0002719\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Recurrent skin infections\\\",\\n            \\\"grounding_id\\\": \\\"hp:0001581\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1672592981\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1997301942\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.2c\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"The cumulative infection curves exhibit the steepest rise in December 2020 and March 2021 , corresponding to the two peaks in the new case counts .\\\\nBy the end of 2021 , 71 % of the Ontario population would have been vaccinated with at least one dose , with 57 % fully vaccinated ( Fig.2c ) .\\\\nAt that time , 11K would have died from COVID , with 36 , 47 , and 17 % from wild type , Alpha , and Delta , respectively ( Fig.2d ) .\\\",\\n              \\\"char_start\\\": 2337,\\n              \\\"char_end\\\": 2343,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587257\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit9\\\"\\n            },\\n            \\\"name\\\": \\\"wild type\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1742903609\\\"\\n            },\\n            \\\"description\\\": \\\"57% fully vaccinated\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2315,\\n              \\\"char_end\\\": 2335,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587257\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit9\\\"\\n            },\\n            \\\"description\\\": \\\"Original strain of SARS-CoV-2\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"wild type haemoglobin\\\",\\n            \\\"grounding_id\\\": \\\"idomal:0001234\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"+/+\\\",\\n            \\\"grounding_id\\\": \\\"miro:00000032\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1676757554\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:433557046\\\"\\n            },\\n            \\\"name\\\": \\\"least one dose of vaccine\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"The drop in the susceptible population becomes significant after December 2020 ( Fig.3a ) and is driven primarily by the vaccine deployment .\\\\nBy the end of June 2021 , only 37 % of the Ontario population are susceptible , with the majority having received at least one dose of vaccine ( Fig.3b , c ) .\\\\nThe number of active infections peaks at the end of 2020 , followed by an even higher peak at the end of spring ( Fig.3d ) .\\\",\\n              \\\"char_start\\\": 2898,\\n              \\\"char_end\\\": 2923,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587342\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit12\\\"\\n            },\\n            \\\"name\\\": \\\"vaccine rollout\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit12\\\"\\n            },\\n            \\\"description\\\": \\\"Distribution and administration of vaccines\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1862708991\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"one\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 2,\\n                \\\"block\\\": 2,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 2904,\\n                \\\"char_end\\\": 2907,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587342\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"human age within one month at vaccination\\\",\\n            \\\"grounding_id\\\": \\\"vo:0004944\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8113138675689697,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587353\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"distribution\\\",\\n            \\\"grounding_id\\\": \\\"cemo:distribution\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"influenza vaccines\\\",\\n            \\\"grounding_id\\\": \\\"vo:0003495\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1511085452\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1682762855\\\"\\n            },\\n            \\\"name\\\": \\\"11K\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"By the end of 2021 , 71 % of the Ontario population would have been vaccinated with at least one dose , with 57 % fully vaccinated ( Fig.2c ) .\\\\nAt that time , 11K would have died from COVID , with 36 , 47 , and 17 % from wild type , Alpha , and Delta , respectively ( Fig.2d ) .\\\\nThe year-end infection and death statistics are within 10 % of reported data in Ontario ( 750K infections and 10.2K deaths ) 16 .\\\",\\n              \\\"char_start\\\": 2360,\\n              \\\"char_end\\\": 2363,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587439\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit13\\\"\\n            },\\n            \\\"name\\\": \\\"booster vaccine\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1149102777\\\"\\n            },\\n            \\\"description\\\": \\\"time, 11K would have died from COVID, with 36, 47, and 17% from wild type, Alpha, and Delta\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2354,\\n              \\\"char_end\\\": 2445,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587439\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit13\\\"\\n            },\\n            \\\"description\\\": \\\"Additional dose of vaccine to enhance immunity\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Booster\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C28320\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"vaccine dose\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000595\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-303059524\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1034756161\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.3d\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"By the end of June 2021 , only 37 % of the Ontario population are susceptible , with the majority having received at least one dose of vaccine ( Fig.3b , c ) .\\\\nThe number of active infections peaks at the end of 2020 , followed by an even higher peak at the end of spring ( Fig.3d ) .\\\\nThese are the wild-type and Alpha-driven waves identified in Fig.2a and described above .\\\",\\n              \\\"char_start\\\": 3048,\\n              \\\"char_end\\\": 3054,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587566\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit14\\\"\\n            },\\n            \\\"name\\\": \\\"N501Y mutation\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:176545860\\\"\\n            },\\n            \\\"description\\\": \\\"even higher peak at the end of spring\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"rate of cases with at least one comorbidity\\\",\\n                \\\"grounding_id\\\": \\\"cemo:rate_of_cases_with_at_least_one_comorbidity\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.810994029045105,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587591\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 3009,\\n              \\\"char_end\\\": 3046,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587566\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit14\\\"\\n            },\\n            \\\"description\\\": \\\"Mutation in SARS-CoV-2 spike protein\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"S-N501Y\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000277\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"SARS Subunit Spike Protein Vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0011486\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:527532433\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:79768610\\\"\\n            },\\n            \\\"name\\\": \\\"year-end infection\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"At that time , 11K would have died from COVID , with 36 , 47 , and 17 % from wild type , Alpha , and Delta , respectively ( Fig.2d ) .\\\\nThe year-end infection and death statistics are within 10 % of reported data in Ontario ( 750K infections and 10.2K deaths ) 16 .\\\\nPredicted population dynamics are shown in Fig.3 .\\\",\\n              \\\"char_start\\\": 2474,\\n              \\\"char_end\\\": 2492,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587650\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit15\\\"\\n            },\\n            \\\"name\\\": \\\"E484K mutation\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit15\\\"\\n            },\\n            \\\"description\\\": \\\"Mutation in SARS-CoV-2 spike protein\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-925241618\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"10\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 2,\\n                \\\"block\\\": 2,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 2525,\\n                \\\"char_end\\\": 2527,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587650\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS Subunit Spike Protein Vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0011486\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"E484K in SARS-CoV-2 S protein\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000668\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1952535670\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:79768610\\\"\\n            },\\n            \\\"name\\\": \\\"year-end infection\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"At that time , 11K would have died from COVID , with 36 , 47 , and 17 % from wild type , Alpha , and Delta , respectively ( Fig.2d ) .\\\\nThe year-end infection and death statistics are within 10 % of reported data in Ontario ( 750K infections and 10.2K deaths ) 16 .\\\\nPredicted population dynamics are shown in Fig.3 .\\\",\\n              \\\"char_start\\\": 2474,\\n              \\\"char_end\\\": 2492,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587746\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit16\\\"\\n            },\\n            \\\"name\\\": \\\"transmissibility\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit16\\\"\\n            },\\n            \\\"description\\\": \\\"Ability of a virus to spread between individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2077956845\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"%\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 2,\\n                \\\"block\\\": 2,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 2527,\\n                \\\"char_end\\\": 2528,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587746\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 transmissibility\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001279\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"spread\\\",\\n            \\\"grounding_id\\\": \\\"probonto:k0000049\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1550505153\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:79768610\\\"\\n            },\\n            \\\"name\\\": \\\"year-end infection\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"At that time , 11K would have died from COVID , with 36 , 47 , and 17 % from wild type , Alpha , and Delta , respectively ( Fig.2d ) .\\\\nThe year-end infection and death statistics are within 10 % of reported data in Ontario ( 750K infections and 10.2K deaths ) 16 .\\\\nPredicted population dynamics are shown in Fig.3 .\\\",\\n              \\\"char_start\\\": 2474,\\n              \\\"char_end\\\": 2492,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit17\\\"\\n            },\\n            \\\"name\\\": \\\"COVID-19\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit17\\\"\\n            },\\n            \\\"description\\\": \\\"Coronavirus disease 2019\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-925241618\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"10\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 2,\\n                \\\"block\\\": 2,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 2525,\\n                \\\"char_end\\\": 2527,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2077956845\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"%\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 2,\\n                \\\"block\\\": 2,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 2527,\\n                \\\"char_end\\\": 2528,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587844\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Severe acute respiratory syndrome coronavirus 2\\\",\\n            \\\"grounding_id\\\": \\\"ncbitaxon:2697049\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"COVID-19\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001141\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:44342288\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:476191044\\\"\\n            },\\n            \\\"name\\\": \\\"entrance\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"On January 1 2020 , we assume that the entire Ontario population was susceptible , except for 15 infected symptomatic individuals ( wild-type ) .\\\\nThe Alpha strain was introduced into Ontario via the entrance of 50 asymptomatic infected individuals per day for 1.5months at the end of 2020 ; Delta was introduced similarly in February and March 2021 ( 25 asymptomatic infected individuals per day ) .\\\\nThese parameters were chosen to product simulation results that match the initial rise of each of the VOC , Vaccination became available on December 14 2020 ; details for vaccination rates can be found in the supplement .\\\",\\n              \\\"char_start\\\": 565,\\n              \\\"char_end\\\": 573,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587953\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit18\\\"\\n            },\\n            \\\"name\\\": \\\"infection rate (\\\\u03b2)\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit18\\\"\\n            },\\n            \\\"description\\\": \\\"Rate at which the virus spreads\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1017812709\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"individuals per day\\\",\\n              \\\"grounding\\\": [\\n                {\\n                  \\\"grounding_text\\\": \\\"average daily number of new infections generated per case (rt)\\\",\\n                  \\\"grounding_id\\\": \\\"cemo:average_daily_number_of_new_infections_generated_per_case_rt\\\",\\n                  \\\"source\\\": [],\\n                  \\\"score\\\": 0.7630041241645813,\\n                  \\\"provenance\\\": {\\n                    \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                    \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587977\\\"\\n                  }\\n                }\\n              ],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 2,\\n                \\\"block\\\": 2,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 602,\\n                \\\"char_end\\\": 621,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587953\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"rate\\\",\\n            \\\"grounding_id\\\": \\\"probonto:k0000603\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Response Rate\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C94502\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1960087092\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-560132878\\\"\\n            },\\n            \\\"name\\\": \\\"March 2021\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"On January 1 2020 , we assume that the entire Ontario population was susceptible , except for 15 infected symptomatic individuals ( wild-type ) .\\\\nThe Alpha strain was introduced into Ontario via the entrance of 50 asymptomatic infected individuals per day for 1.5months at the end of 2020 ; Delta was introduced similarly in February and March 2021 ( 25 asymptomatic infected individuals per day ) .\\\\nThese parameters were chosen to product simulation results that match the initial rise of each of the VOC , Vaccination became available on December 14 2020 ; details for vaccination rates can be found in the supplement .\\\",\\n              \\\"char_start\\\": 703,\\n              \\\"char_end\\\": 713,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588028\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit19\\\"\\n            },\\n            \\\"name\\\": \\\"recovery rate (\\\\u0194)\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit19\\\"\\n            },\\n            \\\"description\\\": \\\"\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-163972007\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"individuals per day\\\",\\n              \\\"grounding\\\": [\\n                {\\n                  \\\"grounding_text\\\": \\\"average daily number of new infections generated per case (rt)\\\",\\n                  \\\"grounding_id\\\": \\\"cemo:average_daily_number_of_new_infections_generated_per_case_rt\\\",\\n                  \\\"source\\\": [],\\n                  \\\"score\\\": 0.7630041241645813,\\n                  \\\"provenance\\\": {\\n                    \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                    \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588052\\\"\\n                  }\\n                }\\n              ],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 2,\\n                \\\"block\\\": 2,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 740,\\n                \\\"char_end\\\": 759,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588028\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"AE recovery rate\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001869\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"incomplete AE recovery\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001873\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1580628517\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:818956569\\\"\\n            },\\n            \\\"name\\\": \\\"alphaW\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Parameters that are varied include those that describe the clinical features of the viruses as well as provincial policy and pharmaceutical intervention .\\\\nClinical features of the viruses that were considered include its infectivity ( betaW ) , the fraction of infections that are asymptomatic ( sigmaW ) , the infectivity ratio between asymptomatic and symptomatic individuals ( alphaW ) , mortality rate ( muW ) , and recovery rates ( gammaWA and gammaWI , varied simultaneously ) .\\\\nRecall the baseline assumption that asymptomatic individuals are assumed to be more active and 3 times more likely to spread the disease than symptomatic ones ( alphaW = 3 ) .\\\",\\n              \\\"char_start\\\": 824,\\n              \\\"char_end\\\": 830,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588552\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit20\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b2W\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1795560910\\\"\\n            },\\n            \\\"description\\\": \\\"asymptomatic and symptomatic individuals\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"becoming symptomatic\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000224\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7515280842781067,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588568\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 782,\\n              \\\"char_end\\\": 822,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588552\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit20\\\"\\n            },\\n            \\\"description\\\": \\\"virus infectivity of the wild-type strain\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 infectivity\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001284\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"wild type haemoglobin\\\",\\n            \\\"grounding_id\\\": \\\"idomal:0001234\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1846480138\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2140979605\\\"\\n            },\\n            \\\"name\\\": \\\"muW\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Parameters that are varied include those that describe the clinical features of the viruses as well as provincial policy and pharmaceutical intervention .\\\\nClinical features of the viruses that were considered include its infectivity ( betaW ) , the fraction of infections that are asymptomatic ( sigmaW ) , the infectivity ratio between asymptomatic and symptomatic individuals ( alphaW ) , mortality rate ( muW ) , and recovery rates ( gammaWA and gammaWI , varied simultaneously ) .\\\\nRecall the baseline assumption that asymptomatic individuals are assumed to be more active and 3 times more likely to spread the disease than symptomatic ones ( alphaW = 3 ) .\\\",\\n              \\\"char_start\\\": 849,\\n              \\\"char_end\\\": 852,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588628\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit21\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b2V\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:304322664\\\"\\n            },\\n            \\\"description\\\": \\\"mortality rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"mortality rate\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000445\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.9990238547325134,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588650\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 833,\\n              \\\"char_end\\\": 847,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588628\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit21\\\"\\n            },\\n            \\\"description\\\": \\\"vaccine escape rate\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Ventricular escape rhythm\\\",\\n            \\\"grounding_id\\\": \\\"hp:0005155\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"rate\\\",\\n            \\\"grounding_id\\\": \\\"probonto:k0000603\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1532099766\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1593074097\\\"\\n            },\\n            \\\"name\\\": \\\"betaW\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Parameters that are varied include those that describe the clinical features of the viruses as well as provincial policy and pharmaceutical intervention .\\\\nClinical features of the viruses that were considered include its infectivity ( betaW ) , the fraction of infections that are asymptomatic ( sigmaW ) , the infectivity ratio between asymptomatic and symptomatic individuals ( alphaW ) , mortality rate ( muW ) , and recovery rates ( gammaWA and gammaWI , varied simultaneously ) .\\\\nRecall the baseline assumption that asymptomatic individuals are assumed to be more active and 3 times more likely to spread the disease than symptomatic ones ( alphaW = 3 ) .\\\",\\n              \\\"char_start\\\": 685,\\n              \\\"char_end\\\": 690,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588744\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit22\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03c91\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1685937370\\\"\\n            },\\n            \\\"description\\\": \\\"infectivity\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 672,\\n              \\\"char_end\\\": 683,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588744\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit22\\\"\\n            },\\n            \\\"description\\\": \\\"vaccination rate\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit22\\\"\\n            },\\n            \\\"description\\\": \\\"vaccination rate for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"vaccination rate\\\",\\n            \\\"grounding_id\\\": \\\"askemo:0000012\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"secondary vaccination\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000903\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1960993140\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1121912434\\\"\\n            },\\n            \\\"name\\\": \\\"alphaW\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Clinical features of the viruses that were considered include its infectivity ( betaW ) , the fraction of infections that are asymptomatic ( sigmaW ) , the infectivity ratio between asymptomatic and symptomatic individuals ( alphaW ) , mortality rate ( muW ) , and recovery rates ( gammaWA and gammaWI , varied simultaneously ) .\\\\nRecall the baseline assumption that asymptomatic individuals are assumed to be more active and 3 times more likely to spread the disease than symptomatic ones ( alphaW = 3 ) .\\\\nThus , the number of infections directly depends on , and is in fact highly sensitive to , betaW , sigmaW , alphaW , and also to the recovery rate gammaW , which impacts how many new infections an infected individual can cause .\\\",\\n              \\\"char_start\\\": 1080,\\n              \\\"char_end\\\": 1086,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588834\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit23\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03c92\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit23\\\"\\n            },\\n            \\\"description\\\": \\\"dosing interval\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit23\\\"\\n            },\\n            \\\"description\\\": \\\"dosing interval for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1656338763\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"3\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 3,\\n                \\\"block\\\": 2,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 1089,\\n                \\\"char_end\\\": 1090,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588834\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"generation interval\\\",\\n            \\\"grounding_id\\\": \\\"cemo:generation_interval\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"confidence interval\\\",\\n            \\\"grounding_id\\\": \\\"stato:0000196\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:2023095270\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:183896673\\\"\\n            },\\n            \\\"name\\\": \\\"I\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Small variations in these four parameters ( 5 % ) result in changes in the number of infections and deaths that are an order of magnitude larger ; see Fig.4 .\\\\nCOVID-19 mortality rate muW I affects the number of infected individuals who are alive and can participate in the spread of the disease .\\\\nBecause COVID-19 mortality rate can vary substantially depending on health care infrastructure , we varied muW I by 50 % .\\\",\\n              \\\"char_start\\\": 1496,\\n              \\\"char_end\\\": 1497,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588896\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit24\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b7R\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:289633229\\\"\\n            },\\n            \\\"description\\\": \\\"COVID-19 mortality rate muW\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"mortality rate\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000445\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8306654095649719,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588919\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1468,\\n              \\\"char_end\\\": 1495,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588896\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit24\\\"\\n            },\\n            \\\"description\\\": \\\"rate of loss of immunity due to infection\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit24\\\"\\n            },\\n            \\\"description\\\": \\\"rate of transition from recovered class to SVR\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Meruvax I\\\",\\n            \\\"grounding_id\\\": \\\"vo:0003109\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.994598925113678,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588904\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"acquired immunity to malaria\\\",\\n            \\\"grounding_id\\\": \\\"idomal:0000543\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"rate\\\",\\n            \\\"grounding_id\\\": \\\"probonto:k0000603\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:332339292\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1787362729\\\"\\n            },\\n            \\\"name\\\": \\\"PZ\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"However , compared to other clinical features of SARSCoV-2 , the mortality rate has a relatively small effect on the infected population , since < 5 % of them die ( Fig.4 ) .\\\\nProvincial policy and pharmaceutical interventions that were considered include NPI that reduce the effective disease infectivity ( via scaling by lambda ) , vaccination rate ( omega1 ) , delay between the first and second vaccine doses ( omega2 , PZ and omega2 , AZ , varied simultaneously ) , and vaccine escape rate ( betaW V ) .\\\\nlambda and omega1 are varied by 5 % .\\\",\\n              \\\"char_start\\\": 2213,\\n              \\\"char_end\\\": 2215,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588944\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit25\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b2X R\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2014054376\\\"\\n            },\\n            \\\"description\\\": \\\"omega2,PZ and omega2,AZ, varied\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2206,\\n              \\\"char_end\\\": 2237,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588944\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit25\\\"\\n            },\\n            \\\"description\\\": \\\"rate of infection of individuals with partial immunity from having recovered from a different variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered Rate\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C173781\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-302164219\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-536825094\\\"\\n            },\\n            \\\"name\\\": \\\"AZ\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"However , compared to other clinical features of SARSCoV-2 , the mortality rate has a relatively small effect on the infected population , since < 5 % of them die ( Fig.4 ) .\\\\nProvincial policy and pharmaceutical interventions that were considered include NPI that reduce the effective disease infectivity ( via scaling by lambda ) , vaccination rate ( omega1 ) , delay between the first and second vaccine doses ( omega2 , PZ and omega2 , AZ , varied simultaneously ) , and vaccine escape rate ( betaW V ) .\\\\nlambda and omega1 are varied by 5 % .\\\",\\n              \\\"char_start\\\": 2227,\\n              \\\"char_end\\\": 2229,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589000\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit26\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03c3X\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1323344085\\\"\\n            },\\n            \\\"description\\\": \\\"omega2\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2220,\\n              \\\"char_end\\\": 2226,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589000\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit26\\\"\\n            },\\n            \\\"description\\\": \\\"ratio of asymptomatic versus symptomatic infections\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit26\\\"\\n            },\\n            \\\"description\\\": \\\"ratio of asymptomatic versus symptomatic infections for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"asymptomatic host\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000236\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"epstein-barr virus infection AE\\\",\\n            \\\"grounding_id\\\": \\\"oae:0007029\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1790727618\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1466935117\\\"\\n            },\\n            \\\"name\\\": \\\"lambda\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"The Alpha and Delta strains are not included .\\\\nWe assume that NPI begin on March 1 2020 , with the restrictiveness index lambda taken to be uniformly 0.5 ( i.e ., infectivity beta 's halved ) for simplicity .\\\\nVaccination begins on April 1 2020 ( not the end of 2020 , for this simplified one-year simulation ) , with baseline dosing interval taken to be 4weeks for Pfizer and 8weeks for AstraZeneca ( dosing interval is one of the parameters varied ) 17 .\\\",\\n              \\\"char_start\\\": 130,\\n              \\\"char_end\\\": 136,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589054\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit27\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b1X\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1018584051\\\"\\n            },\\n            \\\"description\\\": \\\"restrictiveness index\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Breteau Index\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000311\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7518984079360962,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589075\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 108,\\n              \\\"char_end\\\": 129,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589054\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit27\\\"\\n            },\\n            \\\"description\\\": \\\"degree of increased infectivity \\\\u03b2 (due to mobility) of asymptomatic infected individuals compared to symptomatic ones\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 infectivity\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001284\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"asymptomatic human female infected by SARS-CoV-2\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000297\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:615518326\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:693162218\\\"\\n            },\\n            \\\"name\\\": \\\"beta's\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"The Alpha and Delta strains are not included .\\\\nWe assume that NPI begin on March 1 2020 , with the restrictiveness index lambda taken to be uniformly 0.5 ( i.e ., infectivity beta 's halved ) for simplicity .\\\\nVaccination begins on April 1 2020 ( not the end of 2020 , for this simplified one-year simulation ) , with baseline dosing interval taken to be 4weeks for Pfizer and 8weeks for AstraZeneca ( dosing interval is one of the parameters varied ) 17 .\\\",\\n              \\\"char_start\\\": 182,\\n              \\\"char_end\\\": 188,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589134\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit28\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b3X\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:348377089\\\"\\n            },\\n            \\\"description\\\": \\\"i.e., infectivity\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 164,\\n              \\\"char_end\\\": 181,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589134\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit28\\\"\\n            },\\n            \\\"description\\\": \\\"disease recovery rate\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit28\\\"\\n            },\\n            \\\"description\\\": \\\"disease recovery rate for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"AE recovery rate\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001869\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"incomplete AE recovery\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001873\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-891560124\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1230812496\\\"\\n            },\\n            \\\"name\\\": \\\"alphaX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Thus , we will discuss cross-variant results .\\\\nAs can be seen in Fig.5 , most wild-type specific parameters have opposite effects on wild-type and on the other variants ( betaX , sigmaX , alphaX , gammaX , betaX V ) .\\\\nThis suggests that promoting the spread of the wild-type variant protects the population from Alpha and Delta , due to the partial natural immunity individuals acquire after recovering from wild-type infections .\\\",\\n              \\\"char_start\\\": 4788,\\n              \\\"char_end\\\": 4794,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589214\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit29\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03bb\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2121287105\\\"\\n            },\\n            \\\"description\\\": \\\"betaX, sigmaX\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Snoqualmie\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C44815\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7998793125152588,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589230\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 4773,\\n              \\\"char_end\\\": 4786,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589214\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit29\\\"\\n            },\\n            \\\"description\\\": \\\"NPI stringency\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit29\\\"\\n            },\\n            \\\"description\\\": \\\"NPI stringency for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"importin subunit alpha-5 (human)\\\",\\n            \\\"grounding_id\\\": \\\"pr:P52294\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"National Provider Identifier\\\",\\n            \\\"grounding_id\\\": \\\"opmi:0000503\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:919462373\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1800332912\\\"\\n            },\\n            \\\"name\\\": \\\"betaX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Thus , we will discuss cross-variant results .\\\\nAs can be seen in Fig.5 , most wild-type specific parameters have opposite effects on wild-type and on the other variants ( betaX , sigmaX , alphaX , gammaX , betaX V ) .\\\\nThis suggests that promoting the spread of the wild-type variant protects the population from Alpha and Delta , due to the partial natural immunity individuals acquire after recovering from wild-type infections .\\\",\\n              \\\"char_start\\\": 4773,\\n              \\\"char_end\\\": 4778,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589253\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit30\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03bcI\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1335422591\\\"\\n            },\\n            \\\"description\\\": \\\"betaX V\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"V antigen\\\",\\n                \\\"grounding_id\\\": \\\"vo:0010876\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7732263207435608,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589268\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 4804,\\n              \\\"char_end\\\": 4811,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589253\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit30\\\"\\n            },\\n            \\\"description\\\": \\\"mortality rate of infected individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit30\\\"\\n            },\\n            \\\"description\\\": \\\"mortality rate of infected individuals for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"mortality rate\\\",\\n            \\\"grounding_id\\\": \\\"stato:0000414\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"neonatal mortality rate\\\",\\n            \\\"grounding_id\\\": \\\"sdgio:00020030\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-935644632\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1286808048\\\"\\n            },\\n            \\\"name\\\": \\\"V\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Thus , we will discuss cross-variant results .\\\\nAs can be seen in Fig.5 , most wild-type specific parameters have opposite effects on wild-type and on the other variants ( betaX , sigmaX , alphaX , gammaX , betaX V ) .\\\\nThis suggests that promoting the spread of the wild-type variant protects the population from Alpha and Delta , due to the partial natural immunity individuals acquire after recovering from wild-type infections .\\\",\\n              \\\"char_start\\\": 4810,\\n              \\\"char_end\\\": 4811,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589294\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit31\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b2X V\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-631812455\\\"\\n            },\\n            \\\"description\\\": \\\"gammaX, betaX\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 4796,\\n              \\\"char_end\\\": 4809,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589294\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit31\\\"\\n            },\\n            \\\"description\\\": \\\"vaccine escape rate for a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"V antigen\\\",\\n            \\\"grounding_id\\\": \\\"vo:0010876\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7732263207435608,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589302\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Ventricular escape rhythm\\\",\\n            \\\"grounding_id\\\": \\\"hp:0005155\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Disease-specific Survival Rate\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C94504\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:553752076\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1059618170\\\"\\n            },\\n            \\\"name\\\": \\\"fers\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Specifically , betaX ( X = W , A , or D ) , sigmaX , R was increased 4 folds to assess the alphaX , gammaX , and omega1 were increased by 5 % , lambda by 10 % , and muI , betaX V , and omega2 by 50 % .\\\\nbetaX scenario in which recovery from one variant of fers only limited protected from other VOCs .\\\\netaX R was doubled to test the effect of a shorter immunity period .\\\",\\n              \\\"char_start\\\": 4286,\\n              \\\"char_end\\\": 4290,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589335\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit32\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b2X\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit32\\\"\\n            },\\n            \\\"description\\\": \\\"virus infectivity of a specific variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit32\\\"\\n            },\\n            \\\"description\\\": \\\"infection rate for unvaccinated individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:364778551\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"one\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 3,\\n                \\\"block\\\": 2,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 4271,\\n                \\\"char_end\\\": 4274,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589335\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SARS-CoV-2 infectivity\\\",\\n            \\\"grounding_id\\\": \\\"idocovid19:0001284\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"specific host infectivity\\\",\\n            \\\"grounding_id\\\": \\\"vsmo:0000144\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1662231047\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1904001986\\\"\\n            },\\n            \\\"name\\\": \\\"5%\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"As expected , changes in muW I are immediately reflected in the number of deaths .\\\\nHowever , compared to other clinical features of SARSCoV-2 , the mortality rate has a relatively small effect on the infected population , since < 5 % of them die ( Fig.4 ) .\\\\nProvincial policy and pharmaceutical interventions that were considered include NPI that reduce the effective disease infectivity ( via scaling by lambda ) , vaccination rate ( omega1 ) , delay between the first and second vaccine doses ( omega2 , PZ and omega2 , AZ , varied simultaneously ) , and vaccine escape rate ( betaW V ) .\\\",\\n              \\\"char_start\\\": 1950,\\n              \\\"char_end\\\": 1952,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589382\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit33\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03bc\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit33\\\"\\n            },\\n            \\\"description\\\": \\\"natural death rate\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"SG33-VP2/5\\\",\\n            \\\"grounding_id\\\": \\\"vo:0004706\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0000001192092896,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589390\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Death by Natural Cause\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C82465\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"rate\\\",\\n            \\\"grounding_id\\\": \\\"probonto:k0000603\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-465381980\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-548675649\\\"\\n            },\\n            \\\"name\\\": \\\"gammaW\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Recall the baseline assumption that asymptomatic individuals are assumed to be more active and 3 times more likely to spread the disease than symptomatic ones ( alphaW = 3 ) .\\\\nThus , the number of infections directly depends on , and is in fact highly sensitive to , betaW , sigmaW , alphaW , and also to the recovery rate gammaW , which impacts how many new infections an infected individual can cause .\\\\nSmall variations in these four parameters ( 5 % ) result in changes in the number of infections and deaths that are an order of magnitude larger ; see Fig.4 .\\\",\\n              \\\"char_start\\\": 1234,\\n              \\\"char_end\\\": 1240,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589431\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit34\\\"\\n            },\\n            \\\"name\\\": \\\"VM\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1627664391\\\"\\n            },\\n            \\\"description\\\": \\\"recovery rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Recovered Rate\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C173781\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8412715196609497,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589448\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1220,\\n              \\\"char_end\\\": 1233,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589431\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit34\\\"\\n            },\\n            \\\"description\\\": \\\"rate of reduced infection for vaccinated individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated with a licensed vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001378\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001376\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1430855057\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2122514767\\\"\\n            },\\n            \\\"name\\\": \\\"R\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Key model parameters were increased to determine the effects on the number of infections and deaths associated with each variant .\\\\nIn addition to parameters considered in the above analysis , we also considered two parameters that mediate VOC interactions : betaX R , rate of infection of individuals with partial immunity from having recovered from a different variant , and etaR , rate of loss of immunity due to infection .\\\\nSome of these parameters have distinct values for each of the variants .\\\",\\n              \\\"char_start\\\": 3714,\\n              \\\"char_end\\\": 3715,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590080\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit35\\\"\\n            },\\n            \\\"name\\\": \\\"V\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1223032199\\\"\\n            },\\n            \\\"description\\\": \\\"rate of loss of immunity due to infection\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"probability of infection over time\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000530\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.831021785736084,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590105\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 3830,\\n              \\\"char_end\\\": 3871,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590080\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit35\\\"\\n            },\\n            \\\"description\\\": \\\"vaccine type (either V1 or V2)\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"ViroKey SARS-CoV-2 RT-PCR Test v2.0\\\",\\n            \\\"grounding_id\\\": \\\"cido:0020325\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"KimForest SARS-CoV-2 Detection Kit v1\\\",\\n            \\\"grounding_id\\\": \\\"cido:0020179\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"8-1\\\"\\n            },\\n            \\\"name\\\": \\\"location_key\\\",\\n            \\\"dataset\\\": {\\n              \\\"id\\\": {\\n                \\\"id\\\": \\\"8\\\"\\n              },\\n              \\\"name\\\": \\\"usa-vaccinations.csv\\\",\\n              \\\"metadata\\\": \\\"https://github.com/DARPA-ASKEM/program-milestones/blob/main/6-month-milestone/evaluation/scenario_3/ta_1/google-health-data/usa-vaccinations.csv\\\"\\n            }\\n          }\\n        ]\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:2134716306\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2122514767\\\"\\n            },\\n            \\\"name\\\": \\\"R\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Key model parameters were increased to determine the effects on the number of infections and deaths associated with each variant .\\\\nIn addition to parameters considered in the above analysis , we also considered two parameters that mediate VOC interactions : betaX R , rate of infection of individuals with partial immunity from having recovered from a different variant , and etaR , rate of loss of immunity due to infection .\\\\nSome of these parameters have distinct values for each of the variants .\\\",\\n              \\\"char_start\\\": 3714,\\n              \\\"char_end\\\": 3715,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590151\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit36\\\"\\n            },\\n            \\\"name\\\": \\\"M\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-240847643\\\"\\n            },\\n            \\\"description\\\": \\\"rate of infection of individuals with partial immunity\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"rate of cases with at least one comorbidity\\\",\\n                \\\"grounding_id\\\": \\\"cemo:rate_of_cases_with_at_least_one_comorbidity\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8423323035240173,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590168\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 3717,\\n              \\\"char_end\\\": 3771,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590151\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit36\\\"\\n            },\\n            \\\"description\\\": \\\"vaccine type (either V1 or V2)\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"ViroKey SARS-CoV-2 RT-PCR Test v2.0\\\",\\n            \\\"grounding_id\\\": \\\"cido:0020325\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"KimForest SARS-CoV-2 Detection Kit v1\\\",\\n            \\\"grounding_id\\\": \\\"cido:0020179\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"8-1\\\"\\n            },\\n            \\\"name\\\": \\\"location_key\\\",\\n            \\\"dataset\\\": {\\n              \\\"id\\\": {\\n                \\\"id\\\": \\\"8\\\"\\n              },\\n              \\\"name\\\": \\\"usa-vaccinations.csv\\\",\\n              \\\"metadata\\\": \\\"https://github.com/DARPA-ASKEM/program-milestones/blob/main/6-month-milestone/evaluation/scenario_3/ta_1/google-health-data/usa-vaccinations.csv\\\"\\n            }\\n          }\\n        ]\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1308192125\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2122514767\\\"\\n            },\\n            \\\"name\\\": \\\"R\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Key model parameters were increased to determine the effects on the number of infections and deaths associated with each variant .\\\\nIn addition to parameters considered in the above analysis , we also considered two parameters that mediate VOC interactions : betaX R , rate of infection of individuals with partial immunity from having recovered from a different variant , and etaR , rate of loss of immunity due to infection .\\\\nSome of these parameters have distinct values for each of the variants .\\\",\\n              \\\"char_start\\\": 3714,\\n              \\\"char_end\\\": 3715,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590204\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit37\\\"\\n            },\\n            \\\"name\\\": \\\"AX\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-240847643\\\"\\n            },\\n            \\\"description\\\": \\\"rate of infection of individuals with partial immunity\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"rate of cases with at least one comorbidity\\\",\\n                \\\"grounding_id\\\": \\\"cemo:rate_of_cases_with_at_least_one_comorbidity\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8423323035240173,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590222\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 3717,\\n              \\\"char_end\\\": 3771,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590204\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit37\\\"\\n            },\\n            \\\"description\\\": \\\"class for asymptomatic infections of vaccinated and unvaccinated individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"unvaccinated with a licensed vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001379\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"unvaccinated organism\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001383\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1519012352\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-485876254\\\"\\n            },\\n            \\\"name\\\": \\\"four parameters\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Thus , the number of infections directly depends on , and is in fact highly sensitive to , betaW , sigmaW , alphaW , and also to the recovery rate gammaW , which impacts how many new infections an infected individual can cause .\\\\nSmall variations in these four parameters ( 5 % ) result in changes in the number of infections and deaths that are an order of magnitude larger ; see Fig.4 .\\\\nCOVID-19 mortality rate muW I affects the number of infected individuals who are alive and can participate in the spread of the disease .\\\",\\n              \\\"char_start\\\": 1340,\\n              \\\"char_end\\\": 1355,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590258\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit38\\\"\\n            },\\n            \\\"name\\\": \\\"IXV\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit38\\\"\\n            },\\n            \\\"description\\\": \\\"class for symptomatic infections of vaccinated individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1959361323\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"%\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 3,\\n                \\\"block\\\": 2,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 1358,\\n                \\\"char_end\\\": 1359,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590258\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated with a licensed vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001378\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001376\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:795884335\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1390511752\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.4\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Because dosing interval can vary greatly within the population , and because vaccine escape rate is not sufficiently well characterized , these two parameters were varied by 50 % .\\\\nThe vaccine-related results suggest that among these three factors , an effective vaccine deployment ( captured in omega1 ) is the key in combating a pandemic , and success may be achieved even by means of a less-than-ideal vaccine with higher escape rate ( Fig.4 ) .\\\\nSince the predicted numbers of infections and deaths are substantially more sensitive to variations in omega1 than omega2 , if vaccine supply is limited , prioritizing the first dose by lengthening the dosing interval would be advisable , as was done in Canada .\\\",\\n              \\\"char_start\\\": 3040,\\n              \\\"char_end\\\": 3045,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590304\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit39\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03bcXV\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:246592660\\\"\\n            },\\n            \\\"description\\\": \\\"higher escape rate\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 3020,\\n              \\\"char_end\\\": 3038,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590304\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit39\\\"\\n            },\\n            \\\"description\\\": \\\"mortality rate for symptomatic infections of vaccinated individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"mortality rate\\\",\\n            \\\"grounding_id\\\": \\\"stato:0000414\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"neonatal mortality rate\\\",\\n            \\\"grounding_id\\\": \\\"sdgio:00020030\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1041191212\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1931272243\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.4\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"lambda and omega1 are varied by 5 % .\\\\nSince NPI are modelled by scaling betaW directly , they have large effects on model predictions ( Fig.4 ) .\\\\nVaccination rate has lesser but still significant effects on the spread of the disease .\\\",\\n              \\\"char_start\\\": 2422,\\n              \\\"char_end\\\": 2427,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590363\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit40\\\"\\n            },\\n            \\\"name\\\": \\\"dIXV\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:817805856\\\"\\n            },\\n            \\\"description\\\": \\\"model predictions\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Susceptible-Infected-Resistant model\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000549\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8817113041877747,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590386\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2403,\\n              \\\"char_end\\\": 2420,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590363\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit40\\\"\\n            },\\n            \\\"description\\\": \\\"change in the number of symptomatic infections of vaccinated individuals over time\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated in route\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000547\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated with a licensed vaccine\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001378\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-535082164\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:762532133\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.8b\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"Taken together , the asymptomatic patients , including those who are vaccinated , play a more significant role in spreading the Delta variant , compared to the wild type .\\\\nAnd that difference is even larger in the alternative scenario where most of the vaccines are AstraZeneca ( Fig.8b ) .\\\",\\n              \\\"char_start\\\": 3302,\\n              \\\"char_end\\\": 3308,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591207\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit41\\\"\\n            },\\n            \\\"name\\\": \\\"dt\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1650338856\\\"\\n            },\\n            \\\"description\\\": \\\"alternative scenario where most of the vaccines are AstraZeneca\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"COVAXIN\\\",\\n                \\\"grounding_id\\\": \\\"vo:0004991\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8232312798500061,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591230\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 3237,\\n              \\\"char_end\\\": 3300,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591207\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit41\\\"\\n            },\\n            \\\"description\\\": \\\"change in time\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"\\\",\\n            \\\"grounding_id\\\": \\\"fbbt:00000624\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"DT Polio Adsorbed\\\",\\n            \\\"grounding_id\\\": \\\"vo:0010709\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1637552708\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-486621082\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.7a\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"With a larger portion of the vaccinated population now under reduced vaccine protection , the spread of the VOC is substantially accelerated .\\\\nBy the end of 2021 , the model predicts 794 new Delta infections a day , more than three times higher than the baseline prediction of 234 new Delta infections a day ( Fig.7a ) .\\\\nThe total number of Delta infections and related deaths are also significantly higher , predicted to be 62K and 882 at the end of 2021 , respectively , compared to baseline values of 39K and 689 ( Fig.7b , d ) .\\\",\\n              \\\"char_start\\\": 990,\\n              \\\"char_end\\\": 996,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591268\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit42\\\"\\n            },\\n            \\\"name\\\": \\\"total\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-64792771\\\"\\n            },\\n            \\\"description\\\": \\\"day\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 985,\\n              \\\"char_end\\\": 988,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591268\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit42\\\"\\n            },\\n            \\\"description\\\": \\\"total number of individuals in a specific class\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"protein total increased AE\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001658\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"protein total decreased AE\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001659\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1830320991\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-939186372\\\"\\n            },\\n            \\\"name\\\": \\\"NPI\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"Thus , we consider a scenario with less stringent NPI starting from the fall of 2021 ( September 1 2021 ) , with lambda increased from its baseline value of 0.4 to 0.5 onwards .\\\\nThe model predicts the reduced NPI would accelerate the spread of Delta , such that by March 2022 , the total number of Delta infections would be 50 % higher than baseline ( Fig.7b ) .\\\\nWho are getting infected by the Delta variant , and who are the carriers ?\\\",\\n              \\\"char_start\\\": 2112,\\n              \\\"char_end\\\": 2115,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591373\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit43\\\"\\n            },\\n            \\\"name\\\": \\\"W\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2100959297\\\"\\n            },\\n            \\\"description\\\": \\\"reduced\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2104,\\n              \\\"char_end\\\": 2111,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591373\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit43\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with immunity to the variant they were infected with\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Susceptible-Infected-Resistant model\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000549\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1864118410\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-121832131\\\"\\n            },\\n            \\\"name\\\": \\\"Delta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"What if a larger fraction of the vaccines were AstraZeneca , as is the case in the UK18 .\\\\nA notable difference between the two vaccine types is that the Pfizer vaccine of fers stronger protection than AstraZeneca against all COVID variants , especially Delta , after either one or two doses .\\\\nFor instance , an individual having received both doses of the Pfizer vaccine is 88 % protected against the Delta variant , where as with the AstraZeneca vaccine the protection is only at 60 % 19 .\\\",\\n              \\\"char_start\\\": 385,\\n              \\\"char_end\\\": 390,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591445\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-385630701\\\"\\n            },\\n            \\\"description\\\": \\\"COVID variants\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 358,\\n              \\\"char_end\\\": 372,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591445\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1461588612\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1763488841\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.8a\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"This difference may be attributable to the vaccination status of the infected population .\\\\nDue to the larger vaccine breakthrough rate of the Delta variant , almost a quarter of the infected individuals have been vaccinated ( Fig.8a ) ; in contrast , for the wild type , vaccinated individuals make up a negligible fraction of the infected population ( Fig.3 ) .\\\\nBecause vaccination protects one from most major COVID-19 symptoms , most of the vaccinated infections are assumed to be asymptomatic ( 85 % compared to 50 % for the unvaccinated ) .\\\",\\n              \\\"char_start\\\": 2721,\\n              \\\"char_end\\\": 2727,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591545\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1754146058\\\"\\n            },\\n            \\\"description\\\": \\\"have been vaccinated\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2699,\\n              \\\"char_end\\\": 2719,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591545\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1956562617\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:350961012\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.3\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"This difference may be attributable to the vaccination status of the infected population .\\\\nDue to the larger vaccine breakthrough rate of the Delta variant , almost a quarter of the infected individuals have been vaccinated ( Fig.8a ) ; in contrast , for the wild type , vaccinated individuals make up a negligible fraction of the infected population ( Fig.3 ) .\\\\nBecause vaccination protects one from most major COVID-19 symptoms , most of the vaccinated infections are assumed to be asymptomatic ( 85 % compared to 50 % for the unvaccinated ) .\\\",\\n              \\\"char_start\\\": 2843,\\n              \\\"char_end\\\": 2848,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591603\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1322440919\\\"\\n            },\\n            \\\"description\\\": \\\"negligible fraction of the infected population\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"fraction of vector adults affected\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000437\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8530557751655579,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591664\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2795,\\n              \\\"char_end\\\": 2841,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591603\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1164908205\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-726685136\\\"\\n            },\\n            \\\"name\\\": \\\"be 62K and 882 at the end of 2021, respectively, compared to baseline values of 39K and 689\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"By the end of 2021 , the model predicts 794 new Delta infections a day , more than three times higher than the baseline prediction of 234 new Delta infections a day ( Fig.7a ) .\\\\nThe total number of Delta infections and related deaths are also significantly higher , predicted to be 62K and 882 at the end of 2021 , respectively , compared to baseline values of 39K and 689 ( Fig.7b , d ) .\\\\nIf the provincial vaccination rate were lower , such that by September 1 2021 only 67 % of the population are vaccinated with at least one dose , compared to the baseline vaccinated percentage of 74 % ( Fig.7c ) , the total number of Delta infections and deaths would increase by 75 % by the end of March 2022 ; see Fig.7b , d. Beginning mid June 2021 , Ontario began to gradually reopen , with in-person classes set to resume in September .\\\",\\n              \\\"char_start\\\": 1099,\\n              \\\"char_end\\\": 1190,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591703\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-461395540\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"882\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 7,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 1110,\\n                \\\"char_end\\\": 1113,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591703\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Sponsor-Investigator\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C142695\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8208585381507874,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591714\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1822299949\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1785832053\\\"\\n            },\\n            \\\"name\\\": \\\"protection\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"A notable difference between the two vaccine types is that the Pfizer vaccine of fers stronger protection than AstraZeneca against all COVID variants , especially Delta , after either one or two doses .\\\\nFor instance , an individual having received both doses of the Pfizer vaccine is 88 % protected against the Delta variant , where as with the AstraZeneca vaccine the protection is only at 60 % 19 .\\\\nWe conduct a simulation in which only 40 % of the vaccines are Pfizer .\\\",\\n              \\\"char_start\\\": 586,\\n              \\\"char_end\\\": 596,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591810\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1522082591\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"19\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 7,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 611,\\n                \\\"char_end\\\": 613,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591810\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"protection efficacy\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000456\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8532915711402893,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591819\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1839289179\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1785832053\\\"\\n            },\\n            \\\"name\\\": \\\"protection\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"A notable difference between the two vaccine types is that the Pfizer vaccine of fers stronger protection than AstraZeneca against all COVID variants , especially Delta , after either one or two doses .\\\\nFor instance , an individual having received both doses of the Pfizer vaccine is 88 % protected against the Delta variant , where as with the AstraZeneca vaccine the protection is only at 60 % 19 .\\\\nWe conduct a simulation in which only 40 % of the vaccines are Pfizer .\\\",\\n              \\\"char_start\\\": 586,\\n              \\\"char_end\\\": 596,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591897\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1120267797\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"%\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 7,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 610,\\n                \\\"char_end\\\": 611,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591897\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"protection efficacy\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000456\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8532915711402893,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591909\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:390122022\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1785832053\\\"\\n            },\\n            \\\"name\\\": \\\"protection\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"A notable difference between the two vaccine types is that the Pfizer vaccine of fers stronger protection than AstraZeneca against all COVID variants , especially Delta , after either one or two doses .\\\\nFor instance , an individual having received both doses of the Pfizer vaccine is 88 % protected against the Delta variant , where as with the AstraZeneca vaccine the protection is only at 60 % 19 .\\\\nWe conduct a simulation in which only 40 % of the vaccines are Pfizer .\\\",\\n              \\\"char_start\\\": 586,\\n              \\\"char_end\\\": 596,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591985\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1522082591\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"19\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 7,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 611,\\n                \\\"char_end\\\": 613,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591985\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1120267797\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"%\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 7,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 610,\\n                \\\"char_end\\\": 611,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591985\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"protection efficacy\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000456\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8532915711402893,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591994\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1137065363\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:939793819\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.7b\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"The total number of Delta infections and related deaths are also significantly higher , predicted to be 62K and 882 at the end of 2021 , respectively , compared to baseline values of 39K and 689 ( Fig.7b , d ) .\\\\nIf the provincial vaccination rate were lower , such that by September 1 2021 only 67 % of the population are vaccinated with at least one dose , compared to the baseline vaccinated percentage of 74 % ( Fig.7c ) , the total number of Delta infections and deaths would increase by 75 % by the end of March 2022 ; see Fig.7b , d. Beginning mid June 2021 , Ontario began to gradually reopen , with in-person classes set to resume in September .\\\\nThe baseline model assumes that the NPI that remain will still reduce COVID-19 infectivity by 60 % .\\\",\\n              \\\"char_start\\\": 1510,\\n              \\\"char_end\\\": 1516,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592083\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2092884841\\\"\\n            },\\n            \\\"description\\\": \\\"d. Beginning mid-June 2021\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1517,\\n              \\\"char_end\\\": 1543,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592083\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1311518691\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-309991041\\\"\\n            },\\n            \\\"name\\\": \\\"end of March 2022\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"The total number of Delta infections and related deaths are also significantly higher , predicted to be 62K and 882 at the end of 2021 , respectively , compared to baseline values of 39K and 689 ( Fig.7b , d ) .\\\\nIf the provincial vaccination rate were lower , such that by September 1 2021 only 67 % of the population are vaccinated with at least one dose , compared to the baseline vaccinated percentage of 74 % ( Fig.7c ) , the total number of Delta infections and deaths would increase by 75 % by the end of March 2022 ; see Fig.7b , d. Beginning mid June 2021 , Ontario began to gradually reopen , with in-person classes set to resume in September .\\\\nThe baseline model assumes that the NPI that remain will still reduce COVID-19 infectivity by 60 % .\\\",\\n              \\\"char_start\\\": 1487,\\n              \\\"char_end\\\": 1504,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592175\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-471645634\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"75\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 7,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 1476,\\n                \\\"char_end\\\": 1478,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592175\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1669100175\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1320840557\\\"\\n            },\\n            \\\"name\\\": \\\"vaccinated percentage\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"The total number of Delta infections and related deaths are also significantly higher , predicted to be 62K and 882 at the end of 2021 , respectively , compared to baseline values of 39K and 689 ( Fig.7b , d ) .\\\\nIf the provincial vaccination rate were lower , such that by September 1 2021 only 67 % of the population are vaccinated with at least one dose , compared to the baseline vaccinated percentage of 74 % ( Fig.7c ) , the total number of Delta infections and deaths would increase by 75 % by the end of March 2022 ; see Fig.7b , d. Beginning mid June 2021 , Ontario began to gradually reopen , with in-person classes set to resume in September .\\\\nThe baseline model assumes that the NPI that remain will still reduce COVID-19 infectivity by 60 % .\\\",\\n              \\\"char_start\\\": 1371,\\n              \\\"char_end\\\": 1392,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592266\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1807101167\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"%\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 7,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 1398,\\n                \\\"char_end\\\": 1399,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592266\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"vaccinated\\\",\\n            \\\"grounding_id\\\": \\\"vo:0001376\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8089877963066101,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592275\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1998430605\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-261742887\\\"\\n            },\\n            \\\"name\\\": \\\"Neos\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"The spread of a hypothetical , deadlier VOC , Neos .\\\\nAlpha is more infectious than the wild type ; Delta is worse than Alpha ; Lambda may be even worse .\\\",\\n              \\\"char_start\\\": 44,\\n              \\\"char_end\\\": 48,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592687\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:785848723\\\"\\n            },\\n            \\\"description\\\": \\\"spread of a hypothetical, deadlier VOC\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 4,\\n              \\\"char_end\\\": 42,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592687\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:786071264\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1004466560\\\"\\n            },\\n            \\\"name\\\": \\\"its\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"To gain insights , we simulate a dangerous hypothetical variant , which we refer to as `` Neos .\\\\n'' Neos is designed to be deadlier by increasing its ( i ) infectivity ( 14 % higher than the Delta variant ) , ( ii ) vaccine escape rate ( 70 % for one dose of Pfizer or AstraZeneca , similar to Delta which is 67 % ; 25 % and 50 % for two doses of Pfizer and AstraZeneca , respectively ; compared to 12 % and 40 % for Delta ) , and ( iii ) fraction of asymptomatic infections ( 55 % instead of 50 % ) .\\\\nRecovery rate , mortality rate , and other clinical features are assumed to be the same as the wild type .\\\",\\n              \\\"char_start\\\": 426,\\n              \\\"char_end\\\": 429,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592737\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:103720924\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"%\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 8,\\n                \\\"block\\\": 4,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 750,\\n                \\\"char_end\\\": 751,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592737\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1015129557\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2003387435\\\"\\n            },\\n            \\\"name\\\": \\\"50%\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"To gain insights , we simulate a dangerous hypothetical variant , which we refer to as `` Neos .\\\\n'' Neos is designed to be deadlier by increasing its ( i ) infectivity ( 14 % higher than the Delta variant ) , ( ii ) vaccine escape rate ( 70 % for one dose of Pfizer or AstraZeneca , similar to Delta which is 67 % ; 25 % and 50 % for two doses of Pfizer and AstraZeneca , respectively ; compared to 12 % and 40 % for Delta ) , and ( iii ) fraction of asymptomatic infections ( 55 % instead of 50 % ) .\\\\nRecovery rate , mortality rate , and other clinical features are assumed to be the same as the wild type .\\\",\\n              \\\"char_start\\\": 748,\\n              \\\"char_end\\\": 751,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592796\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:436213608\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"55\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 8,\\n                \\\"block\\\": 4,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 733,\\n                \\\"char_end\\\": 735,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592796\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:847069629\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1389549157\\\"\\n            },\\n            \\\"name\\\": \\\"70% for one dose of Pfizer or AstraZeneca, similar to Delta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"To gain insights , we simulate a dangerous hypothetical variant , which we refer to as `` Neos .\\\\n'' Neos is designed to be deadlier by increasing its ( i ) infectivity ( 14 % higher than the Delta variant ) , ( ii ) vaccine escape rate ( 70 % for one dose of Pfizer or AstraZeneca , similar to Delta which is 67 % ; 25 % and 50 % for two doses of Pfizer and AstraZeneca , respectively ; compared to 12 % and 40 % for Delta ) , and ( iii ) fraction of asymptomatic infections ( 55 % instead of 50 % ) .\\\\nRecovery rate , mortality rate , and other clinical features are assumed to be the same as the wild type .\\\",\\n              \\\"char_start\\\": 509,\\n              \\\"char_end\\\": 568,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592857\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1225552525\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"70\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 8,\\n                \\\"block\\\": 4,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 509,\\n                \\\"char_end\\\": 511,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592857\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"AdCOVID\\\",\\n            \\\"grounding_id\\\": \\\"vo:0005153\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8080059289932251,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592865\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1957664339\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:662304642\\\"\\n            },\\n            \\\"name\\\": \\\"25% and 50% for two doses of Pfizer and AstraZeneca\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"To gain insights , we simulate a dangerous hypothetical variant , which we refer to as `` Neos .\\\\n'' Neos is designed to be deadlier by increasing its ( i ) infectivity ( 14 % higher than the Delta variant ) , ( ii ) vaccine escape rate ( 70 % for one dose of Pfizer or AstraZeneca , similar to Delta which is 67 % ; 25 % and 50 % for two doses of Pfizer and AstraZeneca , respectively ; compared to 12 % and 40 % for Delta ) , and ( iii ) fraction of asymptomatic infections ( 55 % instead of 50 % ) .\\\\nRecovery rate , mortality rate , and other clinical features are assumed to be the same as the wild type .\\\",\\n              \\\"char_start\\\": 583,\\n              \\\"char_end\\\": 634,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592910\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1339476510\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"50\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 8,\\n                \\\"block\\\": 4,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 591,\\n                \\\"char_end\\\": 593,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592910\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"M-M-Vax\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000070\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7544083595275879,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592918\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:428284098\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-306035968\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.9f\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"After its introduction , Neos quickly takes hold due to its high transmissivity , and by the end of 2021 , it has overtaken Delta to account for the majority of new infections ( Fig.9c ) .\\\\nBy mid 2022 , the infected individuals would account for 1 % of the entire population ( Fig.9f ) , despite nearly 80 % of the population having been vaccinated .\\\\nMore than 6.6K would have died from Neos ( Fig.9g ) ; that is likely an underestimate , since the number of severe cases might overwhelm the hospitals , elevating the mortality rate .\\\",\\n              \\\"char_start\\\": 1290,\\n              \\\"char_end\\\": 1296,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592966\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:509967361\\\"\\n            },\\n            \\\"description\\\": \\\"mid 2022, the infected individuals would account for 1% of the entire population\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"rate of cases with at least one comorbidity\\\",\\n                \\\"grounding_id\\\": \\\"cemo:rate_of_cases_with_at_least_one_comorbidity\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8129532337188721,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592981\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1208,\\n              \\\"char_end\\\": 1288,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592966\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:2008329411\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1759904592\\\"\\n            },\\n            \\\"name\\\": \\\"NPI\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"Two potential measures are investigated .\\\\nFirst , we consider more stringent NPI , perhaps a provincial lockdown .\\\\nAs noted above , the baseline model includes some NPI that are assumed to lower social contacts by at least 60 % .\\\",\\n              \\\"char_start\\\": 2575,\\n              \\\"char_end\\\": 2578,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593016\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1362700265\\\"\\n            },\\n            \\\"description\\\": \\\"provincial lockdown\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2590,\\n              \\\"char_end\\\": 2609,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593016\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-491568125\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-480736182\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.9c\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"The predicted population dynamics that describe its spread , from August 1 2021 to June 30 2022 , is shown in Fig.9 .\\\\nAfter its introduction , Neos quickly takes hold due to its high transmissivity , and by the end of 2021 , it has overtaken Delta to account for the majority of new infections ( Fig.9c ) .\\\\nBy mid 2022 , the infected individuals would account for 1 % of the entire population ( Fig.9f ) , despite nearly 80 % of the population having been vaccinated .\\\",\\n              \\\"char_start\\\": 1196,\\n              \\\"char_end\\\": 1202,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593082\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1247709526\\\"\\n            },\\n            \\\"description\\\": \\\"account for the majority of new infections\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"number of cases by testing\\\",\\n                \\\"grounding_id\\\": \\\"cemo:number_of_cases_by_testing\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8191622495651245,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593100\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1152,\\n              \\\"char_end\\\": 1194,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593082\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:860821778\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1164225066\\\"\\n            },\\n            \\\"name\\\": \\\"Neos\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"The predicted population dynamics that describe its spread , from August 1 2021 to June 30 2022 , is shown in Fig.9 .\\\\nAfter its introduction , Neos quickly takes hold due to its high transmissivity , and by the end of 2021 , it has overtaken Delta to account for the majority of new infections ( Fig.9c ) .\\\\nBy mid 2022 , the infected individuals would account for 1 % of the entire population ( Fig.9f ) , despite nearly 80 % of the population having been vaccinated .\\\",\\n              \\\"char_start\\\": 1046,\\n              \\\"char_end\\\": 1050,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593135\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2127064530\\\"\\n            },\\n            \\\"description\\\": \\\"introduction\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1032,\\n              \\\"char_end\\\": 1044,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593135\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1468322701\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-216664730\\\"\\n            },\\n            \\\"name\\\": \\\"V3\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"In this simulation , we assume that a third dose of either the Pfizer or AstraZeneca vaccine would reduce vaccine breakthrough of Neos to 10 % and 20 % , respectively ( compared to 25 % and 50 % , respectively , with two doses ) , and also double M that has the protection against Alpha and Delta .\\\\nTo model a third vaccine dose , we add a new population V3 received three vaccine shots .\\\",\\n              \\\"char_start\\\": 4153,\\n              \\\"char_end\\\": 4155,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593205\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1776097829\\\"\\n            },\\n            \\\"description\\\": \\\"new population\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"New Stuyahok\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C44612\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8070313334465027,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593226\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 4138,\\n              \\\"char_end\\\": 4152,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593205\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:211817700\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:333027162\\\"\\n            },\\n            \\\"name\\\": \\\"lambda\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"That is , ( i ) if 60 % of the vaccines are AstraZeneca , ( ii ) if vaccination deployment is slower , and ( iii ) if NPI are relaxed .\\\\nIf the vaccination rate is 20 % lower , the model predicts that the total number of Neos infections would be 3 times the original value ; with 60 % AstraZeneca vaccines , 4.6 times ; fewer restrictions ( lambda = 0.5 instead of 0.4 ) , 5 times .\\\\nSee fig.10b .\\\",\\n              \\\"char_start\\\": 2057,\\n              \\\"char_end\\\": 2063,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593314\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1405952390\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"0.5\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 8,\\n                \\\"block\\\": 4,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 2066,\\n                \\\"char_end\\\": 2069,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593314\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-963867388\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:333027162\\\"\\n            },\\n            \\\"name\\\": \\\"lambda\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"That is , ( i ) if 60 % of the vaccines are AstraZeneca , ( ii ) if vaccination deployment is slower , and ( iii ) if NPI are relaxed .\\\\nIf the vaccination rate is 20 % lower , the model predicts that the total number of Neos infections would be 3 times the original value ; with 60 % AstraZeneca vaccines , 4.6 times ; fewer restrictions ( lambda = 0.5 instead of 0.4 ) , 5 times .\\\\nSee fig.10b .\\\",\\n              \\\"char_start\\\": 2057,\\n              \\\"char_end\\\": 2063,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593428\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1405326093\\\"\\n            },\\n            \\\"description\\\": \\\"lambda\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2057,\\n              \\\"char_end\\\": 2063,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593428\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:514068618\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:333027162\\\"\\n            },\\n            \\\"name\\\": \\\"lambda\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"That is , ( i ) if 60 % of the vaccines are AstraZeneca , ( ii ) if vaccination deployment is slower , and ( iii ) if NPI are relaxed .\\\\nIf the vaccination rate is 20 % lower , the model predicts that the total number of Neos infections would be 3 times the original value ; with 60 % AstraZeneca vaccines , 4.6 times ; fewer restrictions ( lambda = 0.5 instead of 0.4 ) , 5 times .\\\\nSee fig.10b .\\\",\\n              \\\"char_start\\\": 2057,\\n              \\\"char_end\\\": 2063,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593513\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1405326093\\\"\\n            },\\n            \\\"description\\\": \\\"lambda\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 8,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 2057,\\n              \\\"char_end\\\": 2063,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593513\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1405952390\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"0.5\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 8,\\n                \\\"block\\\": 4,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 2066,\\n                \\\"char_end\\\": 2069,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593513\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:34958215\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:989106688\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.9\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 11,\\n              \\\"surrounding_passage\\\": \\\"Unfortunately , our model simulation suggests that the answer is no .\\\\nWithout additional interventions , such a VOC would infect many more and likely overwhelm the health care system ( Fig.9 ) .\\\\nThe situation would likely be worse in another region that has a lower rate of vaccination or less effective vaccines ( Fig.10 ) .\\\",\\n              \\\"char_start\\\": 1381,\\n              \\\"char_end\\\": 1386,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594173\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:94813290\\\"\\n            },\\n            \\\"description\\\": \\\"health care system\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Health Care Organization\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C43960\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8675731420516968,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594196\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 11,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1361,\\n              \\\"char_end\\\": 1379,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594173\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1290099843\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:664216289\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.7\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 11,\\n              \\\"surrounding_passage\\\": \\\"While the Delta strain is undoubtedly wreaking havoc globally , severity differs among countries .\\\\nOur analysis suggests that how fast Delta spreads depends not only on the NPI and on the fraction of the population who are vaccinated , but also on the types of the vaccines distributed ( Fig.7 ) .\\\\n4 .\\\",\\n              \\\"char_start\\\": 667,\\n              \\\"char_end\\\": 672,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594247\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2117503504\\\"\\n            },\\n            \\\"description\\\": \\\"distributed\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 11,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 654,\\n              \\\"char_end\\\": 665,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594247\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1659964566\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1987709851\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.8\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 11,\\n              \\\"surrounding_passage\\\": \\\"Vaccinated individuals have a significant chance of suffering a vaccine breakthrough with Delta .\\\\nModel analysis points to a significant role of the vaccinated individuals in the spread of Delta , particularly in a community where most of the vaccines are AstraZeneca ( Fig.8 ) .\\\\n5 .\\\",\\n              \\\"char_start\\\": 945,\\n              \\\"char_end\\\": 950,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594303\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1457565764\\\"\\n            },\\n            \\\"description\\\": \\\"community where most of the vaccines are AstraZeneca\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"COVAXIN\\\",\\n                \\\"grounding_id\\\": \\\"vo:0004991\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8213240504264832,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594324\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 11,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 891,\\n              \\\"char_end\\\": 943,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594303\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-856046416\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1740553002\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.10\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 11,\\n              \\\"surrounding_passage\\\": \\\"Without additional interventions , such a VOC would infect many more and likely overwhelm the health care system ( Fig.9 ) .\\\\nThe situation would likely be worse in another region that has a lower rate of vaccination or less effective vaccines ( Fig.10 ) .\\\",\\n              \\\"char_start\\\": 1508,\\n              \\\"char_end\\\": 1514,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594380\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-681188948\\\"\\n            },\\n            \\\"description\\\": \\\"less effective vaccines\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"effective\\\",\\n                \\\"grounding_id\\\": \\\"vo:0000805\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7866713404655457,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594408\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 11,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1483,\\n              \\\"char_end\\\": 1506,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594380\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-598133204\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-248854092\\\"\\n            },\\n            \\\"name\\\": \\\"epsilon\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\\\nThese models can be a valuable decision-support tool for public health .\\\",\\n              \\\"char_start\\\": 1505,\\n              \\\"char_end\\\": 1512,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594645\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:539099570\\\"\\n            },\\n            \\\"description\\\": \\\"vaccine type\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Canine Distemper-Adenovirus Type 2-Parvovirus-Rabies Vaccine\\\",\\n                \\\"grounding_id\\\": \\\"vo:0002414\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8904863595962524,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594669\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1492,\\n              \\\"char_end\\\": 1504,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594645\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-77644022\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-248854092\\\"\\n            },\\n            \\\"name\\\": \\\"epsilon\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\\\nThese models can be a valuable decision-support tool for public health .\\\",\\n              \\\"char_start\\\": 1505,\\n              \\\"char_end\\\": 1512,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594716\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1165854661\\\"\\n            },\\n            \\\"description\\\": \\\"COVID-19 mortality rate muX\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"mortality rate\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000445\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8332589864730835,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594738\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1514,\\n              \\\"char_end\\\": 1541,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594716\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1160080482\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-248854092\\\"\\n            },\\n            \\\"name\\\": \\\"epsilon\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\\\nThese models can be a valuable decision-support tool for public health .\\\",\\n              \\\"char_start\\\": 1505,\\n              \\\"char_end\\\": 1512,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594790\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1165854661\\\"\\n            },\\n            \\\"description\\\": \\\"COVID-19 mortality rate muX\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"mortality rate\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000445\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8332589864730835,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594812\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1514,\\n              \\\"char_end\\\": 1541,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594790\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-752128713\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-810248146\\\"\\n            },\\n            \\\"name\\\": \\\"muX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\\\nThese models can be a valuable decision-support tool for public health .\\\",\\n              \\\"char_start\\\": 1538,\\n              \\\"char_end\\\": 1541,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594857\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1583784791\\\"\\n            },\\n            \\\"description\\\": \\\"COVID-19 mortality rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"mortality rate\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000445\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.9101454615592957,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594883\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1514,\\n              \\\"char_end\\\": 1537,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594857\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Saxman\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C44726\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7636157870292664,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594865\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-629925471\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:680344900\\\"\\n            },\\n            \\\"name\\\": \\\"NPI lambda)\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\\\nThese models can be a valuable decision-support tool for public health .\\\",\\n              \\\"char_start\\\": 1543,\\n              \\\"char_end\\\": 1554,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594928\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1165854661\\\"\\n            },\\n            \\\"description\\\": \\\"COVID-19 mortality rate muX\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"mortality rate\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000445\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8332589864730835,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594992\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1514,\\n              \\\"char_end\\\": 1541,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594928\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1084065351\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:680344900\\\"\\n            },\\n            \\\"name\\\": \\\"NPI lambda)\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\\\nThese models can be a valuable decision-support tool for public health .\\\",\\n              \\\"char_start\\\": 1543,\\n              \\\"char_end\\\": 1554,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595038\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1066303140\\\"\\n            },\\n            \\\"description\\\": \\\"beta\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"beta distribution\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000078\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.807852566242218,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595061\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1486,\\n              \\\"char_end\\\": 1490,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595038\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1751229178\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:680344900\\\"\\n            },\\n            \\\"name\\\": \\\"NPI lambda)\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\\\nThese models can be a valuable decision-support tool for public health .\\\",\\n              \\\"char_start\\\": 1543,\\n              \\\"char_end\\\": 1554,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595108\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1066303140\\\"\\n            },\\n            \\\"description\\\": \\\"beta\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"beta distribution\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000078\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.807852566242218,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595129\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1486,\\n              \\\"char_end\\\": 1490,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595108\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1086028280\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:680344900\\\"\\n            },\\n            \\\"name\\\": \\\"NPI lambda)\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\\\nThese models can be a valuable decision-support tool for public health .\\\",\\n              \\\"char_start\\\": 1543,\\n              \\\"char_end\\\": 1554,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595175\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1066303140\\\"\\n            },\\n            \\\"description\\\": \\\"beta\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"beta distribution\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000078\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.807852566242218,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595202\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1486,\\n              \\\"char_end\\\": 1490,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595175\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1225515740\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-114903013\\\"\\n            },\\n            \\\"name\\\": \\\"beta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"The present model is formulated using data from Ontario , Canada ( Ontario COVID-19 Science Advisory Table ) .\\\\nGeographical and socio-economic parameters can be refitted to simulate VOC dynamics in a different province in Canada or a different country ( e.g ., infectivity beta , vaccine type epsilon , COVID-19 mortality rate muX , NPI lambda ) .\\\\nThese models can be a valuable decision-support tool for public health .\\\",\\n              \\\"char_start\\\": 1486,\\n              \\\"char_end\\\": 1490,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595246\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1989796303\\\"\\n            },\\n            \\\"description\\\": \\\"e.g., infectivity\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 13,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1468,\\n              \\\"char_end\\\": 1485,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595246\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"beta distribution\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000078\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.807852566242218,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595254\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:2043881519\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:109668800\\\"\\n            },\\n            \\\"name\\\": \\\"SVR\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": \\\"Population in the province is divided into several classes based on their health and vaccination status .\\\\nTwo `` susceptible '' populations are tracked : the original susceptible individuals ( denoted ' S ' ) , who are unvaccinated and have never been infected , and those who become susceptible again after losing their immunity from either vaccination or infection ( denoted ' SVR ' ; more about loss of immunity M class .\\\\nTwo below ) .\\\",\\n              \\\"char_start\\\": 518,\\n              \\\"char_end\\\": 521,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595487\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2084842899\\\"\\n            },\\n            \\\"description\\\": \\\"denoted '\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 509,\\n              \\\"char_end\\\": 518,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595487\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1942444907\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:90135231\\\"\\n            },\\n            \\\"name\\\": \\\"spread\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": \\\"Methods Computational model description .\\\\nThe SV2 ( AIR ) 3 model simulates the spread of three SARS-CoV-2 strains in Ontario : wild type , Alpha , and Delta .\\\\nPopulation in the province is divided into several classes based on their health and vaccination status .\\\",\\n              \\\"char_start\\\": 75,\\n              \\\"char_end\\\": 81,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595536\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2022960899\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"SARS-CoV-2 strains\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 14,\\n                \\\"block\\\": 1,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 91,\\n                \\\"char_end\\\": 109,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595536\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"droplet spread transmission\\\",\\n            \\\"grounding_id\\\": \\\"trans:0000008\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8682812452316284,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595545\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1027255289\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1768699793\\\"\\n            },\\n            \\\"name\\\": \\\"sigmaX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"An infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\\\nWe assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\\\nSymptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\\\",\\n              \\\"char_start\\\": 775,\\n              \\\"char_end\\\": 781,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595715\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1260547704\\\"\\n            },\\n            \\\"description\\\": \\\"virus type\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus-Rabies Virus Vaccine\\\",\\n                \\\"grounding_id\\\": \\\"vo:0002466\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8640658855438232,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595737\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 750,\\n              \\\"char_end\\\": 760,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595715\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Snoqualmie\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C44815\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7998793125152588,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595723\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-933677463\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1768699793\\\"\\n            },\\n            \\\"name\\\": \\\"sigmaX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"An infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\\\nWe assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\\\nSymptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\\\",\\n              \\\"char_start\\\": 775,\\n              \\\"char_end\\\": 781,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595762\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:697409747\\\"\\n            },\\n            \\\"description\\\": \\\"fraction\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 766,\\n              \\\"char_end\\\": 774,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595762\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Snoqualmie\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C44815\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7998793125152588,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595770\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-960278729\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1768699793\\\"\\n            },\\n            \\\"name\\\": \\\"sigmaX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"An infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\\\nWe assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\\\nSymptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\\\",\\n              \\\"char_start\\\": 775,\\n              \\\"char_end\\\": 781,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595807\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:697409747\\\"\\n            },\\n            \\\"description\\\": \\\"fraction\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 766,\\n              \\\"char_end\\\": 774,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595807\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Snoqualmie\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C44815\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7998793125152588,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595816\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1961690714\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-977150681\\\"\\n            },\\n            \\\"name\\\": \\\"muX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"We assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\\\nSymptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\\\\nVaccinated individuals may be infected as well , at a reduced rate of betaX VM ( < betaX ) , where V is either V1 or V2 , and M denotes the vaccine type .\\\",\\n              \\\"char_start\\\": 877,\\n              \\\"char_end\\\": 880,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595853\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1186019931\\\"\\n            },\\n            \\\"description\\\": \\\"mortality rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"mortality rate\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000445\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.9990238547325134,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595875\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 861,\\n              \\\"char_end\\\": 875,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595853\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Saxman\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C44726\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7636157870292664,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595861\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:702864283\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:854818942\\\"\\n            },\\n            \\\"name\\\": \\\"mu\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"We assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\\\nSymptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\\\\nVaccinated individuals may be infected as well , at a reduced rate of betaX VM ( < betaX ) , where V is either V1 or V2 , and M denotes the vaccine type .\\\",\\n              \\\"char_start\\\": 909,\\n              \\\"char_end\\\": 911,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595897\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2100133414\\\"\\n            },\\n            \\\"description\\\": \\\"natural death\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Death by Natural Cause\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C82465\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8426523208618164,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595918\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 894,\\n              \\\"char_end\\\": 907,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595897\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:604822229\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1369001096\\\"\\n            },\\n            \\\"name\\\": \\\"muX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Asymptomatic infections of vaccinated individuals enter AX class , same as infections of unvaccinated individuals .\\\\nIn contrast , symptomatic infections of vaccinated individuals are assumed to have a better survival rate ( with a mortality rate muX V < muX ) , and are represented as a separate infected class IX V. Unvaccinated asymptomatic patients vaccinate at the same rate as the susceptible population ( omega1 ) .\\\",\\n              \\\"char_start\\\": 1372,\\n              \\\"char_end\\\": 1375,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595944\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1900234311\\\"\\n            },\\n            \\\"description\\\": \\\"mortality rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"mortality rate\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000445\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.9990238547325134,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595966\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1357,\\n              \\\"char_end\\\": 1371,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595944\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Saxman\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C44726\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7636157870292664,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595952\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1847156755\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1859364483\\\"\\n            },\\n            \\\"name\\\": \\\"betaX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Symptomatic infection is associated with a mortality rate ( muX ) higher than natural death ( mu ) , but asymptomatic infection does not increase one 's mortality rate .\\\\nVaccinated individuals may be infected as well , at a reduced rate of betaX VM ( < betaX ) , where V is either V1 or V2 , and M denotes the vaccine type .\\\\nAsymptomatic infections of vaccinated individuals enter AX class , same as infections of unvaccinated individuals .\\\",\\n              \\\"char_start\\\": 1062,\\n              \\\"char_end\\\": 1067,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596079\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2056794527\\\"\\n            },\\n            \\\"description\\\": \\\"may be infected as well, at a reduced rate of betaX VM\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"rate of cases with at least one comorbidity\\\",\\n                \\\"grounding_id\\\": \\\"cemo:rate_of_cases_with_at_least_one_comorbidity\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.804816484451294,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596099\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 1004,\\n              \\\"char_end\\\": 1058,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596079\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:491930989\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1136418701\\\"\\n            },\\n            \\\"name\\\": \\\"betaX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"R + alphaX ( CID :31 ) AX + AX R ( CID :30 ) .\\\\nExcept for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\\",\\n              \\\"char_start\\\": 309,\\n              \\\"char_end\\\": 314,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596165\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-582391022\\\"\\n            },\\n            \\\"description\\\": \\\"rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Rate\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C25636\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.999626636505127,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596183\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 304,\\n              \\\"char_end\\\": 308,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596165\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1283479641\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1136418701\\\"\\n            },\\n            \\\"name\\\": \\\"betaX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"R + alphaX ( CID :31 ) AX + AX R ( CID :30 ) .\\\\nExcept for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\\",\\n              \\\"char_start\\\": 309,\\n              \\\"char_end\\\": 314,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596221\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2042889412\\\"\\n            },\\n            \\\"description\\\": \\\"infected by one of the viruses at rate betaX\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"rate of cases with at least one comorbidity\\\",\\n                \\\"grounding_id\\\": \\\"cemo:rate_of_cases_with_at_least_one_comorbidity\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8505942225456238,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596237\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 270,\\n              \\\"char_end\\\": 314,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596221\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1291825073\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1136418701\\\"\\n            },\\n            \\\"name\\\": \\\"betaX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"R + alphaX ( CID :31 ) AX + AX R ( CID :30 ) .\\\\nExcept for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\\",\\n              \\\"char_start\\\": 309,\\n              \\\"char_end\\\": 314,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596274\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2042889412\\\"\\n            },\\n            \\\"description\\\": \\\"infected by one of the viruses at rate betaX\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"rate of cases with at least one comorbidity\\\",\\n                \\\"grounding_id\\\": \\\"cemo:rate_of_cases_with_at_least_one_comorbidity\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8505942225456238,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596288\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 270,\\n              \\\"char_end\\\": 314,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596274\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1542387382\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-309769174\\\"\\n            },\\n            \\\"name\\\": \\\"IX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"R + alphaX ( CID :31 ) AX + AX R ( CID :30 ) .\\\\nExcept for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\\",\\n              \\\"char_start\\\": 397,\\n              \\\"char_end\\\": 399,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596327\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-544155356\\\"\\n            },\\n            \\\"description\\\": \\\"denoted IX\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 389,\\n              \\\"char_end\\\": 399,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596327\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1477307630\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-6512288\\\"\\n            },\\n            \\\"name\\\": \\\"X\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"R + alphaX ( CID :31 ) AX + AX R ( CID :30 ) .\\\\nExcept for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\\",\\n              \\\"char_start\\\": 421,\\n              \\\"char_end\\\": 422,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596381\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:661514884\\\"\\n            },\\n            \\\"description\\\": \\\"one of the SARS-CoV-2 viruses\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"WIBP-CorV\\\",\\n                \\\"grounding_id\\\": \\\"vo:0005160\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8196014165878296,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596405\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 432,\\n              \\\"char_end\\\": 461,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596381\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1386308471\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-880206136\\\"\\n            },\\n            \\\"name\\\": \\\"alphaX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Except for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\\\nWe assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\\",\\n              \\\"char_start\\\": 642,\\n              \\\"char_end\\\": 648,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596442\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1964283175\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-959922248\\\"\\n            },\\n            \\\"name\\\": \\\"AX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Except for the symptomatic patients ( see below ) , all die naturally Both susceptible classes ( S and SVR ) become infected by one of the viruses at rate betaX , potentially by coming in contact with a symptomatic infected individual ( denoted IX ) , where superscript ' X ' denotes one of the SARS-CoV-2 viruses : ' W ' for wild-type , ' A ' for Alpha , and ' D ' for Delta .\\\\nAn infection can also be caused by an asymptomatic infected individual ( denoted AX ) , with a higher rate of alphaXbetaX , where alphaX > 1 with the assumption that asymptomatic individuals are more socially active .\\\\nWe assume that for a virus type X, a fraction sigmaX of the infections are asymptomatic .\\\",\\n              \\\"char_start\\\": 596,\\n              \\\"char_end\\\": 598,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596472\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit44\\\"\\n            },\\n            \\\"name\\\": \\\"A\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-377704025\\\"\\n            },\\n            \\\"description\\\": \\\"denoted\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 588,\\n              \\\"char_end\\\": 595,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596472\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit44\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with partial immunity to a different variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:346088061\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1820723565\\\"\\n            },\\n            \\\"name\\\": \\\"RX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": \\\"The model assumes that an individuated infected by one variant cannot be infected by a second variant .\\\\nInfected individuals recover and enter class RX at a rate of gammaX .\\\\nRecovered individuals are entirely protected from the variant that they were infected with , but may be infected by a different variant at rate betaY R , where Y !\\\",\\n              \\\"char_start\\\": 148,\\n              \\\"char_end\\\": 150,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596674\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit45\\\"\\n            },\\n            \\\"name\\\": \\\"D\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1197916351\\\"\\n            },\\n            \\\"description\\\": \\\"class\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"obsolete class\\\",\\n                \\\"grounding_id\\\": \\\"vo:0000597\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8032230734825134,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596691\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 142,\\n              \\\"char_end\\\": 147,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596674\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit45\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with partial immunity to a different variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1153919973\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1498101629\\\"\\n            },\\n            \\\"name\\\": \\\"R\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": \\\"Infected individuals recover and enter class RX at a rate of gammaX .\\\\nRecovered individuals are entirely protected from the variant that they were infected with , but may be infected by a different variant at rate betaY R , where Y !\\\\n= X, and betaY R < betaY to represent some degree of protection .\\\",\\n              \\\"char_start\\\": 321,\\n              \\\"char_end\\\": 322,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596781\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit46\\\"\\n            },\\n            \\\"name\\\": \\\"PZ\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-487650874\\\"\\n            },\\n            \\\"description\\\": \\\"rate betaY\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Rate\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C25636\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.999626636505127,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596800\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 310,\\n              \\\"char_end\\\": 320,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596781\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit46\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with immunity to all three viruses\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1969515142\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:763804929\\\"\\n            },\\n            \\\"name\\\": \\\"betaY\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": \\\"Infected individuals recover and enter class RX at a rate of gammaX .\\\\nRecovered individuals are entirely protected from the variant that they were infected with , but may be infected by a different variant at rate betaY R , where Y !\\\\n= X, and betaY R < betaY to represent some degree of protection .\\\",\\n              \\\"char_start\\\": 315,\\n              \\\"char_end\\\": 320,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596846\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit47\\\"\\n            },\\n            \\\"name\\\": \\\"AZ\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:50919761\\\"\\n            },\\n            \\\"description\\\": \\\"may be infected by a different variant at rate betaY R\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"number of cases exposed by local (one or cluster) case\\\",\\n                \\\"grounding_id\\\": \\\"cemo:number_of_cases_exposed_by_local_one_or_cluster_case\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7855899930000305,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596861\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 268,\\n              \\\"char_end\\\": 322,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596846\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit47\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with immunity to all three viruses\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1220406750\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:763804929\\\"\\n            },\\n            \\\"name\\\": \\\"betaY\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": \\\"Infected individuals recover and enter class RX at a rate of gammaX .\\\\nRecovered individuals are entirely protected from the variant that they were infected with , but may be infected by a different variant at rate betaY R , where Y !\\\\n= X, and betaY R < betaY to represent some degree of protection .\\\",\\n              \\\"char_start\\\": 315,\\n              \\\"char_end\\\": 320,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596945\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit48\\\"\\n            },\\n            \\\"name\\\": \\\"\\\\u03b3\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1070158172\\\"\\n            },\\n            \\\"description\\\": \\\"different variant at rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"rate of cases with at least one comorbidity\\\",\\n                \\\"grounding_id\\\": \\\"cemo:rate_of_cases_with_at_least_one_comorbidity\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7559011578559875,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596962\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 289,\\n              \\\"char_end\\\": 314,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596945\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit48\\\"\\n            },\\n            \\\"description\\\": \\\"rate of recovery for infected individuals\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"recovery rate\\\",\\n            \\\"grounding_id\\\": \\\"askemo:0000013\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"AE recovery rate\\\",\\n            \\\"grounding_id\\\": \\\"oae:0001869\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1422446413\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:763804929\\\"\\n            },\\n            \\\"name\\\": \\\"betaY\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": \\\"Infected individuals recover and enter class RX at a rate of gammaX .\\\\nRecovered individuals are entirely protected from the variant that they were infected with , but may be infected by a different variant at rate betaY R , where Y !\\\\n= X, and betaY R < betaY to represent some degree of protection .\\\",\\n              \\\"char_start\\\": 315,\\n              \\\"char_end\\\": 320,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597009\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit49\\\"\\n            },\\n            \\\"name\\\": \\\"dAX\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1070158172\\\"\\n            },\\n            \\\"description\\\": \\\"different variant at rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"rate of cases with at least one comorbidity\\\",\\n                \\\"grounding_id\\\": \\\"cemo:rate_of_cases_with_at_least_one_comorbidity\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7559011578559875,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597027\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 289,\\n              \\\"char_end\\\": 314,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597009\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit49\\\"\\n            },\\n            \\\"description\\\": \\\"change in the number of asymptomatic infections over time\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"relative change in new infections\\\",\\n            \\\"grounding_id\\\": \\\"cemo:relative_change_in_new_infections\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"epstein-barr virus infection AE\\\",\\n            \\\"grounding_id\\\": \\\"oae:0007029\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1754528603\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1513298016\\\"\\n            },\\n            \\\"name\\\": \\\"muX\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": \\\"= X, and betaY R < betaY to represent some degree of protection .\\\\nInfected recovered individuals are denoted IX R , which like IX V are associated with a better survival rate ( muX R < muX ) .\\\\nRecovered individuals lose their partial immunity and enter SVR at a rate of etaR .\\\",\\n              \\\"char_start\\\": 515,\\n              \\\"char_end\\\": 518,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597072\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit50\\\"\\n            },\\n            \\\"name\\\": \\\"S\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-523860896\\\"\\n            },\\n            \\\"description\\\": \\\"muX R <\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 1,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 507,\\n              \\\"char_end\\\": 514,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597072\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit50\\\"\\n            },\\n            \\\"description\\\": \\\"susceptible population\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Saxman\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C44726\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7636157870292664,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597081\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"susceptible population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000234\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"count of susceptible population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000087\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-917712060\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1567742145\\\"\\n            },\\n            \\\"name\\\": \\\"s\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"( C ) the author ( s ) 2022 .\\\",\\n              \\\"char_start\\\": 15,\\n              \\\"char_end\\\": 16,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597247\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit51\\\"\\n            },\\n            \\\"name\\\": \\\"SVR\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2032409614\\\"\\n            },\\n            \\\"description\\\": \\\"author\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"author list\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000329\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8084220290184021,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597270\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 8,\\n              \\\"char_end\\\": 14,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597247\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit51\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with partial immunity\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Meruvax I\\\",\\n            \\\"grounding_id\\\": \\\"vo:0003109\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7847759127616882,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597257\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1930130592\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-44815477\\\"\\n            },\\n            \\\"name\\\": \\\"betaW\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": \\\"To identify the strongest determinants of the pandemic severity , we assess the sensitivity of model predictions to variations in key model parameters .\\\\nWe first conduct a sensitivity analysis in a simplified model that represents only the wild-type SARS-CoV-2 , for the year 2020 , but with infectivity betaW elevated .\\\",\\n              \\\"char_start\\\": 322,\\n              \\\"char_end\\\": 327,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597294\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit52\\\"\\n            },\\n            \\\"name\\\": \\\"RY\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-678680227\\\"\\n            },\\n            \\\"description\\\": \\\"infectivity\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 2,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 310,\\n              \\\"char_end\\\": 321,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597294\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit52\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with immunity to a different variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:716487493\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1311637267\\\"\\n            },\\n            \\\"name\\\": \\\"n\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"Rates are indicated on the arrows .\\\\nbeta , infection rate ; , recovery rate ; n , rate of immunity loss ; mu , death rate ; omega , vaccination rate .\\\\nFor a complete definition of the variables , superscripts , and subscripts , see text .\\\",\\n              \\\"char_start\\\": 502,\\n              \\\"char_end\\\": 503,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597377\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit53\\\"\\n            },\\n            \\\"name\\\": \\\"RF\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1113309935\\\"\\n            },\\n            \\\"description\\\": \\\"rate of immunity loss\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"period of persistence of vaccine induced immune response\\\",\\n                \\\"grounding_id\\\": \\\"vo:0000426\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7852755784988403,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597401\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 505,\\n              \\\"char_end\\\": 526,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597377\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit53\\\"\\n            },\\n            \\\"description\\\": \\\"class for recovered individuals with immunity to all three viruses\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"V-LSG/N\\\",\\n            \\\"grounding_id\\\": \\\"vo:0004083\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0000001192092896,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597385\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Recovered from Adverse Event\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C49498\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"recovered population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000163\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1780919070\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1591957904\\\"\\n            },\\n            \\\"name\\\": \\\"omega\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"Rates are indicated on the arrows .\\\\nbeta , infection rate ; , recovery rate ; n , rate of immunity loss ; mu , death rate ; omega , vaccination rate .\\\\nFor a complete definition of the variables , superscripts , and subscripts , see text .\\\",\\n              \\\"char_start\\\": 544,\\n              \\\"char_end\\\": 549,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597437\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit54\\\"\\n            },\\n            \\\"name\\\": \\\"dRF\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:262029104\\\"\\n            },\\n            \\\"description\\\": \\\"vaccination rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"vaccine effectiveness rate\\\",\\n                \\\"grounding_id\\\": \\\"vo:0000443\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8607025742530823,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597460\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 551,\\n              \\\"char_end\\\": 567,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597437\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit54\\\"\\n            },\\n            \\\"description\\\": \\\"change in the number of individuals in RF class over time\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Class\\\",\\n            \\\"grounding_id\\\": \\\"rdfs:Class\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Class\\\",\\n            \\\"grounding_id\\\": \\\"owl:Class\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:2056695833\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:476109798\\\"\\n            },\\n            \\\"name\\\": \\\"mu\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"Rates are indicated on the arrows .\\\\nbeta , infection rate ; , recovery rate ; n , rate of immunity loss ; mu , death rate ; omega , vaccination rate .\\\\nFor a complete definition of the variables , superscripts , and subscripts , see text .\\\",\\n              \\\"char_start\\\": 528,\\n              \\\"char_end\\\": 530,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597494\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit55\\\"\\n            },\\n            \\\"name\\\": \\\"dRX\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1370260727\\\"\\n            },\\n            \\\"description\\\": \\\"death rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"cumulative death rates\\\",\\n                \\\"grounding_id\\\": \\\"cemo:cumulative_death_rates\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.9054759740829468,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597515\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 532,\\n              \\\"char_end\\\": 542,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597494\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit55\\\"\\n            },\\n            \\\"description\\\": \\\"change in the number of individuals in RX class over time\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Class\\\",\\n            \\\"grounding_id\\\": \\\"owl:Class\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"Class\\\",\\n            \\\"grounding_id\\\": \\\"rdfs:Class\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1341709601\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1637930573\\\"\\n            },\\n            \\\"name\\\": \\\"beta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"Rates are indicated on the arrows .\\\\nbeta , infection rate ; , recovery rate ; n , rate of immunity loss ; mu , death rate ; omega , vaccination rate .\\\\nFor a complete definition of the variables , superscripts , and subscripts , see text .\\\",\\n              \\\"char_start\\\": 462,\\n              \\\"char_end\\\": 466,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597551\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit56\\\"\\n            },\\n            \\\"name\\\": \\\"IY\\\",\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:441272718\\\"\\n            },\\n            \\\"description\\\": \\\"infection rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Infection Fatality Rate\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C173780\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.9256949424743652,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597573\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 468,\\n              \\\"char_end\\\": 482,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597551\\\"\\n            }\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"mit56\\\"\\n            },\\n            \\\"description\\\": \\\"infected individuals of a different variant\\\",\\n            \\\"grounding\\\": null,\\n            \\\"extraction_source\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"beta distribution\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000078\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.807852566242218,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597560\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"human infected by SARS-CoV-2\\\",\\n            \\\"grounding_id\\\": \\\"cido:0000292\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          },\\n          {\\n            \\\"grounding_text\\\": \\\"transmission coefficient\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000191\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 1.0,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"MIT extractor V1.0 - text, dataset, formula annotation (chunwei@mit.edu)\\\",\\n              \\\"timestamp\\\": \\\"2023-10-31T20:46:33.801844\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:825197191\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1458421397\\\"\\n            },\\n            \\\"name\\\": \\\"A\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"Figure1 .\\\\nPanel ( A ) , schematic diagram for a simplified version of the SV2 ( AIR ) 3 model , representing only one V and IW R , symptomatic infected class ; AW and virus and one vaccine type .\\\\nS and SVR , susceptible class ; IW , IW AW R , asymptomatic infected class ; RW and RF recovered class .\\\",\\n              \\\"char_start\\\": 17,\\n              \\\"char_end\\\": 18,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597611\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2137874468\\\"\\n            },\\n            \\\"description\\\": \\\"Panel\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 10,\\n              \\\"char_end\\\": 15,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597611\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1978344876\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2059913967\\\"\\n            },\\n            \\\"name\\\": \\\"S.\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"Deaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\\\\nPanel ( B ) shows the full connections associated with the susceptible class S. Arrows indicate movement of S into one of the six infected classes ( the A 's and I 's ) or one of the two vaccinated classes ( V1 's ) .\\\\nMovements from one of these infected or vaccinated into another class are not shown .\\\",\\n              \\\"char_start\\\": 1005,\\n              \\\"char_end\\\": 1007,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597677\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1818973716\\\"\\n            },\\n            \\\"description\\\": \\\"susceptible class\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"susceptible individuals\\\",\\n                \\\"grounding_id\\\": \\\"cemo:susceptible_individuals\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7851424217224121,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597704\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 987,\\n              \\\"char_end\\\": 1004,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597677\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"S. typimurium Vi4072\\\",\\n            \\\"grounding_id\\\": \\\"vo:0004186\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.9999999403953552,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597686\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:2127044537\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1518139039\\\"\\n            },\\n            \\\"name\\\": \\\"B\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"Deaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\\\\nPanel ( B ) shows the full connections associated with the susceptible class S. Arrows indicate movement of S into one of the six infected classes ( the A 's and I 's ) or one of the two vaccinated classes ( V1 's ) .\\\\nMovements from one of these infected or vaccinated into another class are not shown .\\\",\\n              \\\"char_start\\\": 937,\\n              \\\"char_end\\\": 938,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597728\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:999358760\\\"\\n            },\\n            \\\"description\\\": \\\"Panel\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 930,\\n              \\\"char_end\\\": 935,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597728\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"AIDSVAX B/B\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000405\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8989673256874084,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597738\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-58983686\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-801290668\\\"\\n            },\\n            \\\"name\\\": \\\"IW\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"Panel ( A ) , schematic diagram for a simplified version of the SV2 ( AIR ) 3 model , representing only one V and IW R , symptomatic infected class ; AW and virus and one vaccine type .\\\\nS and SVR , susceptible class ; IW , IW AW R , asymptomatic infected class ; RW and RF recovered class .\\\\nArrows denote the movement from one class to another , via infection ( red arrows ) , vaccination ( blue arrows ) , recovery , or loss of immunity .\\\",\\n              \\\"char_start\\\": 217,\\n              \\\"char_end\\\": 219,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597810\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1013283370\\\"\\n            },\\n            \\\"description\\\": \\\"asymptomatic infected class\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"infected population\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000233\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7838175892829895,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597833\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 230,\\n              \\\"char_end\\\": 257,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597810\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-2029925287\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1940093386\\\"\\n            },\\n            \\\"name\\\": \\\"A\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"For a complete definition of the variables , superscripts , and subscripts , see text .\\\\nIn the complete model , three viruses ( W = wild type , A = Alpha , D = Delta ) and two vaccine types ( PZ = Pfizer and AZ = AstraZeneca ) are represented .\\\\nDeaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\\\",\\n              \\\"char_start\\\": 706,\\n              \\\"char_end\\\": 707,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597879\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1291450413\\\"\\n            },\\n            \\\"description\\\": \\\"wild type\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.1A)\\\",\\n                \\\"grounding_id\\\": \\\"vo:0002166\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.784527063369751,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597905\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 695,\\n              \\\"char_end\\\": 704,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597879\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1254443348\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-50685911\\\"\\n            },\\n            \\\"name\\\": \\\"D\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"For a complete definition of the variables , superscripts , and subscripts , see text .\\\\nIn the complete model , three viruses ( W = wild type , A = Alpha , D = Delta ) and two vaccine types ( PZ = Pfizer and AZ = AstraZeneca ) are represented .\\\\nDeaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\\\",\\n              \\\"char_start\\\": 717,\\n              \\\"char_end\\\": 718,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597928\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1291450413\\\"\\n            },\\n            \\\"description\\\": \\\"wild type\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.1A)\\\",\\n                \\\"grounding_id\\\": \\\"vo:0002166\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.784527063369751,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597951\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 695,\\n              \\\"char_end\\\": 704,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597928\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-283348533\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1988267369\\\"\\n            },\\n            \\\"name\\\": \\\"W\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"For a complete definition of the variables , superscripts , and subscripts , see text .\\\\nIn the complete model , three viruses ( W = wild type , A = Alpha , D = Delta ) and two vaccine types ( PZ = Pfizer and AZ = AstraZeneca ) are represented .\\\\nDeaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\\\",\\n              \\\"char_start\\\": 691,\\n              \\\"char_end\\\": 692,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597976\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-622537451\\\"\\n            },\\n            \\\"description\\\": \\\"wild type\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.1A)\\\",\\n                \\\"grounding_id\\\": \\\"vo:0002166\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.784527063369751,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597990\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 695,\\n              \\\"char_end\\\": 704,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597976\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1472238765\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:717663234\\\"\\n            },\\n            \\\"name\\\": \\\"AZ\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"For a complete definition of the variables , superscripts , and subscripts , see text .\\\\nIn the complete model , three viruses ( W = wild type , A = Alpha , D = Delta ) and two vaccine types ( PZ = Pfizer and AZ = AstraZeneca ) are represented .\\\\nDeaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\\\",\\n              \\\"char_start\\\": 767,\\n              \\\"char_end\\\": 769,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598011\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:265642334\\\"\\n            },\\n            \\\"description\\\": \\\"AstraZeneca\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"AstraZeneca\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C177125\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.9995855689048767,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598033\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 772,\\n              \\\"char_end\\\": 783,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598011\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1385936192\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:56437613\\\"\\n            },\\n            \\\"name\\\": \\\"PZ\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": \\\"For a complete definition of the variables , superscripts , and subscripts , see text .\\\\nIn the complete model , three viruses ( W = wild type , A = Alpha , D = Delta ) and two vaccine types ( PZ = Pfizer and AZ = AstraZeneca ) are represented .\\\\nDeaths are indicated only for the symptomatic infected classes , even though natural deaths are represented for all populations .\\\",\\n              \\\"char_start\\\": 751,\\n              \\\"char_end\\\": 753,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598053\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-760162990\\\"\\n            },\\n            \\\"description\\\": \\\"Pfizer and AZ =\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Pfizer Inc.\\\",\\n                \\\"grounding_id\\\": \\\"vo:0004947\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7525688409805298,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598069\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 3,\\n              \\\"block\\\": 4,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 756,\\n              \\\"char_end\\\": 771,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598053\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:611615583\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1777265395\\\"\\n            },\\n            \\\"name\\\": \\\"betaV\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\\\",\\n              \\\"char_start\\\": 522,\\n              \\\"char_end\\\": 527,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598223\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1725396255\\\"\\n            },\\n            \\\"description\\\": \\\"rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Rate\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C25636\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.999626636505127,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598238\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 516,\\n              \\\"char_end\\\": 520,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598223\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:814952678\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1115964660\\\"\\n            },\\n            \\\"name\\\": \\\"muI\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\\\",\\n              \\\"char_start\\\": 464,\\n              \\\"char_end\\\": 467,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598273\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2132818818\\\"\\n            },\\n            \\\"description\\\": \\\"rate of infected individuals\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"average rate of infectious contacts\\\",\\n                \\\"grounding_id\\\": \\\"cemo:average_rate_of_infectious_contacts\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8620831966400146,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598296\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 434,\\n              \\\"char_end\\\": 462,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598273\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:576858469\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:96077972\\\"\\n            },\\n            \\\"name\\\": \\\"lambda\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\\\",\\n              \\\"char_start\\\": 546,\\n              \\\"char_end\\\": 552,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598330\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1273803626\\\"\\n            },\\n            \\\"description\\\": \\\"stringency\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 534,\\n              \\\"char_end\\\": 544,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598330\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1695453225\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-957289098\\\"\\n            },\\n            \\\"name\\\": \\\"beta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\\\",\\n              \\\"char_start\\\": 334,\\n              \\\"char_end\\\": 338,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598392\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2065961831\\\"\\n            },\\n            \\\"description\\\": \\\"infectivity\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 322,\\n              \\\"char_end\\\": 333,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598392\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"beta distribution\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000078\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.807852566242218,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598400\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-2089543753\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1242538179\\\"\\n            },\\n            \\\"name\\\": \\\"gamma\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\\\",\\n              \\\"char_start\\\": 493,\\n              \\\"char_end\\\": 498,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598449\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:376106397\\\"\\n            },\\n            \\\"description\\\": \\\"disease recovery rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Death due to Disease Progression\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C168970\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8151561617851257,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598471\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 470,\\n              \\\"char_end\\\": 491,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598449\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"gamma distribution\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000255\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8174800872802734,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598458\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-146210857\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2030986905\\\"\\n            },\\n            \\\"name\\\": \\\"sigma\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\\\",\\n              \\\"char_start\\\": 294,\\n              \\\"char_end\\\": 299,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598506\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-995615771\\\"\\n            },\\n            \\\"description\\\": \\\"ratio of asymptomatic versus symptomatic infections\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 241,\\n              \\\"char_end\\\": 292,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598506\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-230919232\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:692333997\\\"\\n            },\\n            \\\"name\\\": \\\"beta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to variations in model parameter values , in a one-year simulation ( 2020 ) of wild-type viral dynamics .\\\\nParameters examined include virus infectivity ( beta ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\\nAsterisk ( * ) denote parameters that were varied by 50 % ; other parameters were varied by 5 % .\\\",\\n              \\\"char_start\\\": 234,\\n              \\\"char_end\\\": 238,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598560\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:95196513\\\"\\n            },\\n            \\\"description\\\": \\\"virus infectivity\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Sindbis virus vaccine\\\",\\n                \\\"grounding_id\\\": \\\"vo:0003043\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7953133583068848,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598599\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 6,\\n              \\\"block\\\": 2,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 215,\\n              \\\"char_end\\\": 232,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598560\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"beta distribution\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000078\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.807852566242218,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598568\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1759113608\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-659649705\\\"\\n            },\\n            \\\"name\\\": \\\"lambda\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\",\\n              \\\"char_start\\\": 906,\\n              \\\"char_end\\\": 912,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598686\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2102379480\\\"\\n            },\\n            \\\"description\\\": \\\"stringency\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 894,\\n              \\\"char_end\\\": 904,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598686\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-868577489\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:740455928\\\"\\n            },\\n            \\\"name\\\": \\\"beta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\",\\n              \\\"char_start\\\": 644,\\n              \\\"char_end\\\": 648,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598813\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1980366916\\\"\\n            },\\n            \\\"description\\\": \\\"infectivity\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 632,\\n              \\\"char_end\\\": 643,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598813\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"beta distribution\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000078\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.807852566242218,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598822\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-869823682\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1637236798\\\"\\n            },\\n            \\\"name\\\": \\\"gamma\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\",\\n              \\\"char_start\\\": 803,\\n              \\\"char_end\\\": 808,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598902\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-763748697\\\"\\n            },\\n            \\\"description\\\": \\\"disease recovery rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Death due to Disease Progression\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C168970\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8151561617851257,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598928\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 780,\\n              \\\"char_end\\\": 801,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598902\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"gamma distribution\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000255\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8174800872802734,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598910\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1297286117\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:609904275\\\"\\n            },\\n            \\\"name\\\": \\\"etaR\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\",\\n              \\\"char_start\\\": 854,\\n              \\\"char_end\\\": 858,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598995\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2073665918\\\"\\n            },\\n            \\\"description\\\": \\\"infection\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"infection\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000114\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.9989686012268066,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599017\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 843,\\n              \\\"char_end\\\": 852,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598995\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-438207695\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1500361573\\\"\\n            },\\n            \\\"name\\\": \\\"sigma\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\",\\n              \\\"char_start\\\": 604,\\n              \\\"char_end\\\": 609,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599084\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1030514774\\\"\\n            },\\n            \\\"description\\\": \\\"ratio of asymptomatic versus symptomatic infections\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 551,\\n              \\\"char_end\\\": 602,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599084\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:83314069\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-44008016\\\"\\n            },\\n            \\\"name\\\": \\\"betaV\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\",\\n              \\\"char_start\\\": 882,\\n              \\\"char_end\\\": 887,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599164\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-323266353\\\"\\n            },\\n            \\\"description\\\": \\\"vaccine escape rate\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"vaccine effectiveness rate\\\",\\n                \\\"grounding_id\\\": \\\"vo:0000443\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8239560723304749,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599182\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 861,\\n              \\\"char_end\\\": 880,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599164\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-634538974\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-750522701\\\"\\n            },\\n            \\\"name\\\": \\\"muI\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\",\\n              \\\"char_start\\\": 774,\\n              \\\"char_end\\\": 777,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599249\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-863487193\\\"\\n            },\\n            \\\"description\\\": \\\"rate of infected individuals\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"average rate of infectious contacts\\\",\\n                \\\"grounding_id\\\": \\\"cemo:average_rate_of_infectious_contacts\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8620831966400146,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599272\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 744,\\n              \\\"char_end\\\": 772,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599249\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1993378382\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:675843161\\\"\\n            },\\n            \\\"name\\\": \\\"beta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Relative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\",\\n              \\\"char_start\\\": 467,\\n              \\\"char_end\\\": 471,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599337\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1412009529\\\"\\n            },\\n            \\\"description\\\": \\\"virus infectivity\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Sindbis virus vaccine\\\",\\n                \\\"grounding_id\\\": \\\"vo:0003043\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7953133583068848,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599359\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 448,\\n              \\\"char_end\\\": 465,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599337\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"beta distribution\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000078\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.807852566242218,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599345\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:800289603\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1970682056\\\"\\n            },\\n            \\\"name\\\": \\\"c\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to increases in model parameter values , in a two-year simulation interacting VOC dynamics .\\\\nParameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\",\\n              \\\"char_start\\\": 273,\\n              \\\"char_end\\\": 274,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599461\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-230207360\\\"\\n            },\\n            \\\"description\\\": \\\"column\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 266,\\n              \\\"char_end\\\": 272,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599461\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"BoNT/C\\\",\\n            \\\"grounding_id\\\": \\\"vo:0004004\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7589514851570129,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599470\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1558390445\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:106329618\\\"\\n            },\\n            \\\"name\\\": \\\"a\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to increases in model parameter values , in a two-year simulation interacting VOC dynamics .\\\\nParameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\",\\n              \\\"char_start\\\": 233,\\n              \\\"char_end\\\": 234,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599550\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:371412418\\\"\\n            },\\n            \\\"description\\\": \\\"column\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 226,\\n              \\\"char_end\\\": 232,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599550\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-2075507652\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1292040628\\\"\\n            },\\n            \\\"name\\\": \\\"Delta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to increases in model parameter values , in a two-year simulation interacting VOC dynamics .\\\\nParameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\",\\n              \\\"char_start\\\": 259,\\n              \\\"char_end\\\": 264,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599631\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2068630805\\\"\\n            },\\n            \\\"description\\\": \\\"column c\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 266,\\n              \\\"char_end\\\": 274,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599631\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:721581088\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1896128896\\\"\\n            },\\n            \\\"name\\\": \\\"b\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to increases in model parameter values , in a two-year simulation interacting VOC dynamics .\\\\nParameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\",\\n              \\\"char_start\\\": 251,\\n              \\\"char_end\\\": 252,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599723\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1644904032\\\"\\n            },\\n            \\\"description\\\": \\\"column\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 244,\\n              \\\"char_end\\\": 250,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599723\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"AIDSVAX B/B\\\",\\n            \\\"grounding_id\\\": \\\"vo:0000405\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.8989673256874084,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599733\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1895430149\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-933317352\\\"\\n            },\\n            \\\"name\\\": \\\"Alpha\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Sensitivity of model predictions , measured by total infections and deaths , to increases in model parameter values , in a two-year simulation interacting VOC dynamics .\\\\nParameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\",\\n              \\\"char_start\\\": 237,\\n              \\\"char_end\\\": 242,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599806\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-156709321\\\"\\n            },\\n            \\\"description\\\": \\\"column b\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 244,\\n              \\\"char_end\\\": 252,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599806\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1776301662\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-492448180\\\"\\n            },\\n            \\\"name\\\": \\\"Delta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Parameters are varied individually for wild-type ( column a ) , Alpha ( column b ) , and Delta ( column c ) .\\\\nRelative changes in the number of infections and deaths are then computed for wild-type ( yellow bars ) , Alpha ( red bars ) , and Delta ( blue bars ) .\\\\nParameter examined include virus infectivity ( beta ) , rate of infection of individuals recovered from a different variant ( betaR ) , ratio of asymptomatic versus symptomatic infections ( sigma ) , degree of increased infectivity beta ( due to mobility ) of asymptomatic infected individuals compared to symptomatic ones , mortality rate of infected individuals ( muI ) , disease recovery rate ( gamma ) , rate of loss of immunity due to infection ( etaR ) , vaccine escape rate ( betaV ) , NPI stringency ( lambda ) , dosing interval ( omega2 ) , vaccination rate ( omega1 ) .\\\",\\n              \\\"char_start\\\": 402,\\n              \\\"char_end\\\": 407,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599895\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1615859808\\\"\\n            },\\n            \\\"description\\\": \\\"blue bars\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 7,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 409,\\n              \\\"char_end\\\": 418,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599895\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1876321384\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2028255591\\\"\\n            },\\n            \\\"name\\\": \\\"NPI\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 9,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"`` Vac rate , '' vaccination rate reduced by 20 % .\\\\n`` NPI '' , less stringent lockdown measured , with mobility increased by 25 % .\\\\nAmong these scenarios considered , Delta outbreak is the most severe when the majority of the vaccines are AstraZeneca .\\\",\\n              \\\"char_start\\\": 391,\\n              \\\"char_end\\\": 394,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600060\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-427152325\\\"\\n            },\\n            \\\"description\\\": \\\"stringent lockdown measured, with mobility increased by 25%\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 9,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 403,\\n              \\\"char_end\\\": 462,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600060\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:868023049\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2020399361\\\"\\n            },\\n            \\\"name\\\": \\\"Pfizer\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 9,\\n              \\\"block\\\": 6,\\n              \\\"surrounding_passage\\\": \\\"Predicted spread of the Delta variant , from March 2021 to March 2022 , obtained for baseline parameters and three alternative scenarios .\\\\n`` PZ / AZ , '' lower fraction of vaccines being Pfizer ( from 95 to 40 % ) , with the reduction made up with AstraZeneca , which of fers reduced protection from Delta infections and a longer dosing delay .\\\\n`` Vac rate , '' vaccination rate reduced by 20 % .\\\",\\n              \\\"char_start\\\": 190,\\n              \\\"char_end\\\": 196,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600162\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-474620134\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"%\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 9,\\n                \\\"block\\\": 6,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 211,\\n                \\\"char_end\\\": 212,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600162\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Pfizer\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C177123\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.9995554089546204,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600170\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-739144679\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-169454598\\\"\\n            },\\n            \\\"name\\\": \\\"Fig.4\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 10,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"It is well understood that for any infectious disease , the major factors that determine how fast it spreads include infectivity , the extent of the NPI , and vaccination rate .\\\\nFor COVID-19 , our sensitivity analysis reveals two additional factors , the prevalence of asymptomatic infections and the enhanced infectivity of asymptomatic patients ( Fig.4 ) .\\\",\\n              \\\"char_start\\\": 345,\\n              \\\"char_end\\\": 350,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600400\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:674776079\\\"\\n            },\\n            \\\"description\\\": \\\"enhanced infectivity of asymptomatic patients\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"percentage of asymptomatic of confirmed cases\\\",\\n                \\\"grounding_id\\\": \\\"cemo:percentage_of_asymptomatic_of_confirmed_cases\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.768237292766571,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600422\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 10,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 298,\\n              \\\"char_end\\\": 343,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600400\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1447664274\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:560216930\\\"\\n            },\\n            \\\"name\\\": \\\"PZ\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 10,\\n              \\\"surrounding_passage\\\": \\\"( a ) Susceptible individuals , original population and those who lost their immunity acquired either from an infection or vaccination .\\\\n( b ) Vaccinated with only one dose or both , with either Pfizer ( PZ ) or AstraZeneca ( AZ ) .\\\\n( C ) new infections per day ( Neos , Alpha , Delta ) since August 1 2021 .\\\",\\n              \\\"char_start\\\": 293,\\n              \\\"char_end\\\": 295,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600478\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1697504455\\\"\\n            },\\n            \\\"description\\\": \\\"either Pfizer\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 10,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 278,\\n              \\\"char_end\\\": 291,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600478\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:937246848\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1272919843\\\"\\n            },\\n            \\\"name\\\": \\\"AZ\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 10,\\n              \\\"surrounding_passage\\\": \\\"( a ) Susceptible individuals , original population and those who lost their immunity acquired either from an infection or vaccination .\\\\n( b ) Vaccinated with only one dose or both , with either Pfizer ( PZ ) or AstraZeneca ( AZ ) .\\\\n( C ) new infections per day ( Neos , Alpha , Delta ) since August 1 2021 .\\\",\\n              \\\"char_start\\\": 313,\\n              \\\"char_end\\\": 315,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600516\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-88807827\\\"\\n            },\\n            \\\"description\\\": \\\"AstraZeneca\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"AstraZeneca\\\",\\n                \\\"grounding_id\\\": \\\"ncit:C177125\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.9995855689048767,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600537\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 11,\\n              \\\"block\\\": 10,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 300,\\n              \\\"char_end\\\": 311,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600516\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-795860774\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1746125849\\\"\\n            },\\n            \\\"name\\\": \\\"NPI\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 12,\\n              \\\"block\\\": 5,\\n              \\\"surrounding_passage\\\": \\\"`` Vac rate , '' vaccination rate reduced by 20 % .\\\\n`` NPI '' , less stringent lockdown measured , with mobility increased by 25 % .\\\\n( a ) Number of new Neos infections .\\\",\\n              \\\"char_start\\\": 423,\\n              \\\"char_end\\\": 426,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600641\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1664213421\\\"\\n            },\\n            \\\"description\\\": \\\"stringent lockdown measured, with mobility increased by 25%\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 12,\\n              \\\"block\\\": 5,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 435,\\n              \\\"char_end\\\": 494,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600641\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:1959808490\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1065713676\\\"\\n            },\\n            \\\"name\\\": \\\"Pfizer\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 12,\\n              \\\"block\\\": 5,\\n              \\\"surrounding_passage\\\": \\\"Results are obtained for baseline parameters and three alternative scenarios .\\\\n`` PZ / AZ , '' lower fraction of vaccines being Pfizer ( from 95 to 40 % ) , with the reduction made up with AstraZeneca , which of fers reduced protection from Delta infections and a longer dosing delay .\\\\n`` Vac rate , '' vaccination rate reduced by 20 % .\\\",\\n              \\\"char_start\\\": 222,\\n              \\\"char_end\\\": 228,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600728\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1755210173\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"%\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 12,\\n                \\\"block\\\": 5,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 243,\\n                \\\"char_end\\\": 244,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600728\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Pfizer\\\",\\n            \\\"grounding_id\\\": \\\"ncit:C177123\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.9995554089546204,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600737\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1741730311\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2030280181\\\"\\n            },\\n            \\\"name\\\": \\\"70% of the Ontario population\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 12,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"As previously noted , a significant number of the Delta infections are caused by vaccinated individuals with asymptomatic infections .\\\\nConsequently , even with > 70 % of the Ontario population have received at least one vaccine dose , some NPI must remain to prevent the further spread of Delta , or the emergence and rapid spread of the next series of more dangerous VOC .\\\\nWhen in-person classes resume in public schools and college in September , any Delta outbreak and the emergence of new VOC must be closely monitored , and if necessary , NPI must be reinstated .\\\",\\n              \\\"char_start\\\": 248,\\n              \\\"char_end\\\": 277,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600880\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"count of simulated population\\\",\\n            \\\"grounding_id\\\": \\\"apollosv:00000022\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7830394506454468,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600889\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1995693754\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:2085801335\\\"\\n            },\\n            \\\"name\\\": \\\"news\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 12,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"And for these NPI to be effective , they must begin sufficiently early .\\\\nThe news that a third ( or fourth ) dose of the Pfizer vaccine enhances one 's protection against VOC is exciting25 .\\\\nIndeed , the combination of NPI and a booster shot may be necessary in our fight against a future , more transmissible and deadlier VOC .\\\",\\n              \\\"char_start\\\": 722,\\n              \\\"char_end\\\": 726,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600952\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1437501135\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"exciting25\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 12,\\n                \\\"block\\\": 7,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 820,\\n                \\\"char_end\\\": 830,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600952\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1128287073\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:993894564\\\"\\n            },\\n            \\\"name\\\": \\\"W\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\\\",\\n              \\\"char_start\\\": 71,\\n              \\\"char_end\\\": 72,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601146\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-681436695\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"2\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 14,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 47,\\n                \\\"char_end\\\": 48,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601146\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-680787754\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:993894564\\\"\\n            },\\n            \\\"name\\\": \\\"W\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\\\",\\n              \\\"char_start\\\": 71,\\n              \\\"char_end\\\": 72,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601235\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:499808299\\\"\\n            },\\n            \\\"description\\\": \\\"AZ v m 2  x=W\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 93,\\n              \\\"char_end\\\": 106,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601235\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1717504424\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:993894564\\\"\\n            },\\n            \\\"name\\\": \\\"W\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\\\",\\n              \\\"char_start\\\": 71,\\n              \\\"char_end\\\": 72,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601362\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:499808299\\\"\\n            },\\n            \\\"description\\\": \\\"AZ v m 2  x=W\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 93,\\n              \\\"char_end\\\": 106,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601362\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-681436695\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"2\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 14,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 47,\\n                \\\"char_end\\\": 48,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601362\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:513256652\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-486607980\\\"\\n            },\\n            \\\"name\\\": \\\"D\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\\\",\\n              \\\"char_start\\\": 110,\\n              \\\"char_end\\\": 111,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601473\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1067643941\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"1\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 14,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 114,\\n                \\\"char_end\\\": 115,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601473\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1599769952\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:812880442\\\"\\n            },\\n            \\\"name\\\": \\\"AZ\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\\\",\\n              \\\"char_start\\\": 151,\\n              \\\"char_end\\\": 153,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601573\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1628876281\\\"\\n            },\\n            \\\"description\\\": \\\"v i x  - Gamma    M=\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 128,\\n              \\\"char_end\\\": 148,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601573\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1123702885\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1832677529\\\"\\n            },\\n            \\\"name\\\": \\\"DT Total  ry\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 8,\\n              \\\"surrounding_passage\\\": \\\"dI x v x x x x Beta Beta + Micro v v 1 , m i x v 2 , m i x DT Total 1 x = W , a , D Total + m = PZ , AZ v m 2 x = W , a , D = 1 - Sigma x v i x - Gamma M = PZ , AZ v m ( 7 ) dI x R x x x + Micro R i x R ( 8) DT Total ry = 1 - Sigma x Beta v i x y =x - gamma .\\\",\\n              \\\"char_start\\\": 195,\\n              \\\"char_end\\\": 207,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601673\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1908242220\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"1\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 14,\\n                \\\"block\\\": 8,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 211,\\n                \\\"char_end\\\": 212,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601673\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1421467959\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2073168936\\\"\\n            },\\n            \\\"name\\\": \\\"x RY Beta\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 9,\\n              \\\"surrounding_passage\\\": \\\"Y =x - Gamma dAX x x x x x x i x Beta = Sigma v1 + Beta v 1 v 2 DT Total ( CID :29 ) + Sigma ( s + SVR ) ( CID :31 ) ( CID :30 ) x = W , A , D v ( CID :31 ) ( CID :30 ) x = W , a , Dftbeta V2ffI x Total ( CID :29 ) - Ftomega1 + Gamma + microffAX ( 9 ) dAX R x x x RY Beta = Sigma R i x R ( 10 ) DT Total ( CID :31 ) y =x - ( CID :30 ) Gamma + Micro ( CID :29 ) AX .\\\",\\n              \\\"char_start\\\": 225,\\n              \\\"char_end\\\": 234,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601773\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:725759874\\\"\\n            },\\n            \\\"description\\\": \\\"x x RY\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 9,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 223,\\n              \\\"char_end\\\": 229,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601773\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-502448825\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1599136411\\\"\\n            },\\n            \\\"name\\\": \\\"CID\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 9,\\n              \\\"surrounding_passage\\\": \\\"Y =x - Gamma dAX x x x x x x i x Beta = Sigma v1 + Beta v 1 v 2 DT Total ( CID :29 ) + Sigma ( s + SVR ) ( CID :31 ) ( CID :30 ) x = W , A , D v ( CID :31 ) ( CID :30 ) x = W , a , Dftbeta V2ffI x Total ( CID :29 ) - Ftomega1 + Gamma + microffAX ( 9 ) dAX R x x x RY Beta = Sigma R i x R ( 10 ) DT Total ( CID :31 ) y =x - ( CID :30 ) Gamma + Micro ( CID :29 ) AX .\\\",\\n              \\\"char_start\\\": 138,\\n              \\\"char_end\\\": 141,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601871\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:719080638\\\"\\n            },\\n            \\\"description\\\": \\\"Dftbeta V2ffI\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 9,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 152,\\n              \\\"char_end\\\": 165,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601871\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-245957849\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:280540233\\\"\\n            },\\n            \\\"name\\\": \\\"V2ffI\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 9,\\n              \\\"surrounding_passage\\\": \\\"Y =x - Gamma dAX x x x x x x i x Beta = Sigma v1 + Beta v 1 v 2 DT Total ( CID :29 ) + Sigma ( s + SVR ) ( CID :31 ) ( CID :30 ) x = W , A , D v ( CID :31 ) ( CID :30 ) x = W , a , Dftbeta V2ffI x Total ( CID :29 ) - Ftomega1 + Gamma + microffAX ( 9 ) dAX R x x x RY Beta = Sigma R i x R ( 10 ) DT Total ( CID :31 ) y =x - ( CID :30 ) Gamma + Micro ( CID :29 ) AX .\\\",\\n              \\\"char_start\\\": 160,\\n              \\\"char_end\\\": 165,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601959\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2030978223\\\"\\n            },\\n            \\\"description\\\": \\\"Dftbeta\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 14,\\n              \\\"block\\\": 9,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 152,\\n              \\\"char_end\\\": 159,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601959\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:1346749703\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-405996026\\\"\\n            },\\n            \\\"name\\\": \\\"lambda\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 5,\\n              \\\"surrounding_passage\\\": \\\"As the number of COVID-19 rose , on March 23 2020 the Ontario government began a number of public health safety measures , which varied in severity over time , including stay-at-home orders , workplace safety measures , restrictions on public events and social gatherings , temporary shutdown of selected businesses , and mandatory mask wearing .\\\\nThese NPI reduce the transmissivity of COVID-19 , and are represented by scaling all betaX 's and betaX V , M 's simultaneously by a NPI severity index lambda , where 0 < = lambda < = 1 .\\\\nThe time-varying function lambda is chosen in part based on Ontario COVID-19 lockdown timeline and Google mobility data , and in part to fit the predicted new case numbers against provincial data available prior to July 2021 ; the values of lambda for 2020-2021 are shown in Fig.S1 .\\\",\\n              \\\"char_start\\\": 521,\\n              \\\"char_end\\\": 527,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602855\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [],\\n        \\\"value_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:464742218\\\"\\n            },\\n            \\\"value\\\": {\\n              \\\"amount\\\": \\\"1\\\",\\n              \\\"grounding\\\": [],\\n              \\\"extraction_source\\\": {\\n                \\\"page\\\": 15,\\n                \\\"block\\\": 5,\\n                \\\"surrounding_passage\\\": null,\\n                \\\"char_start\\\": 531,\\n                \\\"char_end\\\": 532,\\n                \\\"document_reference\\\": {\\n                  \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n                }\\n              }\\n            },\\n            \\\"units\\\": null,\\n            \\\"type\\\": null,\\n            \\\"bounds\\\": null,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602855\\\"\\n            }\\n          }\\n        ],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1566681075\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1414919006\\\"\\n            },\\n            \\\"name\\\": \\\"lambda\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 5,\\n              \\\"surrounding_passage\\\": \\\"As the number of COVID-19 rose , on March 23 2020 the Ontario government began a number of public health safety measures , which varied in severity over time , including stay-at-home orders , workplace safety measures , restrictions on public events and social gatherings , temporary shutdown of selected businesses , and mandatory mask wearing .\\\\nThese NPI reduce the transmissivity of COVID-19 , and are represented by scaling all betaX 's and betaX V , M 's simultaneously by a NPI severity index lambda , where 0 < = lambda < = 1 .\\\\nThe time-varying function lambda is chosen in part based on Ontario COVID-19 lockdown timeline and Google mobility data , and in part to fit the predicted new case numbers against provincial data available prior to July 2021 ; the values of lambda for 2020-2021 are shown in Fig.S1 .\\\",\\n              \\\"char_start\\\": 502,\\n              \\\"char_end\\\": 508,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602954\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1219973510\\\"\\n            },\\n            \\\"description\\\": \\\"severity index\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"Breteau Index\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000311\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.808208703994751,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602978\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 5,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 487,\\n              \\\"char_end\\\": 501,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602954\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-972044033\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1609199231\\\"\\n            },\\n            \\\"name\\\": \\\"lambda\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 5,\\n              \\\"surrounding_passage\\\": \\\"These NPI reduce the transmissivity of COVID-19 , and are represented by scaling all betaX 's and betaX V , M 's simultaneously by a NPI severity index lambda , where 0 < = lambda < = 1 .\\\\nThe time-varying function lambda is chosen in part based on Ontario COVID-19 lockdown timeline and Google mobility data , and in part to fit the predicted new case numbers against provincial data available prior to July 2021 ; the values of lambda for 2020-2021 are shown in Fig.S1 .\\\",\\n              \\\"char_start\\\": 560,\\n              \\\"char_end\\\": 566,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603050\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1560584713\\\"\\n            },\\n            \\\"description\\\": \\\"time-varying function\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"seasonal function parameter\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000273\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8261008858680725,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603077\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 15,\\n              \\\"block\\\": 5,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 538,\\n              \\\"char_end\\\": 559,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603050\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:431433590\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1166198558\\\"\\n            },\\n            \\\"name\\\": \\\"A.T.L\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": \\\"Author contributions conceptualization , A.T.L .\\\\nand M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\\\nand M.S .; writing - - original draft preparation , A.T.L .; writing - - review and editing , M.S. and A.T.L .; visualization , A.T.L .; project administration and funding acquisition , A.T.L .\\\",\\n              \\\"char_start\\\": 130,\\n              \\\"char_end\\\": 135,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603273\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1180241410\\\"\\n            },\\n            \\\"description\\\": \\\"M.S.; methodology\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 51,\\n              \\\"char_end\\\": 68,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603273\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:622838043\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1166198558\\\"\\n            },\\n            \\\"name\\\": \\\"A.T.L\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": \\\"Author contributions conceptualization , A.T.L .\\\\nand M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\\\nand M.S .; writing - - original draft preparation , A.T.L .; writing - - review and editing , M.S. and A.T.L .; visualization , A.T.L .; project administration and funding acquisition , A.T.L .\\\",\\n              \\\"char_start\\\": 130,\\n              \\\"char_end\\\": 135,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603366\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-798456128\\\"\\n            },\\n            \\\"description\\\": \\\"A.T.L.; data curation\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"data parsing\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000566\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8749537467956543,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603381\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 107,\\n              \\\"char_end\\\": 128,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603366\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-303100857\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-1166198558\\\"\\n            },\\n            \\\"name\\\": \\\"A.T.L\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": \\\"Author contributions conceptualization , A.T.L .\\\\nand M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\\\nand M.S .; writing - - original draft preparation , A.T.L .; writing - - review and editing , M.S. and A.T.L .; visualization , A.T.L .; project administration and funding acquisition , A.T.L .\\\",\\n              \\\"char_start\\\": 130,\\n              \\\"char_end\\\": 135,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603461\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-798456128\\\"\\n            },\\n            \\\"description\\\": \\\"A.T.L.; data curation\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"data parsing\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000566\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.8749537467956543,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603476\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 107,\\n              \\\"char_end\\\": 128,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603461\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-1713386033\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:446109225\\\"\\n            },\\n            \\\"name\\\": \\\"M.S.\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": \\\"and M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\\\nand M.S .; writing - - original draft preparation , A.T.L .; writing - - review and editing , M.S. and A.T.L .; visualization , A.T.L .; project administration and funding acquisition , A.T.L .\\\\nAll authors have read and agreed to the published version of the manuscript .\\\",\\n              \\\"char_start\\\": 221,\\n              \\\"char_end\\\": 225,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603553\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1503915347\\\"\\n            },\\n            \\\"description\\\": \\\"editing\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 212,\\n              \\\"char_end\\\": 219,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603553\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-627640234\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1856363209\\\"\\n            },\\n            \\\"name\\\": \\\"A.T.L\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": \\\"and M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\\\nand M.S .; writing - - original draft preparation , A.T.L .; writing - - review and editing , M.S. and A.T.L .; visualization , A.T.L .; project administration and funding acquisition , A.T.L .\\\\nAll authors have read and agreed to the published version of the manuscript .\\\",\\n              \\\"char_start\\\": 309,\\n              \\\"char_end\\\": 314,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603682\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2070179544\\\"\\n            },\\n            \\\"description\\\": \\\"funding acquisition\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 288,\\n              \\\"char_end\\\": 307,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603682\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"E:-1848496646\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-229313771\\\"\\n            },\\n            \\\"name\\\": \\\"A.T.L\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": \\\"Author contributions conceptualization , A.T.L .\\\\nand M.S .; methodology , validation , analysis , and resources , A.T.L .; data curation , A.T.L .\\\",\\n              \\\"char_start\\\": 40,\\n              \\\"char_end\\\": 45,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603775\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-982351631\\\"\\n            },\\n            \\\"description\\\": \\\"Author contributions conceptualization\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 3,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 0,\\n              \\\"char_end\\\": 38,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603775\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-62286782\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1130222314\\\"\\n            },\\n            \\\"name\\\": \\\"s\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"Open Access This article is licensed under a Creative Commons Attribution 4.0 International License , which permits use , sharing , adaptation , distribution and reproduction in any medium or format , as long as you give appropriate credit to the original author ( s ) and the source , provide a link to the Creative Commons licence , and indicate if changes were made .\\\\nThe images or other third party material in this article are included in the article 's Creative Commons licence , unless indicated otherwise in a credit line to the material .\\\",\\n              \\\"char_start\\\": 259,\\n              \\\"char_end\\\": 260,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603874\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:-2107321472\\\"\\n            },\\n            \\\"description\\\": \\\"original author\\\",\\n            \\\"grounding\\\": [\\n              {\\n                \\\"grounding_text\\\": \\\"author list\\\",\\n                \\\"grounding_id\\\": \\\"apollosv:00000329\\\",\\n                \\\"source\\\": [],\\n                \\\"score\\\": 0.7829368710517883,\\n                \\\"provenance\\\": {\\n                  \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n                  \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603899\\\"\\n                }\\n              }\\n            ],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 243,\\n              \\\"char_end\\\": 258,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603874\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [\\n          {\\n            \\\"grounding_text\\\": \\\"Meruvax I\\\",\\n            \\\"grounding_id\\\": \\\"vo:0003109\\\",\\n            \\\"source\\\": [],\\n            \\\"score\\\": 0.7847759127616882,\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"SKEMA-TR-Embedding\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603882\\\"\\n            }\\n          }\\n        ],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"anchored_entity\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"R:-561348916\\\"\\n        },\\n        \\\"mentions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:644227346\\\"\\n            },\\n            \\\"name\\\": \\\"mmons\\\",\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": \\\"If material is not included in the article 's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use , you will need to obtain permission directly from the copyright holder .\\\\nTo view a copy of this licence , visit http :// creat iveco mmons .\\\\norg / licen ses / by / 4 .\\\",\\n              \\\"char_start\\\": 827,\\n              \\\"char_end\\\": 832,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603933\\\"\\n            }\\n          }\\n        ],\\n        \\\"text_descriptions\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"T:1629415388\\\"\\n            },\\n            \\\"description\\\": \\\"creat iveco\\\",\\n            \\\"grounding\\\": [],\\n            \\\"extraction_source\\\": {\\n              \\\"page\\\": 16,\\n              \\\"block\\\": 7,\\n              \\\"surrounding_passage\\\": null,\\n              \\\"char_start\\\": 815,\\n              \\\"char_end\\\": 826,\\n              \\\"document_reference\\\": {\\n                \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n              }\\n            },\\n            \\\"provenance\\\": {\\n              \\\"method\\\": \\\"Skema TR Pipeline rules\\\",\\n              \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603933\\\"\\n            }\\n          }\\n        ],\\n        \\\"value_descriptions\\\": [],\\n        \\\"groundings\\\": [],\\n        \\\"data_columns\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"document_collection\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"documents\\\": [\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"s41598-022-06159-x (1).pdf\\\"\\n            },\\n            \\\"source_file\\\": \\\"s41598-022-06159-x (1).pdf\\\",\\n            \\\"doi\\\": \\\"\\\"\\n          },\\n          {\\n            \\\"id\\\": {\\n              \\\"id\\\": \\\"1\\\"\\n            },\\n            \\\"source_file\\\": \\\"44b9158cad9a3098e5272cf906ef88a2__filename\\\",\\n            \\\"doi\\\": \\\"\\\"\\n          }\\n        ]\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1687473227\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585404\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1687473227\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585437\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1687473227\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585448\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1099021099\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585523\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1099021099\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585536\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1012021369\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585599\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1012021369\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585611\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1111183205321914260\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1012021369\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"World Health Organization\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585622\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-779055136\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585686\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-779055136\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585698\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1111183205321914260\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-779055136\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"World Health Organization\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585707\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-779055136\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585717\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-657071160\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585872\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-657071160\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585882\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-657071160\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"April 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585892\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-657071160\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"3 June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585906\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-657071160\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"July 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585921\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1574680068\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"July 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585982\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"7595783505243143026\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1574680068\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"WHO\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.585995\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5177116372746314001\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1574680068\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"North America\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586004\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2730056309469988308\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1574680068\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Oxford-AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586017\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-627600896\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586079\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-627600896\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586090\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1111183205321914260\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-627600896\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"World Health Organization\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586101\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-627600896\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586112\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-627600896\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"April 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586122\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1894470453\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586228\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:183719204\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"3 June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586294\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:183719204\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"July 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586305\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1111183205321914260\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-320992724\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"World Health Organization\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586367\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-320992724\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586377\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-320992724\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586388\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-320992724\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"April 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586397\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-320992724\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"3 June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586407\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-380273488\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"3 June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586466\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-380273488\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"July 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586477\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"7595783505243143026\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-380273488\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"WHO\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.586487\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-308499566\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587189\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-308499566\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"December 2020\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587203\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-308499566\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587213\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-308499566\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"July 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587228\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-308499566\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587238\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1672592981\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587297\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1672592981\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"December 2020\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587307\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1672592981\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587317\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-3540222956639707560\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1672592981\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"COVID\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587327\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1676757554\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587401\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1676757554\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"December 2020\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587414\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1676757554\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587425\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1511085452\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587480\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1511085452\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"December 2020\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587491\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1511085452\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587501\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-3540222956639707560\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1511085452\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"COVID\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587552\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-303059524\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"December 2020\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587615\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-303059524\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587625\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-303059524\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587635\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:527532433\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587689\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-3540222956639707560\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:527532433\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"COVID\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587702\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:527532433\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587713\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:527532433\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"December 2020\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587722\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:527532433\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587731\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1952535670\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587792\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1952535670\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"December 2020\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587801\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1952535670\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587811\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1952535670\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587822\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-3540222956639707560\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1952535670\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"COVID\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587831\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1550505153\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587898\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-3540222956639707560\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1550505153\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"COVID\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587908\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1550505153\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587918\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1550505153\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"December 2020\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587928\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1550505153\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.587939\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:44342288\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588003\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:44342288\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588013\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1960087092\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588076\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1960087092\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588086\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1580628517\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588590\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1580628517\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588602\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1580628517\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588612\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1846480138\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588672\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1846480138\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588719\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1846480138\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588730\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1532099766\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588790\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1532099766\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588806\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1532099766\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588817\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1960993140\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588870\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1960993140\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588880\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:332339292\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.588986\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-302164219\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589038\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1790727618\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589096\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1790727618\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589109\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1790727618\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589119\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:615518326\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589179\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:615518326\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589189\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:615518326\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589200\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1662231047\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.589416\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1430855057\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590130\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:2134716306\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590190\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1308192125\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590244\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:795884335\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590348\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1041191212\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.590407\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-535082164\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591253\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1637552708\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591313\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1637552708\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591324\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1637552708\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591335\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1637552708\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591344\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1637552708\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591356\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1830320991\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591416\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1830320991\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2022\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591427\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1864118410\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591488\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1864118410\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591498\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1864118410\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591511\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1864118410\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591520\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1864118410\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591530\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1461588612\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591590\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1956562617\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591687\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1164908205\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591749\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1164908205\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591759\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1164908205\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591771\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1164908205\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591781\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1164908205\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591794\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1822299949\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591853\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1822299949\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591864\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1822299949\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591874\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1822299949\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591883\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1839289179\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591939\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1839289179\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591951\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1839289179\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591961\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1839289179\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.591970\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:390122022\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592038\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:390122022\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592049\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:390122022\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592058\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:390122022\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592069\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1137065363\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592128\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1137065363\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592140\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1137065363\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592151\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1137065363\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592161\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1311518691\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592220\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1311518691\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592231\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1311518691\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592241\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1311518691\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592251\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1669100175\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592310\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1669100175\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592320\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1669100175\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592366\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1669100175\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"June 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592376\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:786071264\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592780\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1015129557\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592840\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:847069629\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592895\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1957664339\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.592950\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:428284098\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593003\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:2008329411\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593059\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:2008329411\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593069\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-491568125\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593121\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:860821778\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593191\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1468322701\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593246\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1468322701\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593258\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"9196459189987031493\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1468322701\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"which\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593267\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1468322701\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593277\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1468322701\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593289\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1468322701\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2022\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593299\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:211817700\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593359\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:211817700\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593368\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:211817700\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593378\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-963867388\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593476\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-963867388\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593488\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-963867388\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593498\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:514068618\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593569\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:514068618\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593580\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:514068618\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.593589\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:34958215\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594218\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:34958215\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594231\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1290099843\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594290\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1659964566\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594347\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1659964566\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594357\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1659964566\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594366\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-598133204\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594691\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-598133204\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594702\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-77644022\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594763\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-77644022\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594774\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1160080482\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594833\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1160080482\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594845\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-752128713\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594904\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-752128713\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.594914\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-629925471\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595013\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-629925471\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595023\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1084065351\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595082\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1084065351\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595094\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1751229178\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595151\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1751229178\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595163\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1086028280\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595222\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1086028280\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595232\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1225515740\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595291\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1225515740\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595302\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:2043881519\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595523\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6656807016960893394\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1942444907\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595589\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1942444907\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.595600\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:604822229\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596023\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:604822229\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596036\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:604822229\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596046\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:604822229\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596057\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:604822229\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596066\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1847156755\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596118\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1847156755\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596130\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1847156755\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596141\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1847156755\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596150\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:491930989\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596206\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1283479641\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596259\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1291825073\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596311\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1542387382\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596367\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1477307630\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596428\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:346088061\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596713\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:346088061\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596725\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:346088061\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596736\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:346088061\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596747\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:346088061\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596764\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1153919973\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596823\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1153919973\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596833\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1969515142\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596921\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1969515142\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596932\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1220406750\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596987\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1220406750\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.596997\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1422446413\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597047\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1422446413\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597058\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1754528603\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597116\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1930130592\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597331\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:716487493\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597425\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1780919070\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597480\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:2056695833\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597539\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1341709601\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597596\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:825197191\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597651\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:825197191\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597663\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6143938794794778449\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-58983686\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"VOC\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597853\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-5756132935071079135\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-58983686\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"SVR\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.597865\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:611615583\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598259\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:814952678\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598316\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:576858469\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598377\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1695453225\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598436\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-2089543753\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598492\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-146210857\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598545\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-230919232\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598622\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1759113608\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598764\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1759113608\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598777\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1759113608\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598787\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1759113608\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598798\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-868577489\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598857\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-868577489\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598867\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-868577489\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598876\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-868577489\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598889\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-869823682\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598950\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-869823682\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598961\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-869823682\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598972\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-869823682\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.598982\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1297286117\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599038\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1297286117\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599049\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1297286117\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599060\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1297286117\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599069\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-438207695\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599122\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-438207695\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599133\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-438207695\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599142\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-438207695\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599151\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:83314069\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599201\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:83314069\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599214\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:83314069\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599227\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:83314069\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599236\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-634538974\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599295\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-634538974\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599304\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-634538974\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599313\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-634538974\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599323\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1993378382\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599382\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1993378382\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599394\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1993378382\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599437\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1993378382\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599447\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:800289603\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599501\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:800289603\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599511\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:800289603\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599525\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:800289603\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599537\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1558390445\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599588\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1558390445\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599599\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1558390445\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599609\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1558390445\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599618\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-2075507652\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599679\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-2075507652\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599689\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-2075507652\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599700\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-2075507652\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599710\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:721581088\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599761\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:721581088\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599772\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:721581088\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599781\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:721581088\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599790\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1895430149\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599850\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1895430149\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599860\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1895430149\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599869\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1895430149\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599879\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1776301662\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599935\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1776301662\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599946\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1776301662\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599956\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-2902571932492443446\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1776301662\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Pfizer\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.599966\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1876321384\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600103\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1876321384\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2022\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600114\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"9196459189987031493\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1876321384\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"which\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600124\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1876321384\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600134\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1876321384\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600147\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:868023049\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600238\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:868023049\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"March 2022\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600248\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"9196459189987031493\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:868023049\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"which\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600260\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:868023049\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600271\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:868023049\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600280\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-739144679\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600442\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"9196459189987031493\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-795860774\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"which\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600682\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-795860774\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600694\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-795860774\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600704\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-795860774\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600713\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"9196459189987031493\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1959808490\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"which\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600779\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1959808490\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600790\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4465670777268672531\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:1959808490\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AstraZeneca\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600799\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"5649036413160770716\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1741730311\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Neos\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600915\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1741730311\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600926\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1741730311\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600938\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1995693754\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.600992\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1995693754\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601006\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1128287073\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601178\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1128287073\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601188\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1128287073\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601197\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1128287073\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601208\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1128287073\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601221\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-680787754\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601272\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-680787754\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601282\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-680787754\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601293\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-680787754\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601304\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-680787754\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601349\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1717504424\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601415\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1717504424\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601429\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1717504424\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601440\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1717504424\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601449\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1717504424\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601460\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:513256652\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601517\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:513256652\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601530\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:513256652\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601540\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:513256652\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601549\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:513256652\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601560\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1599769952\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601616\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1599769952\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601627\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1599769952\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601637\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1599769952\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601646\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1599769952\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601656\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1123702885\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601711\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1123702885\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601721\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1123702885\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601732\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1123702885\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601741\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1123702885\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601752\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1421467959\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601817\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1421467959\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601828\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1421467959\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601837\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1421467959\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601849\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1421467959\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601858\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-502448825\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601903\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-502448825\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601914\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-502448825\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601925\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-502448825\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601935\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-502448825\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601944\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-7955947886743420174\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-245957849\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"x\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601986\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-942088709085686913\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-245957849\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Micro\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.601997\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"682249285375859648\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-245957849\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"PZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602008\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6335243503299725048\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-245957849\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"AZ\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602778\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1952131805326656659\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-245957849\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"D\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602789\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1346749703\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602907\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1346749703\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602918\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"714152609938435503\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1346749703\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Google\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602928\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:1346749703\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"July 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.602939\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1566681075\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603001\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1566681075\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603013\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"714152609938435503\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1566681075\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Google\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603025\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1566681075\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"July 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603036\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-4298961581852288150\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-972044033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Ontario\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603096\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"1338862567378819490\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-972044033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"NPI\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603107\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"714152609938435503\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-972044033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Google\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603116\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-853588310126217076\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-972044033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Natural Sciences and Engineering Research Council of Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603127\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6488996057273214108\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-972044033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Nserc Discovery Award\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603136\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6053394954652950638\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-972044033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada 150 Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603147\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1685434613467854918\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-972044033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canadian Institutes of Health Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603157\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"3185139421556535230\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-972044033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Immunity Task Force\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603168\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"8129740313160126952\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-972044033\\\"\\n          }\\n        ],\\n        \\\"location\\\": null,\\n        \\\"time\\\": {\\n          \\\"datetime\\\": \\\"July 2021\\\",\\n          \\\"start_datetime\\\": null,\\n          \\\"end_datetime\\\": null,\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603178\\\"\\n          },\\n          \\\"grounding\\\": null\\n        }\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-853588310126217076\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:431433590\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Natural Sciences and Engineering Research Council of Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603305\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6488996057273214108\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:431433590\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Nserc Discovery Award\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603316\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6053394954652950638\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:431433590\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada 150 Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603325\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1685434613467854918\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:431433590\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canadian Institutes of Health Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603335\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"3185139421556535230\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:431433590\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Immunity Task Force\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603344\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-853588310126217076\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:622838043\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Natural Sciences and Engineering Research Council of Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603405\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6488996057273214108\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:622838043\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Nserc Discovery Award\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603417\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6053394954652950638\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:622838043\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada 150 Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603427\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1685434613467854918\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:622838043\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canadian Institutes of Health Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603436\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"3185139421556535230\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:622838043\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Immunity Task Force\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603447\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-853588310126217076\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-303100857\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Natural Sciences and Engineering Research Council of Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603497\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6488996057273214108\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-303100857\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Nserc Discovery Award\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603507\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6053394954652950638\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-303100857\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada 150 Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603519\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1685434613467854918\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-303100857\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canadian Institutes of Health Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603528\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"3185139421556535230\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-303100857\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Immunity Task Force\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603539\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-853588310126217076\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1713386033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Natural Sciences and Engineering Research Council of Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603623\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6488996057273214108\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1713386033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Nserc Discovery Award\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603637\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6053394954652950638\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1713386033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada 150 Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603646\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1685434613467854918\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1713386033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canadian Institutes of Health Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603657\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"3185139421556535230\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-1713386033\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Immunity Task Force\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603667\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-853588310126217076\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-627640234\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Natural Sciences and Engineering Research Council of Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603722\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6488996057273214108\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-627640234\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Nserc Discovery Award\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603733\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6053394954652950638\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-627640234\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada 150 Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603743\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1685434613467854918\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-627640234\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canadian Institutes of Health Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603752\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"3185139421556535230\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-627640234\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Immunity Task Force\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603761\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-853588310126217076\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1848496646\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Natural Sciences and Engineering Research Council of Canada\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603812\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-6488996057273214108\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1848496646\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Nserc Discovery Award\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603822\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"6053394954652950638\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1848496646\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canada 150 Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603832\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"-1685434613467854918\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1848496646\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Canadian Institutes of Health Research\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603842\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"3185139421556535230\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"E:-1848496646\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Immunity Task Force\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603851\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    },\\n    {\\n      \\\"type\\\": \\\"scenario_context\\\",\\n      \\\"amr_element_id\\\": null,\\n      \\\"payload\\\": {\\n        \\\"id\\\": {\\n          \\\"id\\\": \\\"7814043800575125331\\\"\\n        },\\n        \\\"extractions\\\": [\\n          {\\n            \\\"id\\\": \\\"R:-62286782\\\"\\n          }\\n        ],\\n        \\\"location\\\": {\\n          \\\"location\\\": \\\"Springer Nature\\\",\\n          \\\"provenance\\\": {\\n            \\\"method\\\": \\\"SKEMA-TR-Context-1.0\\\",\\n            \\\"timestamp\\\": \\\"2023-10-29T20:32:10.603918\\\"\\n          },\\n          \\\"grounding\\\": null,\\n          \\\"extraction_source\\\": null\\n        },\\n        \\\"time\\\": null\\n      }\\n    }\\n  ]\\n}\", \"width\": \"100%\", \"height\": \"600px\"}\n",
       "                    \n",
       "                            // postMessage to send the data to the iframe\n",
       "                            console.log('sender', window.location.origin)\n",
       "                            \n",
       "                            iframeWindow.postMessage(data,'*');\n",
       "                        };\n",
       "\n",
       "                            console.log('setting iframe content.')\n",
       "                            let viewer_html = atob(\"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\");\n",
       "                            let iframe = document.getElementById(\"jsonviewer_mbSVczAp\");\n",
       "                            let iframeDocument = iframe.contentDocument || iframe.contentWindow.document;\n",
       "\n",
       "                            iframeDocument.open();\n",
       "                            iframeDocument.write(viewer_html);\n",
       "                            iframeDocument.close();\n",
       "                        }\n",
       "                    init();\n",
       "                </script>\n",
       "            </div>\n",
       "            "
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "display_json(response.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "edc61e4e",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "mitaskem",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
